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ABSTRACT
In recent years, the understanding of the structure and functions of biological 
macromoleculcs has advanced rapidly, the result of which is a better mechanistic 
understanding of many biological processes. As an outgrowth of this understanding, 
organic molecules that react with biological macromolecules (DNA) or adopt 
conformations responsible for specific functions in biological macromolecules (peptides 
and proteins) have been synthesized and computational modeling studies performed. 
Polycyclic aromatic hydrocarbons (PAHs) and p-peptides are among synthetic organic 
compounds known to interact with natural biological macromolecules. This interaction 
may affect the specific biological functions of the biomacromolecules. A variety of 
synthetic methodologies have been employed in the synthesis of benzo[c]phenanthrene 
derivatives, single electron oxidation nucleoside adducts and deoxynucleoside derivatives 
(Part 1). In Part 2 heterogeneous backbone oligomers containing the p-amino acid, trans- 
2-aminocyclohexanecarboxylic acid (ACHC). and a-amino acids Ala, Phe, Val, Lys, and 
Tyr in an alternating sequence have been synthesized. Computational modeling studies 
have been applied in studying the diastereoselectivity of reaction intermediates in the 
PAH syntheses (Part 1), the interaction between the organic compounds and 
biomacromoleculcs (P-peptides with proteins Fos and Jun, Part 2), and the 
conformational preference (conformations of a/p-peptides, Part 2). Computational 
modeling based on molecular and quantum mechanical techniques were applied to 
complement the syntheses in Parts 1 and 2.
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GENERAL INTRODUCTION TO PARTS ONE AND TWO
The majority of the work presented in this dissertation is synthetic, with 
computational modeling studies performed to better understand the kinds of organic 
molecules that react with biological macromolccules and their conformations.
The synthesis in Part I involves PAHs and nucleoside derivatives. Members of 
the environmentally ubiquitous class of polycyclic aromatic hydrocarbons are thought to 
undergo metabolic activation to carcinogens either via oxidative metabolism to diol 
epoxides or through radical cations. Both species have been shown to cause DNA 
alkylation through covalent modification of DNA. Diastereoseleclive synthesis of the 
diol epoxide and some derivatives of bcn/o[ciphenanthrene have been developed. Single 
electron oxidation of PAHs produces radical cations that then react with a variety of 
nucleophilic sites in deoxyadenosine and deoxyguanosine producing adducted 
nuclcobascs and nucleosides. For the first time, stable adducts at the cxocyclic amino 
groups of nucleosides produced by single electron oxidation of PAHs have been 
synthesized via a palladium-catalyzed carbon-nitrogen bond formation. A convenient 
and concise strategy for the synthesis of nucleoside derivatives has also been 
demonstrated.
The synthesis in Part 2 involves heterogeneous backbone oligomers. 
Heterogeneous oligomers arc synthetic oligomers containing both a- and P-amino acids, 
capable of mimicking the secondary structures and folding arrangement of natural protein 
molecules.
I
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A variety of synthetic strategies have been employed for coupling a- and P-amino 
acids, in the synthesis of heterogeneous oligomers, making use of Z-, Boc- or Fmoc- 
protcctcd amino groups, benzyl esters for the acid terminus and, carbodiimidc methods 
for the coupling steps. A simple, practical, and scalable synthetic approach has been 
applied in the synthesis of p-amino acid monomers in high enantiomeric purity, needed 
for coupling with commercially available a-amino acids in the synthesis of heterogeneous 
oligomers. For the first lime, heterogeneous oligomers containing a- and P-amino acids 
in an alternating sequence have been synthesized by both solid phase and solution phase 
methodologies. Oligomers have been fully characterized and preliminary conformational 
analysis performed indicating some ordered conformation in solution.
Both synthetic projects (Parts 1 and 2) are complemented with computational 
modeling. In Part 1, computational modeling studies based on the use of molecular 
mechanics (MM) and quantum mechanics (QM) calculations to evaluate the 
diastereoselectivity of synthetic intermediates have been performed. Computationally, 
the diastereoselectivity of some synthetic steps encountered in the case of 
bcnzo[c]phcnanthrene and reported for the case of benzo[a]pyrene have been evaluated. 
In Part 2, conformational search methods based on Monte Carlo (MC) and torsion driving 
have been applied to evaluate molecular conformations and to study the interactions 
between a- and P-peptide helices held by flexible linkers. The sections that follow 
describe some of the general methods used in modeling.
General Methods in Molecular Modeling
Computational chemistry generally attempts to predict the properties of molecules 
without much experimental information. Computational chemistry has been growing for
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more than 40 years, and in recent times it is commonly been used in collaboration with 
experiment in most research laboratories. The knowledge of the preferred geometry of a 
molecule and of its corresponding energy is of critical importance. From this information 
one may infer the relation between structure and activity. As the cost of computers and 
computer time drops, the simulation of molecules and their properties becomes more 
competitive with experimentation.
The most stable conformation of a molecule can be determined by model building 
the desired structure and optimizing the structure either (a) classically or (b) quantum 
mechanically by minimization using first- or second- derivative techniques. Different 
conformations can be modeled. Combining molecular modeling techniques with 
experimental information provides a powerful tool for research purposes. Determining 
the difference in stability between two isomers requires finding the lowest energy 
conformation (global minimum) of each isomer. Molecular mechanics (MM) can be 
used for finding the low-energy conformations, while quantum mechanics (QM) can be 
used to assess the relative energies and equilibrium geometries for the conformers.1 It 
becomes increasingly difficult, however, to model large flexible molecules because of the 
large number of degrees of freedom. Two pertinent issues are the determination of the 
most stable conformation (global minimum) and the location of other minima on the 
potential energy surface, otherwise known as the multiple minima problem.2 In molecular 
modeling studies, most of the quantities of interest, such as conformations, equilibrium 
geometries and heats of reaction, come from the construction of a potential energy 
surface, which is a plot of the energy against the reaction coordinate (Figure 1).'
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Figure 1 One dimensional potential energy surface.
On the potential energy surface, the energy minima and maxima are collectively 
referred to as stationary points. An energy minimum is referred to as a local minimum 
and corresponds to a stable molecule although some unstable intermediates may be 
situated at a local minimum. The lowest energy local minimum is referred to as the 
global minimum. Random search methods such as the Monte Carlo (MC) 
conformational search are able to facilitate easy treatment of systems with large numbers 
of degrees of freedom."7
Molecular Mechanics
Molecular mechanics (MM) is based on a classical approach to calculate the 
energy of a system.8 MM seeks to achieve a reasonably good description of the 
conformational behavior of molecules with a relatively simple mathematical model. MM 
treats a molecule as a set of charged point masses (atoms) connected together with 
springs. MM is used to assess individual molecular structures, the number of minima and
ced with permission of the copyright owner. Further reproduction prohibited without permission.
5
the energy differences between these minima. MM calculates the total energy of a 
molecule by using an empirical function which sums various individual energy terms.8 
The energy terms of a particular conformation of a molecule include bond stretching, 
valence angle bending, torsion, and nonbond interaction terms, such as van der Waals and 
electrostatic interactions (equation 1).
total #l>t total tangles total Mtnnhm.% nonbondrd atoms
Eim l= x  F"",r* + 2 E^  + + X  2 Er ~ “  (i)
I I I i 1
The energy components are broken down into bonded and non-bonded energies as 
described below. Most of the computational work described in part one of this thesis 
uses the MMFF94 force field,1’ and so the form of this force field will be used to 
exemplify force fields in general. While elegant MM force fields have been and are still 
being developed for the treatment of all elements,8 most of the force fields for the 
treatment of organic molecules have similar general forms, known as the bonded- and 
non-bonded-energy terms.
Bonded Energies
Bonded interactions among atoms arc broken down into two-, three-, and four- 
atom interactions. The bond term (involving two atoms) is referred to as a 1-2 interaction 
term, the angle bending term (involving three atoms) is referred to as a 1-3 interaction 
term, and the torsion term (involving four atoms) is referred to as a 1-4 interaction term. 
The first three summations (Equation 1) represent all the bonds, bond angles and dihedral 
angles of a particular molecule. Generally, classical, all-atom force fields include 
stretching, bending, and torsional interactions. Some force fields may also include the 
effects of interactions between two or more of these components. For example the 
MMFF94 force field includes stretching, bending, torsional and other composite
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interactions (stretch bending and out-of-plane bending interactions).9 These composite 
interactions can give better approximate descriptions of molecular conformations but are 
generally smaller in magnitude than stretches, bends, and torsional effects. The bond 
term is a summation over all the bonds in a structure, with the energy of each bond 
evaluated depending on how far it is distorted from its equilibrium value. The bond 
stretching and valence angle bending terms arc represented in the form of quadratic 
equations.8
(2)
£ w < a) = { * w ( « - « . ) 3 (3)
The bond distance and angle are represented respectively by r  and a  while r0 and do arc 
the equilibrium bond length and angle. The parameters Kanwh and K w  are the stretch 
and bond force constants respectively. The equilibrium bond length and angle are the 
preferred values, and any deviation from this value by compression or expansion leads to 
an energetic penalty. The force constant parameters determine the amount by which the 
energy of a system increases for a given deviation from the ideal value. A good 
approximation for the energetic effects of deviations in the bond length or angle, within 
about 0.10 A or 10 degrees, is provided by these mathematical descriptions.
In practice, torsional parameters are added to the non-bonded terms so as to give a 
more accurate fit to experimental data. Torsional parameters are also key to the utility of 
a force field, and the accuracy of simulations carried with the force field.9 The MMFF949 
force field uses a torsional energy function of the form shown in equation (4).
Elmum = j{V1(l + cosO) + V,J(l-cos2c&) + V',(l + cos3<h)) (4)
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Equation (4) is a threefold representation where 0  is the torsion angle between four 
atoms, while V|, V;, and V3 are constants depending on the atom types (Figure 2).10'"
E= 1 + cos $ b E=1-cos(2<ji)
7~S,
/
/ V , V
A v
-180 -120 -80 0  80  120 100
Angle (•)
c E= 1 -f cos (30)
Figure 2 The one (a)-, two (b)-, and threefold (c) components of the torsional energy 
function.
The last two terms in Equation (4) represent the two- and threefold components of 
the torsional energy (Figure 2 b and c). The twofold energy function forms the largest 
part of the torsional energy functions and describes double bonds. The double bonds 
prefer one of two specific orientations (0 and 180°), and are distorted from having all 
substituents coplanar only with a large increase in energy. The threefold torsional 
expression describes typical interactions between substituents on sp3-sp3 bonds. In this 
case, substituents prefer to assume staggered (±60 or 180°) instead of eclipsed 
orientations. The onefold torsional potential has no exact analogue to a specific 
molecular interaction, but rather modifies the effects of the two- and threefold torsional 
potentials (Figure 2 a).
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Non-bonded Energies
The non-bonded energies of a molecule typically include van der Waals (VDW) 
and coulombic interactions. Some force fields contain a hydrogen bonding component as 
well (e.g. AMBER).,0I> The energy of solvation is not treated as part of the force field, 
but rather solvent is treated as a background continuum at a set dielectric constant.9 A 
continuum solvent treatment, while being less computationally expensive than the use of 
explicit solvent, can still reproduce effects of solvation.1' Generally, nonbonded 
interactions involving van der Waals (VDW) interactions and electrostatic interactions 
are represented as a sum of both energy terms (equation 5).
F — E + E (5)m mbondtd ^ \< 1 W  T  ^ n m U tm b u
The van der Waals interaction between two non-bonded atoms i and j  is defined by a 
Lennard-Jones potential (equation 6).
The nonbonded distance between the atoms is represented by /fy, while A#, By, and £y are 
constants. The (A,/Ry)12 term deals with atom-atom repulsions whereas the (By/Ry)6 
term treats the atom-atom attractions.
The coulombic (electrostatic) interactions take into account the interaction of 
charges. As a result each atom is assigned a partial charge, depending on the charges of 
the atom, and the interaction of these charges can either be attractive or repulsive. The 
electrostatic energy between two atoms i and j  is defined by the equation below (equation
7).
Erl„ 0 . j)  = Of, x ? / )/(* * K,j) (7)
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The nonbonded distance is represented by R,j, the dielectric constant by e, and the atomic 
charges by q, and qr  In MMFF94, the Lennard-Jones potential (equation 6), and the 
Coulombic terms (equation 7) are replaced by fairly complex equations (not shown).9 For 
calculations on larger structures, the nonbond interaction term dominates the computer 
time required for energy evaluation, because the number of nonbonded atom pairs rises 
with the square of the number of atoms 1 ’
Despite all the information that can be generated from molecular mechanics, it 
does not provide any information on the electronic structure and so cannot be used when 
a molecule is not in its ground state. The energies of two different molecules cannot be 
accurately compared using molecular mechanics, because their respective energies are 
built up from different combinations of the individual energy functions. However, 
molecular mechanics can be used to compare the relative energies of molecules with the 
same connectivity, such as enantiomers and diastereomers. Computational techniques 
based on molecular mechanics are most commonly used to compare different 
conformations of a molecule or molecular complex, to determine energetic favorability. 
Description of Force Field (MMFF94)
Many force fields have been designed for different purposes. It is not the goal of 
this thesis to review the various force fields that are available, for excellent reviews exist 
in the literature. However, a brief description of the force field that was used for our 
calculation is presented. The Merck molecular mechanics force field (MMFF94)9 is able 
to quantitatively account for the molecular geometry and conformation of common 
organic systems. The MMFF94 force field was developed based on fitting experimental 
variables to ab initio results for gas-phase molecules, ions, and biomolecular complexes.9
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MMFF94 is a classical, all-atom force field that is generally used for a variety of systems 
and is carefully parameterized for structures and energetics in the gas-phase.u
Quantum Mechanics
The time-independent Schrodinger equation is given as equation 8.15
fTV = E>V (8)
where / /  is the Hamiltonian operator and lF is a many-particlc wavefunction. The 
Schrodinger equation for a many-particle system cannot be solved exactly without the 
introduction of approximations. One such approximation, the Bom-Oppenheimer 
approximation, assumes that the nuclei do not move. The result is the generation of an 
electron-based Schrodinger equation, which is still not solvable for more than one 
electron (equation 9).
tf* * -  = (9)
The Bom Oppenheimcr approximation solves the Schrodinger equation for the 
arrangement of electrons in a molecule moving in the field of fixed nuclei.15 The energy 
of a molecule and the associated wave function, from which other electronic properties 
can he calculated, are generated.
Approximation methods for determining the electronic structure include the 
Hartree-Fock method, which is based on a separation of variables that replaces the many- 
electron wavefunction by a product of one-electron wavefunctions known as spin 
orbitals.16 The Hartree-Fock approximation generates a set of coupled differential 
equations each involving a single electron. Further approximation methods have been 
developed from the Hartree-Fock method such as the linear combination of atomic 
orbitals (LCAO) approximation and the Roothaan-Hall equations.15 More advanced
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approximation methods include Moller-Plesset models.16 An alternative approach to the 
treatment of correlation in many-electron systems is provided by the density functional 
model.17 Density functional models take into account electron correlation in an explicit 
manner.
Two major draw backs of quantum mechanical calculations, compared to 
molecular mechanics, are their limitations to small molecules and the relative 
requirement of additional computer time and money. For more efficiency and accuracy, 
both molecular mechanics and quantum mechanics should be used complementarily. Due 
to the flexible nature of the organic molecules treated herein (Chapter 3), MM and QM 
are combined with a conformational search method, based on Monte Carlo, to address the 
problem of multiple minima.
Description of Semi-empirical Module (AMD
AMI (Austin Model 1) is a parametric quantum mechanical molecular model 
which is based on the neglect of diatomic differential overlap (NDDO) approximation."* 
AMI has been parameterized for the treatment of a wide variety of compounds, including 
those containing boron.10 Dewar el al. demonstrated the superiority of AMI compared to 
other methods in predicting the heats of formation of boron-containing compounds.1'1 The 
geometry and dipole moment calculated by AMI also agreed well with experiment much 
better than results obtained by the ab initio Hartree-Fock method using a 4-31G* basis 
set. Compared to ab initio methods which are in general more effective, semi-empirical 
AMI methods are much more cost effective and can be used for rather large systems.20
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Conformational Search
Two general methods for exploring conformational space exist: conformational 
search by torsion driving and conformational search using molecular dynamics.11 In 
conformational search by torsion driving, the energy of the molecule is evaluated as the 
conformation is systematically modified through rotation of each selected rotatable bond 
by a given amount. Two different types of torsion driving calculations can be performed 
in Insight II.'3 Both torsion driving methods are systematic search methods in which the 
torsion angles of interest in the molecule are defined, and are then rotated through their 
full range to generate trial structures for minimization. For example to perform a 
systematic search on a molecule with two torsion angles 0 and tg, the angles may be 
rotated in 60° increment from 0 to 360°, producing (360/60)' = 36 trial structures to be 
minimized. The number of trial structures for minimization can be increased by reducing 
the angle increment and vice versa. The disadvantage of the systematic search method is 
that it could be very time consuming especially for large molecules with many degrees of 
freedom. A non systematic search method such as the Monte Carlo method2 is more 
advantageous than the systematic search methods.
Monte Carlo Method
A Monte Carlo (MC) conformational search uses random alterations to the 
molecule’s shape to explore possible conformations. Monte Carlo (MC) is based on a 
stochastic method to explore conformational space. Stochastic techniques are based on 
the use of random numbers and probability statistics to investigate problems. The use of a 
stochastic method to explore conformational space, to solve the multiple-minima problem 
in protein folding was first reported by Li and Scheraga.4 The Metropolis algorithm21 was
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used to sample potential conformations for allowed energy transitions. Internal 
coordinates (torsion angles) were randomly selected and rotated in random increments 
giving a resulting structure that is optimized by energy minimization. The method was 
successfully applied to locate the lowest energy conformer of a pentapeptide.4 An internal 
coordinate, random-variation method has been successfully applied for searching the 
conformational space of a variety of organic molecules.2 The method generally leads to 
the global minimum and the location of all minima consistent with the energetic and 
geometrical constraints for flexible organic molecules.
MC calculations simulate the dynamic behavior of a molecule by random changes 
made to the system, such as the dihedral angle rotation or atom displacement." The 
energy of the trial configuration of atoms is calculated and a choice whether to accept this 
configuration is made. If the energy of a configuration has decreased from the previous 
configuration, then that configuration is accepted. Otherwise, if the energy is higher after 
the random change, then the MeUopolis algorithm is used to determine whether the new 
configuration should be accepted. The new configurations are accepted with a 
probability given by the Boltzmann distribution (Equation 10).21
Nj
•V, = e
A t ( 10)
The Boltzmann constant is represented by k and the absolute temperature by T. A 
random number is chosen between 0 and 1 and compared with the Boltzmann factor, and 
if this number is smaller, then the configuration is accepted and the molecule is moved to 
its new position. If the number is bigger, then the molecule is returned to its previous 
configuration and again subjected to a random alteration.
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The MC program incorporated in PC Spartan Pro11 performs a conformational 
search using the MMFF94 molecular mechanics force field for assigning the lowest 
energy conformation. The equilibrium geometry for each conformer is obtained by 
performing AMI semi-empirical quantum mechanical calculations.1 *
Molecular Dynamics
Molecular dynamics as a conformational search tool uses Newton's classical 
equation of motion to compute the acceleration, and hence the velocity of the atoms from 
the atomic forces.22 At the start of a molecular dynamics simulation, the atoms of the 
molecule under consideration are assigned velocities. The behavior of the molecule is 
then simulated through time. The new positions for the atoms after a short time step 
(order of 1 fs) are calculated from the accelerations and the constraints of the molecular 
mechanics force field. Each atom is then moved to a new position in space. Many 
iteration of this process generates a series of new conformations of the structure known as 
trajectories. 13 The temperature of the simulations and thus the thermal energy of the 
system is directly related to the velocities of the atoms. Both low-temperature and high- 
temperature dynamic simulations can be performed in Insight II.'5 High-temperature 
dynamics is more advantageous than low-temperature dynamics because at a higher 
temperature, there is sufficient energy to climb both lower- and higher-energy barriers 
faster. A molecular dynamics simulation can be allowed to run freely taking its own 
unrestricted path through conformational space, or it can be controlled by imposing 
restraints on parts of the molecule. The molecular dynamics simulation reported in Part 2 
of this dissertation is based on unrestricted path through conformational space.
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SYNTHETIC AND COMPUTATIONAL STUDIES ON PAHs AND SYNTHESIS OF 
NUCLEOSIDE DERIVATIVES
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CHAPTER I
OVERVIEW OF PAHs
Polycyclic aromatic hydrocarbons (PAHs) arc environmental contaminants, 
formed from the incomplete combustion of organic matter. It is very common to find 
these compounds in environmental sources such as air, water, and soil. Another form of 
exposure to these contaminants is from societal activities such as smoking, grilling or 
roasting of foods, and occupations involving the handling and manufacturing of PAH- 
containing materials. The largest sources of PAHs in the air are open burning such as 
burning of gasoline and diesel fuels (automobile pollution), and home heating with wood 
and coal.24'25
PAHs are thought to undergo metabolic activation to carcinogens either via 
oxidative metabolism to diol epoxides,25 or through single-electron oxidation to radical 
cations.26'27 Both species have been shown to cause DNA alkylation through covalent 
modification of DNA.25'27 Several PAHs that contain a bay- or fjord-region exhibit 
cytotoxic, mutagenic and carcinogenic activity, primarily through metabolic activation to 
diol epoxides.25 Two examples of PAHs containing these structural features are shown in 
Figure 1.1.
16
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Figure 1.1 Structures of highly hindered PAHs: benzo[a]pyrene (BaP), and 
benzo[c]phenanthrene (BcPh).
1.1 Historical Background and Carcinogenicity
The story goes that in 1666 after the great fire in London, people began building 
homes with long and twisted chimneys.28 Coal was used for heating with the result that 
deposits of black soot had to be removed periodically from the chimneys. In removing 
these deposits, workers contracted a disease that later became known as cancer of the 
scrotum. In 1775, Percivall Pott, a London-based surgeon, reported that coal dust was the 
cause of this disease.'8 In 1892 Henry T. Butlin, also based in London, reported no 
occurrence of the disease in countries where there was no accumulation of coal 
deposits."18
In 1929, the first synthesis of a carcinogenic PAH. dibcnz[n./i]anthracene, was 
reported.’9 Subsequently, within the same year, the synthesis of the 3-methyl derivative 
of dibenz[a,/i]anthracene was reported.29 These compounds were tested and shown to 
induce cancer in mice.29 In 1930, Hiegler and co-workers began research on the isolation 
of carcinogenic hydrocarbons from tar.’° They found that even at very low 
concentration, a potent carcinogen isolated from tar was still carcinogenic on mouse skin. 
In 1933, benzofalpyrene (BaP) was isolated, in a senes of experiments aimed at 
identifying the chemical composition of the carcinogenic composition of coal tar/ 1 These 
results sparked general interest in the study of PAH carcinogenesis. Also in 1933, Cook
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et al. reported that chemically synthesized benzo[a]pyrene and benzo[e]pyrene (BeP) 
were identical to carcinogenic hydrocarbons from coal-tar.33 Cook and co-workers also 
reported that the application of synthetic benzo[a]pyrene (BaP) to the backs of mice 
resulted in tumors. Their findings were later investigated and confirmed by other
groups.31-33'34
With the advances made in the correlation between PAH and carcinogenicity, it 
became imperative to probe into the structural features underlying the difference between 
carcinogenic and non-carcinogenic PAHs. A number of theories were proposed to 
explain the difference in carcinogenic behavior. One of these theories is based on 
reactive positions on the PAH structure. For example Fieser et al. hypothesized that the 
most reactive position in BaP, carbon 6. was involved in its activation.35 36 This means 
C-6 substituted derivatives of BaP will be expected to be more potent than unsubstituted 
derivatives for the hypothesis to be valid. In contrast, all 6-substituted derivatives of BaP 
tested for carcinogenicity were found to be less potent than the unsubstituted 
derivatives.35'36 This result led to a theory that BaP. and not some metabolite, is directly 
responsible for its carcinogenicity. The inference from the above result was that 
metabolism is a detoxifying event as further proven by Arcos and Argus/ 7 They showed 
that with damaged livers, animals less able to metabolize BaP were more susceptible to 
BaP carcinogenesis.37
The first generally persuasive theory on the relationship between carcinogenicity 
and PAH structure was proposed by Pullman. ’8 This theory, based on quantum 
mechanical calculations, gave a new impetus to research on PAH carcinogenicity. 
According to Pullman, the carcinogenicity of a PAH is related to the susceptibility of the
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‘K-rcgion’ and 'L-region' towards addition reactions (Figure 1.2). Based on the above 
theory, Pullman proposed BaP to be an ideal carcinogen because it's "K- and ‘L-rcgions 
are blocked and thus not exposed to oxidation.38’0 The 'K-rcgion' was proposed to be 
the region of high reactivity while the ‘L-region’ that of low reactivity and detoxification. 
This structure-activity relationship was widely tested with the hope that blocking of the 
‘K-region’ should lead to inactivity while blocking of the ‘L-region’ should lead to 
enhanced activity due to prevention of metabolic detoxification. The results were 
inconsistent among the compounds tested and so the theory was later abandoned.
•  = ’K-region’
0 = 1,-region'
Figure 1.2 The ’K’ and L-rcgions’ of benzo[a]pyrcne.
Considerable progress was made towards understanding the mechanism of 
carcinogenesis in the 1950s and 1960s.’10 The importance of epoxides in the metabolism 
of polycyclic hydrocarbons was first recognized by Boyland.41 The work of Boyland. 
contrary to earlier views that unmodified PAHs were responsible for carcinogenesis, 
suggested that reactive epoxide intermediates might play a significant role in the 
mechanism of carcinogenesis. The binding of PAHs to proteins in mouse skin was 
reported by Miller.42 and later by Abell and Heidelberger.4’ These workers proposed that 
an enzymatic step must be involved in the covalent binding of a PAH to proteins in 
mouse skin. In 1964, Brookes and Lawley found that there was a better correlation with 
carcinogenicity in the binding of polycyclic hydrocarbons to DNA than to protein.44 
Brookes and Lawley further suggested that the reaction betw een polcyclic hydrocarbons
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and DNA was very critical in tumor initiation. The work of Brookes and Lawley was 
later supported by in vitro DNA binding studies which suggested that metabolism was 
vital to the process.-15'46 After an extensive study on a number of carcinogens, Miller 
hypothesized that all carcinogens were generally metabolized to electrophiles which then 
reacted with DNA.-17 A general hypothesis was made based on Pullman’s 'K-region’ 
theory3*'3*’ and Miller’s theory47 in which a given PAH is metabolized to an epoxide 
followed by DNA alkylation The K-region’ epoxides were initially thought to be the 
“ultimate carcinogens". However, Baird el al. found that adducts formed from the 
reaction of the “K-region” epoxides with DNA were different from those formed from 
the parent hydrocarbons.4*
A significant contribution in the understanding of carcinogenesis by PAHs came 
through the discovery of rra;u-7,8-dihydroxy-9,10-epoxy-7.8,9,10-tetrahydrobenzo[a]- 
pyrene (BaPDE) as an intermediate in DNA binding (Figure 1.3).49,50 Following the 
above discovery, several research groups subsequently showed that BaPDE was the 
ultimate carcinogen from BaP.5153
12 1
Figure 1.3 Structure of tra/»-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tctrahydro BaP
With the discovery of BaPDE, it became possible to study the mechanism of 
binding of BaP to DNA and the structure of the products.54 From these studies, it was 
established that the bay-region diol epoxides were responsible for mediating the cellular 
binding of PAH carcinogens to DNA. It is the goal of current research in the field to
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come out with a general theory on the chemistry of PAH-induced mutation and 
carcinogenesis, which will shed some light into cancer, a disease society is plagued with.
1.2 Metabolic Activation of PAHs
Two mechanisms for metabolic activation of PAHs to carcinogens have been 
proposed.25 One of these mechanisms, single-electron oxidation, leads to radical cations 
as intermediates, which have been shown not to be associated with any biological activity 
such as mutagenicity.55 The second mechanism, and which has been widely investigated, 
involves oxidative metabolism to diol epoxides.
The pathway of oxidative metabolism of PAHs to diol epoxide involves two 
phases, known as Phase I and Phase II metabolism.5’’ Phase I metabolism involves the 
initial oxidation and hydroxylation, while Phase II metabolism involves the removal of 
Phase 1 metabolites through conjugation, secondary metabolism and reduction. 
Generally, Phase I transformations are considered activating, and Phase II 
transformations are considered detoxifying.57-00 Various enzymes, such as cytochrome 
P-450 and epoxide hydrolase, are involved in the metabolic pathway (Scheme l . l ).61
Generally, four isomeric diol epoxides are produced from any PAH. These diol 
epoxides have been classified as syn or series- 1 diol epoxides and anti or series-2  diol 
epoxides (Figure 1.4).25 The classification of the diol epoxide as syn and anti is based on 
the orientation of the benzylic hydroxyl group relative to the epoxide. When the bcnzylic 
hydroxyl and epoxide are on the same side, the diol epoxides of series- 1 (syn) are formed. 
On the other hand, the series-2 (anti) diol epoxides are formed when the benzylic 
hydroxyl and epoxide are on opposite sides. The diol epoxides in each series have 
different biological activities related to their stereochemistry.











Scheme 1.1 Metabolic activation of PAHs. Heavy arrows represent the major pathways.
Figure 1.4 Structures of the four isomeric diol epoxide of any PAH.
For example the series-1 diol epoxides of planar PAHs have been shown to be 
inactive as tumorigens except in the non-planar BcPh.62 In contrast, the serics-2 diol 
epoxides are highly tumorigenic.02 In addition, the (R.S.S.R) diol epoxide isomer stands
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out unique in its tumorigcnicity of all the hydrocarbons studied so far.62 A large number 
of diol epoxides have been studied and it has been found that reactivity, conformation, 
and absolute configuration are among the factors that contribute to mutagenicity and 
carcinogenicity.62
1.3 Reaction of PAHs with DNA
As previously mentioned, metabolic activation of PAHs, cither via oxidative 
metabolism or single-electron oxidation, produces species which can cause DNA 
alkylation through covalent modification of DNA. It is believed that these species react 
with the exocyclic amino groups of deoxyadenosine (dA) and deoxyguanosine (dG) to 
produce adducted DNA. Diol epoxides are thought to undergo a C-0 bond scission 
producing a benzylic carbocation, which is trapped by the exocyclic amino groups of dA 
and dG (Scheme 1.2A).63'66 Radical cations can also react at the exocyclic amino groups 
of dG and dA to produce stable lesions (Scheme 1.2B), although apurinic sites in DNA 
are also produced by this species.26 2' Metabolism and DNA binding of any PAH results 
in a possible 16 nucleoside adducts (each diol epoxide reacting with deoxyadenosine and 
deoxyguanosine through both cis and trans oxirane bond scission (Figure 1.5).67 The 
respective hydrocarbon diol epoxides alkylate DNA to different extent and magnitudes. 
They also differ in the ratio of dA to dG adduct formation.67 The current state of 
knowledge in the field has revealed that the (R.S.S.R) diol epoxide of every hydrocarbon 
is trapped to a greater extent by DNA than are the other isomers.





Scheme 1.2 Binding of metabolically activated species to DNA.
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Figure 1.5 Adducts formed from epoxide ring opening of dihydrodiol epoxide 
configurational isomers. 16 dA and dO (Nu) adducts formed (adapted from ref. 25).
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Hence, for detailed structure-biology studies it is necessary to generate 
diastereoselective syntheses of each epoxide-nucleoside lesion. These synthesized 
lesions can then be incorporated into specific sites of biologically relevant 
oligonucleotides. Structural and biological studies with these modified oligonucleotides 
are expected to provide a better understanding of the events in chemical carcinogenesis.
1.4 Conformational Consideration of PAH Diol Epoxides 
The reactivity and biological activity of diol epoxides is dictated by the 
conformational preference of the hydroxyl groups.25 As previously mentioned, diol 
epoxides are classified either as senes-1 or series-2 with the classification dependent on 
the orientation of the epoxide ring relative to the benzylic hydroxyl group. A good 
correlation between the conformational preferences with mutagenicities of diol epoxides 
has been reported.611 Generally, in the absence of unusual factors, the hydroxyl groups of 
scries- 1 diol epoxides are oriented quasi-diaxial, whereas in the serics-2  isomers these 
prefer a quasi-diequatorial conformation, an arrangement in which the hydroxyl groups 
are nearly in the plane of the remainder of the molecule. Study of a number of diol 
epoxides has revealed that the absolute stereochemistry and conformation are important 
factors in tumorigcnicity.t’,, An enhanced biological activity is generally observed when 
the epoxide ring is located in a sterically hindered “bay region” with the hydroxyl groups 
being trails quasi-diequatorial. An exception to this rule is the non-planar benzo[c]- 
phenanthrene (BcPh),7IJ where high tumorigcnicity has been associated with the (S.R.S.R) 
series-1 isomer (Figure 1.6) which has quasi-diequatorial hydroxyl groups. Based on the 
results from numerous studies in PAH carcinogenesis, some general criteria have been
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proposed that a hydrocarbon diol epoxide must possess for high biological activity.68'6̂  
These criteria are listed below.
1. The presence of the epoxide ring in a bay or fjord region.
2. A irons quasi-dicquatorial orientation of hydroxyl groups.
3. An anti-onentation of benzylic hydroxyl relative to epoxide group.
4. An absolute configuration of (R,S,SJt) for the diol epoxide as read from the 
benzylic carbinol carbon to the benzylic epoxide carbon.
1.5 Chemistry of PAH-DNA Interactions
The exact chemistry underlying the reaction of the active PAH metabolite, the 
diol epoxides, with DNA is not fully understood. One school of thought however, based 
on hydrolysis studies of benzo[a]pyrene diol epoxides (BaPDE).71 has suggested that a 
carbocationic intermediate may be involved. Such a carbocation would be prone to 
reaction with a variety of nucleophiles. In an aqueous DNA environment, one would 







Scheme 1.3 Mechanistic rationalization of the difference in reactivity between different 
diol epoxides and DNA.
A mechanism has been proposed involving an intermediate that is either partially 
or completely ionized (Scheme 1.3).72 Thus the reaction of diol epoxides with
OH
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nucleophiles, probably proceeds by protonation, followed by partial or complete 
ionization, and then reaction with the nucleophile. This mechanism implies that 
alkylation by diol epoxides is acid-catalyzed, and the rate depends on the stability of the 
intermediate carbocation. The stability of the carbocation can be estimated from 
theoretical charge distribution in the cation based on Hiickel theory."
The difference between the carbocation intermediate in relation to the structure of 
the diol epoxide is explained by the different extent of charge delocalization around the 
aromatic nucleus and steric hindrance at the bay region.’5 This might mean that the more 
the charge around the aromatic nucleus is delocalized, the more stable the diol epoxide. 
Also the less sterically congested the bay region, the more reactive the diol epoxide. In 
fact it has been shown that unhindered bay region dihydrodiol epoxides having four 
aromatic rings such as, benzo[o]pyrene and dibenz[a,j]anthracene are highly reactive 
towards hydrolysis.72 With four aromatic rings there is greater charge delocalization 
coupled with the uncongested bay region making the diol epoxides readily reactive and 
therefore proceeding through a fully ionized intermediate (Scheme 1.3). On the other 
hand, sterically congested and non planar diol epoxides from benzo[c]phenanthrcne, 
having only three aromatic rings are less reactive.72 The non planar nature of 
benzo[c]phenanthrenc and the presence of only three aromatic groups restricts the 
effective delocalization of charge which could result in its diol epoxide reacting through a 
partially ionized intermediate. 2 In the iight of all these, it was thought that the poor 
trapping of benzo[c]phenanthrene diol epoxide by water could be due to reaction of the 
diol epoxide via a partially ionized intermediate (Scheme I.3).72 The reaction of 
benzo[c]phenanthrene diol epoxide through a partially ionized intermediate would then
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promote better competition between the more nucleophilic DNA and water, unlike in the 
case of a fully ionized intermediate.7'  It was then shown that for the (R,S.S,R) 
stereoisomer, the hindered diol epoxides were trapped more efficiently by DNA than the 
unhindered diol epoxides. 2
1.6 Kinetics of PAH Diol Epoxide-DNA Binding 
The general view in the literature proposes either an external binding site, in 
which the hydrocarbon lies outside the stack of DNA bases, presumably in the narrow 
groove, or it is intercalated.7,1'13 The kinetics based on the interaction of benzo[a]pyrene 
diol epoxide with DNA that has been reported,7,173 is represented by two possible reaction 
pathways shown in Figure 1.6.
Complex 1 (intercalated) BaP-tetrahydrotctrol
BaPDE + DNA
Complex 2 (externally bound)
H*
Covalent binding
Figure 1.6 Two possible reaction pathways of PAH-DNA binding.
Hsu el al. reported that the rale of covalent binding of //an.?-7,8-dihydroxy-anri- 
9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (arm-BaPDE) was greater than that of 
syn-BaPDE. It has been suggested that the decreased reactivity of syn-BaPDE relative to 
rra/i.v-BaPDE is because the syn-isomcr is not in the right conformation to fit into the 
DNA helix, possibly due to its diaxial hydroxyl groups.71 Even within the stable trans- 
BaPDE enantiomers, the relative extents of binding of (+)-(7/?,8S,9S,10/?)-BaPDE and 
(-)-(75,8/f,9/?,105)-BaPDE with DNA have been investigated.'8 80 Although the isomers 
have equal stability, and both binding to DNA and DNA-catalyzed hydrolysis occur at
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the same rate,81 the extent of binding favors the (+)-(7/?,8S,9S,10/f)-cnatiomer.78 80 A 
possible explanation to this difference in extent of binding of the enantiomers is the way 
in which they fit into DNA.
Computer modeling studies were carried out to study the intercalation of both 
enantiomers into DNA.82 The complex with (+)-(7fi,8S,9S,10/?)-<wtfi-BaPDE was 
energetically more favorable. With both enantiomers, it was found that the epoxide ring 
was close to the amino group of guanine, which suggested that physical binding could be 
followed by chemical reaction.82 88 Computational studies have also been carried out on 
the c/s and trails adducts of anti-BaPDE.84'85 In the case of the A2-deoxyguanostne (dG) 
adducts, it was shown that the cis adducts are less conformationally flexible than the 
traits adducts due to steric crowding since the hydroxyl groups are on the same side of 
the benzylic ring as guanine.84 The hydroxyl groups in the traits adducts are on the 
opposite side of the benzylic ring, which makes the minor groove position in DNA 
duplexes more favorable to the traits than cis adducts. Similar studies carried out on the 
(+)-7/?,8S,9S,10/?- and (-)-7S,8/?,9/?,105-irans-aiiri-BaPDE-A'6-deoxyadenosine (dA) 
adducts revealed that intercalation over a major groove results from steric and 
hydrophobic effects.85'86 The hydrophobic pyrenyl moiety is not exposed in the major 
groove but is rather buried within the helix. Computational calculations showed that the 
(-)-lOI? isomer is more stable compared to the (+)-IOS isomer.86 Computational 
investigation of the conformational preference of the (+)-W? and (-)-lS-trans-anti- 
BcPhDE- .V2-dG adducts have recently been reported.87 Conformers that optimized 
stacking interactions, contributing to the stability of intercalated BcPhDE-DNA duplex 
structures, were highly favorable.87 Experimental studies, based on circular dichroism,
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fluorescence quenching, melting and electrophoresis, of anfr-BaPDE-DNA were carried 
out showing the intercalation of the pyrenyl moiety into the DNA helix.88
Experimental evidence supporting an exterior binding site has also been reported 
in the literature. In one report, it was found that the fluorescence of an//-BaPDE-DNA 
was quenched readily by oxygen or iodide ions, implying that the pyrene nucleus was 
exposed to molecules in solution and consequently not intercalated.89 Poulos et a l‘KI 
measured the rate of oxygen quenching of a/i/t-BaPDE-DNA solutions by flash 
photolysis. They found the rate of oxygen quenching to be faster than with intercalated 
species, again supporting the view that the pyrene residues were easily accessible and 
thus found in an exterior binding site. The binding of DNA to the syn isomer of BaPDE 
has also been investigated.91 It was found that the pyrene residues were either intercalated 
or bound externally in a ratio of 2:1 .
As already mentioned in the preceding paragraphs, the interaction between 
polycyclic aromatic hydrocarbons and DNA has been studied by various analytical and 
computational methods. Herein, molecular mechanics and quantum mechanics are used 
to rationalize experimental results. Computer simulations have been carried out without 
using any experimental constraints, except those incorporated in the force field, and it is 
interesting that the results came close to experiment. It is the hope that combining 
computational chemistry with experimental chemistry will help to increase the 
productivity of experimental labors. In chapter 3, the objectives and results of the 
computational studies are presented.
This part of the dissertation will focus on the synthetic and computational studies 
on polycyclic aromatic hydrocarbon derivatives, and the synthesis of nucleoside analogs.
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Chapter 2 involves the synthesis of the fjord region tctrahydroepoxide of 
benzofrjphenanthrene and other derivatives of the non planar benzo[c]phenanthrene. 
Chapter 3 involves computational evaluation of the diastereoselectivity in the synthesis of 
hydroxylated derivatives of benzo[a]pyrene and benzo[c]phenanthrenc. In chapter 4, the 
synthesis of nucleoside adducts corresponding to the binding of polycyclic aromatic 
hydrocarbon radical cations, particularly from benzo[n]pyrene, to deoxyadenosine will be 
reported. Importantly, we have applied our knowledge of palladium catalysis, based on 
previous work in our laboratory, to synthesize single electron oxidation adducts for the 
first time. In chapter 5, synthesis of compounds from other significant collaborative 
group projects will be reported.
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SYNTHESIS OF DIOL EPOXIDE AND DERIVATIVES OF THE FJORD REGION 
BENZO[C]PHENANTHRENE
2.1 Introduction
Benzo[c]phenanthrene (BcPh) is a nonplanar molecule belonging to the class of 
polycyclic aromatic hydrocarbons characterized by a highly congested fjord-region. 
BcPh is a relatively weak carcinogen, '  and its metabolic activation leads to two pairs of 
diastereomeric diol epoxides, namely syn and aiui benzo[c]phenanthrene diol epoxide 










Figure 2.1 Structuresof BcPh and its series-1 and series-2 diol epoxides.
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Both diastereomers have been shown to be highly mutagenic and exhibit 
exceptionally high tumorigenic activity.95'06 Both enantiomers of anti 
benzo[c]phenanthrenc dio! epoxide can react with purines in DNA9394 through cis and 
trans addition leading to the corresponding cis and traits adducts, w'ith a predominance of 
trans addition.93
The congestion of the fjord-region diol epoxide metabolites of BcPh confers 
specific and unusual properties to this class of polycyclic aromatic hydrocarbons unlike 
their less congested bay-region counterparts. For example, ?rarw-3,4-dihydroxy-a/itr-1,2- 
epoxy-1,2,3,4-tetrahydrobcnzo[c]phenanthrene (1/?,25,35,4/?) isomer, Figure 2.1 has 
been reported to exhibit the greatest tumorigenic activity of all hydrocarbon diol epoxides 
tested so far.70 The fjord-region diol epoxides of BcPh are highly efficient DN'A 
alkylating agents compared to other polycyclics.92 In addition, the series 1 (syn) diol 
epoxides show a conformational preference in which the hydroxyl groups have a quasi- 
diequatorial orientation9 9S Generally among polycyclics. the syn isomer prefers a 
conformation in which the hydroxyl groups are quasi-diaxial.98 This unusual 
conformational preference of the hydroxyl groups in the syn isomer of BcPh diol epoxide 
may be responsible for the high tumorigenic activity exhibited by the syn isomer 
(1/?,25,3R,45) isomer, Figure 2.1, not common among other bay-region diol epoxide 
metabolites.'0 Among other carcinogenic PAHs, only the series-2 (anti) stereoisomer 
(l/?,2S,35,4/f) isomer, Figure 2.1 has been shown to exhibit high tumorigenicity.62
The diol epoxides of BcPh also differ from other PAHs in the region at which 
reaction occurs with DNA. Compared to the diol epoxides of benzo[rt]pyrene (BaP), 
chrysene, and benzo[a]anthraccne. which largely alkylate the N~ amino group of
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deoxyguanosine residues, the diol epoxides of BcPh predominantly alkylate the A/6 amino 
group of deoxyadenosine residues.25 00 Reaction of the planar PAHs with DNA occurs in 
the minor groove23 while with the diol epoxides of BcPh, reaction with DNA occurs in 
the major groove.25'09 Thus, the diol epoxides of BcPh are distinguished by their 
exceptionally high level of covalent binding to DNA in vitro and the relatively high ratio 
of deoxyadenosine to deoxyguanosine adducts. High-resolution NMR solution structures 
of adducts of the series-2 isomers of BcPh, (+)-lf? and (-)-lS-tranx-anri-BcPh with dA 
and dG, in DNA have been studied.100 102 These studies have shown that the BcPh moiety 
adopts an intercalated position in the DNA duplex. The (+)-l/? isomer is intercalated on 
the 5’-side of the modified adenine and on the 3'-side of the modified guanine. The (-}- 
IS isomer on the other hand is intercalated on the 3’-position of the modified adenine and 
on the 5'-position of the modified guanine. All adducts cause changes that can lead to 
mutagenesis and cancer initiation through distortion in function of key oncogenes or 
tumor suppressor genes.103105
It is important to synthesize stereochemically defined PAH-DNA adducts for 
biological studies. The first step is to synthesize enanliomerically pure BcPh diol 
epoxides in order that the biological activity of individual isomers can be accessed. In 
this chapter, the syntheses of the diol epoxide and other derivatives of the fjord region 
BcPh are reported.
2.2 Synthesis
Synthesis of diol epoxide was mostly accomplished following literature 
procedures with some modifications where necessary pertaining to the chemistry of 
benzo[c]phenanthrcnc. The key step in the synthesis is the photochemical ring closure of
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l-(2,3-dimethoxyphenyl)-2-(2-naphthyl)ethylene to 3,4-dimethoxybenzo[c]phenanthrene. 
Photochemical ring closure of the appropriate olefins to PAHs in general and to the fjord- 
region BcPh in particular is well documented in the literature.1™’ 110 In all cases reported, 
photocyclization appeared to offer a convenient general synthetic route to PAH 
derivatives since the required olefins can be readily synthesized via the Wittig or
Grignard reactions.
2.2.1 Synthesis of Benzofclphenanthrenc Diol Epoxide 
A retrosynthetic analysis for the synthesis of the diol epoxide of BcPh is shown
below (Figure 2.2).
Figure 2.2 Retrosynthetic analysis for the synthesis of tran.v-3,4-dihydroxy-au/i-1,2- 
epoxy-l,2,3,4-tetrahydrobenzo[c]phenanthrene (2-7).
The required naphthylstyrene substrate 2-3 (Figure 2.2) for the photolysis reaction 
was readily synthesized as follows. Commercially available 2-bromomethyinaphthalene
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2-1 was converted to the methylnaphthalene triphenylphosphonium salt 2-2  by reacting 
with triphenylphosphine under reflux in toluenefScheme 2.1).
Scheme 2.1 Synthesis of methylnaphthalenctriphenylphosphonium bromide.
A Wittig condensation reaction of 2-2 with 2,3-dimethoxybenzaldehyde with 
sodium methoxide in methanol afforded a cis-trans mixture of styrene 2-3 in 97% yield 
(Scheme 2.2).
Scheme 2.2 Synthesis of 1(2,3 dimethoxyphenyl)-2-(2-naphthyl)ethylene (2-3).
The ratio of cis- to rranx-isomer was assigned based on 'H NMR integration of 
the methoxy singlets corresponding to cis and irons olefin. A ratio of approximately 
1:1.5 (cis.trans) was obtained for the mixture. Once the alkene 2-3 was obtained, the 
next step was the photolytic ring closure.
Photocyclization reactions for the conversion of alkenes to polycyclic systems are 
well known. Naget el al. reported the synthesis of alkyl-substituted 
bcnzo[c]phcnanthrene and chrysenes by photocyclization of the requisite 
naphthylstyrene.106 Amin and co-workers107 and subsequently Utermochlen and co­
workers'08 reported an improved photochemical synthesis of chrysene derivatives. The 
photocyclization reaction for the synthesis of polycyclic systems through ultraviolet
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irradiation of a styrene moiety in solution in the presence of catalytic iodine and 
dissolved oxygen has proven to be a valuable synthetic method.109 An improved 
photocyclization methodology involving the use of stoichiometric iodine and propylene 
oxide in the absence of air has also been reported." 0 Liu el al. reported a general 
improvement in yield and purity of products formed from the improved methodology.110 
Both photocyclization methods were used in the synthesis of the benzo[c]phcnanthrcne 
derivatives, with an overall improvement in the yield and purity of the product noticed, as 
had been reported for the improved methodology involving the use of stoichiometric 
iodine and propylene oxide." 11
Photochemical ring closure was carried out by the two methods mentioned in the 
previous paragraph. The first method involved the use of catalytic iodine and oxygen. 
The second method (modified method) involved the use of stoichiometric iodine and 
propylene oxide in the absence of air. Photolytic oxidative ring closure of 2-3 in benzene 
with a 450 W medium-pressure Hg lamp, and a catalytic amount of iodine under oxygen 
proceeded smoothly giving a low 37% yield of 2-4. To improve the yield for this step of 
the synthesis, the modified method" 0 described above was implemented. When the 
photolysis reaction was carried out with excess propylene oxide and stoichiometric 
iodine, in the absence of air, a much improved yield %% of 2-4 was obtained (Scheme 
2.3).
Scheme 2.3 Synthesis of 3,4-dimethoxybcnzo[c]phenanthrene (2-4).
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The possible reasons for the difference in yield and purity of products from both 
methodologies have been reported.1111 In the first method, catalytic amounts of iodine 
plus air were used as oxidant while in the second method stoichiometric amounts of 
iodine was used as oxidant with propylene oxide serving to consume the HI formed. The 
presence of HI can lead to photoreduction of double bonds thereby lowering the product 
yield. But in the presence of propylene oxide, the HI formed is consumed and 
photorcduction is prevented leaving the double bonds to photocyclize to the desired 
product. Photooxidative side reactions that would otherwise be common in the presence 
of air arc also prevented in the absence of air. Stoichiometric iodine therefore, is a good 
oxidizing agent in photocyclization reactions but it must be used in conjunction with 
propylene oxide which is needed to remove the reducing agent HI generated from 
oxidation by iodine.
Once 3,4-dimethoxybenzo[r]phcnanthrenc 2-4 was obtained, the next step was 
the conversion to 3,4-diacetoxybenzo[c]phenanthrene 2-5. The methoxy groups in 2-4 
were cleaved by a two step process involving treatment with boron tribromide in 
methylene chloride followed by acetylation of the resulting catechol with acetic 
anhydride in the presence of 4-AW-dimethylamino pyridine and pyridine in ether to 
afford 2-5 in 88% yield (Scheme 2.4).
1. BBr3, CH2CI2,-5 aC— -  r.t.
2. Ac20, Py. DMAP, Et20
2-4 88% 2-5
Scheme 2.4 Synthesis of 3,4-diacetoxybenzo[c]phenanthrenc (2-5).
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Reduction of 2-5 with sodium borohydridc in ethanol under an oxygen 
atmosphere afforded stereospecifically the desired (+)-fra/i.s-3,4-dihydroxy-3.4- 
dihydrobcnzo[<']phenanthrenc (2-6) in 51% yield (Scheme 2.5). 'H NMR confirmed the 
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Figure 2.3 Partial 'H NMR spectrum (in DMSO-<4) of the saturated ring protons 1-4 of 2- 
6. Viewed from left to right, peaks correspond to H-l, H-2,0-H, O-H, H-4 and H-3.
The NMR chemical shifts and couplings of the saturated ring protons of 2-6 were 
in good agreement with literature values. " 1 The aliphatic resonances of BcPh dihydrodiol 
have been reported in which only one set of signals is observed, indicating fast 
interconversion of potential P and M helical isomers on the NMR time scale.112 Figure
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2.3 shows the aliphatic resonances of 2-6 with only one set of signals observed, 
confirming the existence of only one isomer. A large coupling constant also exist 
between the carbinol protons of 2-6 C/3,4 = 10.1 Hz), which is indicative of a diequatorial 
orientation of the hydroxyl groups.
The final step involved the epoxidation of 2-6 with m-chloroperbenzoic acid. It is 
known that PAH dihydrodiols having a quasi-dicquatorial arrangement of hydroxyl 
groups undergo stereoselective epoxidation with m-chloroperbenzoic acid from the same 
side as the allylic hydroxyl group:” Thus, dihydrodiol 2-6 was stereoselectively 
converted to the anti-diol epoxide 2-7, in which the epoxide oxygen atom is on the 
opposite face to the benzylic hydroxyl group, by treatment with m-chloroperbenzoic acid 
(Scheme 2.6).
Scheme 2.6 Synthesis of (±)-3a,4p-dihydroxy-la,2a-epoxy-l,2,3,4-tetrahydroben- 
zo[c]phenanthrene (2-7).
The epoxidation reaction of 2-6 proceeded smoothly affording 2-7 in 67% yield as 
a single isomer as determined by !H NMR. The 'H NMR spectrum and the physical 
property of the diol epoxide 2-7 was consistent with the structural assignment and was in 
good agreement with that reported in the literature98 The coupling constant for the 
carbinol protons of 2-7 was 7.9 Hz, which is an indication that the conformational 
preference of the hydroxyls 2-7 in solution favors the diequatorial orientation.
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2.2.2 Synthesis of Derivatives of Benzolrlphenanthrene 
The syntheses of other derivatives of benzo[c]phenanthrene were accomplished 
from frans-3,4-dihydro.xy-3.4-dihydrobenzo[c]phcnanthrene 2-6. Two protective groups 
were employed for protection of the hydroxyl groups. The choice of the protecting group 
was made taking into account that a critical step in the reaction sequence involved 
oxidation. Ester groups are especially useful for protection during oxidations and are 
quite stable, compared to other groups. Acetates and benzoates were used as the ester 
derivatives. Acetylation was accomplished by treating 2-6 with pyridine, acetic 
anhydride, and 4-A,,A'-dimethylaminopyridine to afford 2-8 in 80% yield (Scheme 2.7).
Ac20 , Pyr. DMAP 
80%
2-6 2-8
Scheme 2.7 Synthesis of (±)-frans-3,4-diacetoxy-3,4-dihydrobenzo[c]phenanthrene (2-8).
Several reagent combinations were tried to form the benzoate ester derivative. In 
one case the dihydrodiol 2-6 was reacted with benzoyl chloride in pyridine in the 
presence of DMAP. After stirring for 24 hours, reaction did not show any product 
formation as judged by TLC. The initial reaction conditions were modified by 
substituting DMAP with a stronger base, namely NaH. Although product was formed 
upon modification of reaction condition, 'H NMR of product still showed inseparable 
impurities with a modest yield of 60% obtained for the product. The best reaction 
condition was the use of benzoyleyanide, DMF, and EtjN. When reaction was carried 
out under this condition, the product 2-9 was obtained with a yield of 92%, containing a 
trace of inseparable impurities (Scheme 2.8).





Scheme 2.8 Synthesis of (±)-/ra/K-3,4-dibenzoy!oxy-3,4-dihydrobenzo[c]phenanthrene
(2-9).
Osmium-catalyzed dihydroxylation of olefins remains one of the most reliable 
methods for the synthesis of vicinal alcohols." ’ 115 The standard Upjohn dihydroxylation 
procedure uses the NMO/OsOj system, with water needed to remove osmium from the 
diolate.1 The standard Upjohn dihydroxylation reactions are generally carried out in 
aqueous solvent. Dihydroxylation of polyenes using the Narasaka’s modification of the 
Upjohn procedure has been reported.117 Standard Narasaka dihydroxylation procedure 
uses the NMO/OsO* system with phenylboromc acid to remove osmium from the 
diolate.118 Dihydroxylations using the Narasaka conditions are generally carried out in 
anhydrous solvent. Narasaka boronate-capture offers an added advantage of allowing a 
wider range of reaction conditions." 1 It has been shown that catalytic OsOj 
dihydroxylation of BaP dihydrodibenzoate using the Upjohn procedure proceeded with 
reasonably high facial selectivity and produced the 7(5, 8a, 9a. 10a tetraol dibenzoate as 
the major product (Figure 2.4).110
Major (7p. 8a, 9a, 10a) Minor (7(t. 8a, 9P, 103)
Figure 2.4 Tetraol dibenzoates of BaP from dihydroxylation procedures.
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However, the Narasaka dihydroxylation using catalytic 0 s 0 4 and phenylboronic 
acid afforded the 7f), 8a, 9a. 10a tetraol dibenzoate boronate exclusively which upon 
oxidation provided the diastereomerically pure diol.m  Similar chemistry was tested on 
the more sterically congested benzo[c]phenanthrene. Both acetate and benzoate 
protected BcPh derivatives were used for this.
Reaction of 2-8 with 1 equivalent each of NMO and phenylboronic acid provided 
the oxidation product, boronate ester 2-10 in 58% yield (Scheme 2.9). The product was 
analyzed by 'H NMR and electrospray ionization mass spectrometry. Proton NMR 
showed that only one tetraol diacetate boronate isomer was formed. A similar reaction 
was performed with the more bulky benzoate protective group in which an increase in 
yield was noticed.
Scheme 2.9 Synthesis of (±)-3a,4[)-diacetoxy-la,2a-di hydroxy-1.2,3,4-tetrahydro- 
benzo[c]phenanthrene bis(phcnylboronate) (2-10 ).
Reaction of 2-9 with 1 equivalent each of NMO and phenylboronic acid provided 
the oxidation product, boronate ester 2-11 in 72% yield (Scheme 2.10). The product was 
analyzed by !H NMR and high resolution mass spectrometry. Proton NMR showed that 
only one tetraol dibenzoate boronate isomer was formed.
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Ph
Scheme 2.10 Synthesis of (±)-3a,4p-dibenzoyloxy-la,2a-dihydroxy-1,2,3,4-tetrahydro- 
benzo[c]phenanthrcne bis(phenylboronate) (2- 1 1 ).
The deprotection of the boronales was achieved by oxidative cleavage using 
aqueous hydrogen peroxide. The byproducts (phenol and boric acid) were separated 
from the product by column chromatography. Treatment of 2-10 with a 50% aqueous 
solution of hydrogen peroxide in a 1:2 mixture of ethyl acetate in acetone at room 
temperature afforded a 44% yield of 2-12 (Scheme 2.11). The product was characterized 
by 'H NMR and electrospray ionization mass spectrometry.
Ph
Scheme 2.11 Synthesis of (±)-3u,4[i-diacetoxy-l u,2«-dihydroxy-l ,2,3,4-telrahydro- 
benzo[c]phenanthrcnc (2-12 ).
Similarly, treatment of 2-11 with a 50% aqueous solution of hydrogen peroxide in 
a 1:2 mixture of ethyl acetate in acetone at room temperature afforded a 58% yield of 2- 
13 (Scheme 2.12). The product was characterized by 'H NMR and high resolution mass 
spectrometry. Proton NMR showed that two products were formed. The aliphatic 
protons were assigned on the basis of the COSY spectrum of 2-13. Attempts were made
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to synthesize 2-13 directly from 2-9 using the Upjohn procedure and in all cases a 
mixture of products was formed with very low yield, the best being 26%. Details of the 
synthesis are presented in the experimental section.
Scheme 2.12 Synthesis of (±)-3a,4P-dibenzoyloxy-la,2a-dihydroxy-1,2,3,4-tetrahydro- 
benzo[c]phcnanthrene (2-13).
2.2.3 Towards the Synthesis of a Benzofclphenanthrene Amino Triol 
The main goal in the synthesis of derivatives of benzofclphenanthrene, reported in 
the preceding section, was to obtain the amino triol of benzofclphenanthrene (Scheme 
2.13). Such amino tnols upon reaction with fluoro nucleosides will provide 




Scheme 2.13 A plausible pathway to benzofclphenanthrene amino triol.
Regio- and stereo-controlled synthesis of aryl cis aminoalcohols from cis glycols 
using Mattocks chloride has been reported.1"" The chemistry developed1"0 was applied in 
an attempt to synthesize the amino triol of benzofclphenanthrene (Scheme 2.13). The
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route to the amino triol is a four step process involving reaction of the tetraol with u- 
acetoxyisobutyryl chloride (Mattocks chloride) resulting in the formation of a trails 
vicinal chlorohydrin acetate with the halide in the benzylic position. This is subsequently 
followed by displacement of the chloride with an azide ion. deprotection of the ester and 
reduction of the azido group by catalytic hydrogenation. Initial attempts at synthesizing 
the amino triol were unsuccessful. However, much effort was not invested in the 
synthesis to find out why initial attempts were unsuccessful because the project was 
halted when Dr. Lakshman moved to CUNY.
2.3 Summary
The synthesis of the active metabolite of benzo[c]phenanthrene, (+)-rrans-3,4- 
dihydroxy-um;'-1 .2-epoxy-1,2,3.4-ietrahydrobenzo[r]phenanthrene (2-7). has been 
accomplished. Proton NMR showed that the pattern of the aromatic protons of 2-7 was 
consistent with that reported for benzo[c]phenanthrene ring system. This compound was 
sent to a collaborator for DNA binding studies.
Several derivatives of benzo[e]phenanthrenc have also been synthesized. We 
have shown that the Narasaka in situ boronate-capture modification of the Upjohn 
catalytic dihydroxylation procedure can be applied for extended aromatic systems such as 
benzo[c)phenanthrenc. The Narasaka dihydroxylation procedure gave only one boronate 
isomer. Although deprotection of the boronate gave a mixture of products in the case of 
the dibenzoates, overall the yield and purity of the reaction is better than dihydroxylation 
using the standard Upjohn procedure. However, the acetates may be suitable for the 
synthesis of the BcPh aminotriol.
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2.4 Experimental
Melting points (m.p.) were determined on a Thomas Hoover Capillary Melting 
Point Apparatus and arc uncorrected. Proton nuclear magnetic resonance (*H NMR) was 
recorded in deuterated solvents on cither a multi-nuclear Varian VXR-300 (300 MHz) or 
a Bruker AVANCE-500 (500 MHz) spectrometer. Chemical shifts are reported in pans 
per million (ppm, 6). 'H NMR splitting patterns are designated as singlet (s), doublet (d), 
triplet (t), quartet (q), or quintet (quint). All first order splitting patterns arc assigned 
based on the appearance of the multiplct. For those splitting patterns that could not be 
easily visualized or interpreted, a designation of multiple! (m) or broad (br) was used. 
Coupling constants are reported in Hertz (Hz). Analytical thin layer chromatography 
(TLC) was carried out on glass-backed Analtech TLC plates precoated with silica gel 
(250 pm layer thickness) containing a fluorescent indicator. Column chromatography 
was performed using 200-300 mesh silica gel from Natland. Electrospray ionization 
(ESI) mass spectra were determined on a Kratos MS-80 spectrometer. Fast atom 
bombardment mass spectra (FABMS) and high-resolution mass spectra (HRMS) were 
determined on an AX505 spectrometer. Photochemical ling-closures were performed 
with a Hanovia photoreactor equipped with a 450 W medium-pressure Hg lamp and a 
Pyrcx filler. Monitoring the course of the photochemical reaction was accomplished by 
gas chromatography (GC), thin layer chromatography (TLC) and proton nuclear 
magnetic resonance ('H NMR). The injector and detector were maintained at 
temperatures of 200 and 250 °C respectively. All reactions were carried out in freshly 
distilled and dried solvents. Unless otherwise stated, all other commercially available 
reagents and solvents were used without further purification.
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Synthesis of 2-mcihvlnaphtlivItriplicnvlphosphonium Bromide (2-2)
2-2
To a stirred solution of 2-(bromomethyl)naphthalene 2-1 (5.0 g, 22.61 mmol) in 
toluene (30 mL) was added triphenylpliosphine (6.5 g. 24.78 mmol). The mixture was 
heated under reflux overnight. The mixture was cooled to room temperature and hexane 
was added followed by filtration of the precipitated solid. The solid was washed three 
times with hexane to afford the phosphonium salt 2-2 (10.22 g, 94%) as a white powder. 
The phosphonium salt was then used in subsequent reactions without further purification.
To a solution of 2-2 (10.22 g, 21.14 mmol) in MeOH (215 ml.) was added 
NaOMe (2.28 g, 42.22 mmol). A slight color change from yellow to pale yellow was 
observed. The mixture was stirred at room temperature for 1.5 hours followed by the 
addition of 2,3-dimethoxybenzaidehyde (3.16 g, 19.02 mmol). The reaction was allowed 
to proceed at room temperature for 48 hours. After completion of the reaction, as judged 
by TLC. the mixture was diluted with CH2CI2 and washed with H2O. The organic layer 
was dried over Na2SC>4 and the solvent was evaporated. The crude product was 
impregnated onto silica gel and the mixture loaded onto a dry-packed silica column. 
Elution with CH2CI2 afforded 2-3 as a colorless powder (5.97 g, 97%). Integration of the
Synthesis of l-(2.3-dimcihoxvpl)envl)-2-(2-naphthvl)ethene (2-3)
2-3
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methoxy singlets corresponding to cis- and trans-olefins showed a ratio of approximately 
2:3: Rf = 0.28, 1:1 hexane/benzcnc; m.p. 70-72 °C; *11 NMR (300 MHz, CDCIj) 8 7.85- 
7.65, 7.62-7.37, 7.36-7.20 (m, 10H, ArH), 6.90-6.76 (m, 2H, CH=CH), 3.90, 3.89 (s, 3H. 
OCll5), 3.88. 3.87 (s, 3H. OCH,); MS-ESl m/z 313.0 [M + Na]+.
Synthesis of 3.4-dimethoxvbenzolclphenanthrcne (2-4)
Photochemical ring closure of 2-3 to 2-4 was performed by using either catalytic 
I2 in the presence of O2 or stoichiometric I2 and propylene oxide. A description of both 
methods follows with the second method affording better yields.
Method 1: Using Catalytic E and Air
The alkene (4.86 g) was photolyzed in three equal batches. To a solution of the 
alkene 2-3 (1.62 g, 5.59 mmol) in benzene (1 L) was added catalytic amount of iodine 
(30 mg). The resulting mixture was subjected to photolysis while maintaining a sparge of 
air through the mixture for the entire duration of the reaction. The reaction was complete 
within 7 hours. The course of the reaction was monitored by GC (Ir(2.j)= 6.08 and 7.28 
min; tau-n = 7.79 min). The reaction mixture was concentrated on a rotary evaporator. 
The combined crude from the three runs was redissolved in CH2CI2, and washed with 2% 
aqueous Na2S2C>3. The organic layer was dried over anhydrous Na2-S0 4 and concentrated 
by rotary evaporation. The crude product was impregnated onto silica gel, and the 
mixture loaded onto a dry-packed silica column. Elution with a mixture of 2:1 
hexane:benzenc yielded 2-4 as a colorless solid (1.83 g, 37%).
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Method 2: Using Stoichiometric !■> and Propylene Oxide
The alkene (5.94 g, 20.48 mmol) was photolyzed in eight equal aliquots. 
Nitrogen was bubbled through a solution of the alkene 2-3 (0.74 g, 2.55 mmol) and 
iodine (0.72 g, 2.83 mmol) in benzene (963 mL) for 30 minutes followed by the addition 
of propylene oxide (37 mL). The mixture was subjected to photolysis while maintaining 
a constant flow of Nj throughout the entire duration of the reaction. Reaction was 
generally complete within 8 hours as judged by TLC and 'H NMR. The reaction mixture 
was concentrated by rotary evaporation. The combined products from the eight equal 
aliquots was redissolved in CH2CI2 and washed with 15% aqueous NajSjOi. The organic 
layer was dried over NaaSOj and the solvent removed on a rotary evaporator. The crude 
product was then subjected to column chromatography as described in Method I above, 
yielding 2-4 as a colorless solid (5.68 g, 96%).
A sample of the product was rccrystallizcd from methanol giving 2-4 as white 
crystals: Rf = 0.21, 1:1 hexane/benzene; m.p. 105-107 °C; 'l l  NMR (500 MHz, CDCIj) 6 
9.09 (d, J = 8.4 Hz, 1H, ArH), 8.89 (d, J = 9.4 Hz, 1H, ArH), 8.27 (d, J = 8.8 Hz, IH, 
ArH), 8.02 (br d, J = 7.85 Hz, 1H, ArH), 7.88-7.82 (m, 3H, ArH), 7.69-7.61 (m, 2H, 
ArH), 7.44 (d, J -  9.3 Hz, 1H, ArH), 4.09 (s, 6H, 20CHj); MS-fiSI ni/z 311.0 (M + Na]\ 
599.1 [M + Naf.
Synthesis of 3.4-diacctoxvbenzofdphcnanthrcnc (2-5)
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To a stirred solution of 2-4 (3.1 g, 10.75 mmol) in dry CH2CI2 (62.5 mL) was 
added a solution of boron tribromide (23 mL of a l M solution in CH2G 2, 22.7 mmol) at 
-5 °C, under N2 over a period of 10 minutes. The mixture was allowed to warm to room 
temperature and stirred for 2 hours. The mixture was hydrolyzed with ice-cold H2O and 
diluted with CH2CI2. The organic layer was washed several times with distilled H2O to 
neutrality and dried over anhydrous Na^SOj. The organic layer was then concentrated on 
a rotary evaporator and dried further under vacuum. To the residue was added anhydrous 
diethyl ether (269 mL) followed by pyridine (9 mL, 110 mmol), acetic anhydride (20.2 
mL, 214 mmol), and 4-/V,A'-dimethyIaminopyndine (0.14 g, 1.15 mmol). The reaction 
mixture was then stirred at room temperature overnight. The mixture was diluted with 
Et20  and washed with 1 M HCI (100 mL), then with an aqueous saturated solution of 
NaHCOj. The organic layer was dried over anhydrous NuiSOa and evaporated. The 
crude product was purified by SiC>2 flash column chromatography using CH2CI2 as eluent 
to afford 2-5 as a yellowish solid (3.24 g, 88%): Rr = 0.44, CH2CI2; ’ll NMR (300 MHz. 
CDCI3) 6 9.07-9.03 (m, 2H, ArH), 8.04 (dd. J = 2.0. 8.0 Hz, IH, ArH), 7.96-7.88 (m, 3H, 
ArH), 7.83 (app d, J,pp = 8.5 Hz, 1H, ArH). 7.74-7.62 (m, 2H. ArH), 7.54 (d, J = 9.3 Hz, 
111, ArH), 2.53 (s, 3H, OCOCHj), 2.41 (s, 3H, OCOCH3); MS-ESI m/z 367.0 (M + Na]\ 
711.1 (2M + NaJ+.
Synthesis of (±)-/rw»-3.4-dihvdroxv-3.4-dihvdrohcnzofrlphcnanthrene (2-6)
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A portion of the diacctoxybenzo[c)phenathrene 2-5 (0.67 g. 1.95 mmol) was 
dissolved in absolute ethanol (217 mL) and the mixture was sonicated. This was 
followed by the addition of NaBl i4 (0.74 g. 19.6 mmol) portionwise over a 30 minute 
period, while 0 2 was bubbled into the reaction mixture. The reaction mixture was then 
stirred tinder an 0 2 balloon for 48 hours. Dilution with water caused the precipitation of 
a white solid which was filtered, washed with water and extracted into ethyl acetate. The 
organic layer was dried over anhydrous NaiS04 and evaporated. The crude product was 
punfied by column chromatography using ethyl acetate and recrystalli/.cd from hexane to 
yield the pure diol 2-6 (0.26 g, 51%) as white crystals: Rf = 0.17, 1:1 benzene/hexane; 
m.p. 192-194 °C; 'l l  NMR (300 MHz, Me2SO-4) 8 8.54-8.50 (m, 1H, ArH,2), 8.01-7.97 
(m, 1H, ArHi>), 7.91-7.84 (m. 2H, ArH78), 7.76 (app s, 2H. ArH,6). 7.66-7.60 (m, 2H, 
Arllio.i i), 7.20 (dd, J = 10.1,2.1 Hz, 1H, H,), 6.23 (dd, /  = 10.2, 2.2 Hz, 1H, Hj), 5.67 (d, 
J = 5.8 Hz, 1H, OH), 5.35 (d,y = 4.7Hz, 1H. OH). 4.60-4.54 (m.y3.4= 10.1 Hz, 111, H.,), 
4.51-4.44 (m, 1H, Hi); MS-ESI m/z 263.1 [M + H]*.
Synthesis of (±)-3a.4B-dihvdroxv-lu.2a-cpoxv-1.2.3.4-tctrahvdrobenzofclphcnanihrene
A solution of 2-6 (0.08 g, 0.30 mmol) in anhydrous THF (10 mL) was sparged 
with N2 and cooled to -78 °C. To this solution was added m-chloroperbenzoic acid (0.42 
g, 2.43 mmol) and the mixture was allowed to warm and stirred at room temperature for 1 
hour under N2. The mixture was then diluted with diethyl ether and washed sequentially
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with ice-cold 0.5 M solution of NaOH, II20, and brine. Dilution with diethyl ether 
caused the formation of an emulsion which persisted after adding brine. Dilution with 
ethyl acetate followed by washing with ice-cold 0.5 M solution of NaOH and brine gave 
a solution without emulsion. The organic layer was dried over anhydrous Na2S04 and 
evaporated to provide a faint yellow solid. The resulting solid residue was dissolved in 
cold diethyl ether and centrifuged, followed by trituration with cold 25% hexane in 
diethyl ether. This afforded the diol epoxide 2-7 as a white powder (0.058 g, 67%): R( = 
0.39, ethyl acetate; m.p. 183-185 °C; 'H NMK (500 MHz, Me2SO-<4) 6 8.67-8.64 (m, 
1H, ArH,2), 8.05-8.03 (m, IH, ArH,>), 7.98 (app d, = 8.2 Hz, 1H, ArHg), 7.91 (app d, 
yapp = 8.2 Hz, 1H, A1H7), 7.81 (app q, Jw  = 8.8 Hz, 2H, ArH5.6), 7.69-7.67 (m, 2H, 
ArHio.n), 5.84 (d. J = 6.2 Hz, 1H, OH), 5.65 (d, J = 5.0 Hz, 1H. OH), 4.74 (d. J = 4.7 Hz, 
1H, If,), 4.62-4.60 (m, JiA = 7.9 Hz, 1H, H„), 3.81-3.79 (m, IH, H3), 3.72-3.70 (m, IH, 
II2); MS-ESI mJz 301.1 [M + Na]L
Synthesis of (±l-fra>i.v-3.4-diaectoxv-3.4-dili vdrobenzofclDhenanthrcne (2-8)
The dihydrodiol 2-6 (0.66 g, 2.52 mmol) was dissolved in diethyl ether (58 mL) 
and sonicated. To the resulting solution was added pyridine (1.94 mL) followed by acetic 
anhydride (4.4 mL, 46 mmol), and 4-ALV-dimethylaminopyridine (0.03 g, 0.25 mmol). 
The mixture was stirred at room temperature overnight and was subsequently diluted with 
EtiO and washed with 1 N HCI, followed by aqueous saturated solution of NaHCC>3. The 
organic layer was dried in anhydrous Na2SQ4 and evaporated. The crude product was
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purified by Si02 column chromatography to afford 2-8 (0.70 g, 80%) as a pale brown 
solid: Rr = 0.54, 2% acetone in CH2Ct2; m.p. 148-150 °C; 'H NMK (500 MHz. CDCh) 8
8.53 (d, 7 = 7.1 Hz, 1H, ArH), 7.94-7.92 (in. III, ArH), 7.82 (d, 7 = 8.0 Hz, 1H, ArH), 
7.75 (app d, Jm  = 8.7 Hz, 1H, ArH), 7.68-7.64 (m, 2H, ArH), 7.64-7.58 (m, 2H, ArH),
7.54 (app d, Jm  = 8.0 Hz, 1H, Ht), 6.37 (d, 7 = 6.8 Hz, IH, R,), 6.27 (dd, 7=  10, 4 Hz, 
III, H3), 5.76-5.73 (m, 1H, H:), 2.18 (s, 3H, OCOCHj), 2.13 (s, 3H, OCOCH.,); MS-ESI 
m/z 369.0 [M + Na]', 715.1 [2M + Na]+.
Svnthesis of (±)-mm.v-3,4-dihenzovloxv-3.4-dihvdrobcnzolclphenanthrene (2-9)
A sample of the dihydrodiol 2-6 (0.01 g, 0.04 mmol) was dissolved in DMF (0.60 
mL) and Et3N (0.051 mL) was added. Benzoylcyanide (0.013 g, 0.10 mmol) dissolved in 
DMF (0.3 mL) was added and the mixture was stirred at room temperature for 40 
minutes. The mixture was diluted with ethyl acetate and washed with H20  followed by 
brine. The organic layer was dried over anhydrous Na2S04 and evaporated to afford the 
crude product. The crude product was purified by Si02 column chromatography using 
30% ethyl acetate in hexane to yield the dibenzoate 2-9 (0.0165 g, 92%) as a yellowish 
oil containing a trace of unseparated impurities: Rf = 0.76, ethyl acetate; 'l l  NMR (300 
MHz, CDCh) 5 8.59-8.54 (m, 1H, ArH), 8.18-7.36 (m, 18H. ArH & H,). 6.84 (d, 7=  8.5 
Hz. 1H, H4), 6.40 (dd, 7 = 10.2, 3.5 Hz, 111, H3), 6.25-6.20 (m, HI, H2); I1RMS ealed for 
C32H220 4 470.1518, found 470.1495.
2-9
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Into a 25 mL round-bottomed flask under a nitrogen atmosphere was added 
0 s0 4 (1.82 mg, 7.16 pmol) dissolved in CH2CI2 (1.5 mL). This was followed by the 
addition of phenylboronic acid (38.5 mg, 0.32 mmol), solid NMO (37.0 mg, 0.32 mmol), 
and 2-8 (0.10 g, 0.29 mmol) dissolved in CHjCb (1 mL). Additional CH2CI2 (3.2 mL) 
was added to rinse reactants off the sides of the flask and to bring volume to the desired 
amount. The reaction was stilted at room temperature under a nitrogen atmosphere for 
17 hours. A 10% aqueous solution of sodium sulfite (5 mL) was added to quench the 
reaction mixture, and the two-phase mixture was stirred for 15 minutes. The layers were 
separated, and the aqueous layer was extracted twice with CH2CI2 (100 mL, total 
volume). The combined organic layers were dried over anhydrous NaiSOj, filtered, and 
concentrated in vacuo. The crude product was purified by a trituration procedure in 
which the product was dissolved in a minimum amount of diethyl ether and excess 
hexane added followed by sonication until a precipitate formed. The resulting precipitate 
was centrifuged, rinsed with more hexane, and dried under vacuum to afford 2-10  (0.08 
g, 58%) as a gray powder: Rf = 0.37, 10% ethyl acetate in CH2CI2; 'l l  NMR (500 MHz, 
CDClj) 6 9.27 (d, J = 8.3 Hz, 1H, ArH), 7.90-7.83 (m, 3H, ArH), 7.74-7.64 (m, 4H, 
ArH), 7.48-7.46 (m, 3H, ArH), 7.34-7.32 (m, 2H, ArH), 6.61 (d, J = 8.0 Hz, 1H, H,)_
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6.48 (d, J = 8.6 Hz, 1H, H4), 5.28-5.26 (m. 1H, Hj), 5.09-5.07 (m, III, Hj), 2.15 (s, 3H, 
OCOCHj), 1.96 (s, 3H. OCOCHj); MS-ESI m Jz 491.1 [M + N af, 959.2 [2M + Na]+. 
Synthesis of (±t-3a.4p-dibcnzovloxv-la.2u-dihvdroxv-1.2.3.4- 
tetrahvdrobenzofclphenanthrene bis(phenvlboronate) (2-1 1 )
Ph
,0-0
Into a 25 mL round-bottomed flask under a nitrogen atmosphere, was added 
0 s0 4 (1.76 mg, 6.92 pmol) dissolved in CH2CI2 (1.5 mL). This was followed by the 
addition of phcnylboronic acid (37 mg, 0.30 mmol), solid NMO (35.6 mg, 0,30 mmol), 
and 2-9 (0.12 g, 0.26 mmol) dissolved in CH2CI2 (1 mL). Additional CH2CI2 (3.0 111L) 
was added to rinse reactants off the sides of the flask and bring volume to the desired 
amount. The reaction was stirred at room temperature under a nitrogen atmosphere for 
19 hours. A 10% aqueous solution of sodium sulfite (5 mL) was added to quench the 
reaction mixture, and the two-phase mixture was stirred for 25 minutes. The layers were 
separated, and the aqueous layer was extracted twice with CH2CI2 (100 mL, total 
volume). The combined organic layers were dried over anhydrous Na2S0 4, filtered, and 
concentrated in vacuo. The crude product was purified by a trituration procedure in 
which the product was dissolved in a minimum amount of diethyl ether and excess 
hexane added followed by sonication until a precipitate formed. The resulting precipitate 
was centrifuged, rinsed with more hexane, and dried under vacuum to afford 2 -11  (0.11 
g, 72%) as a gray solid. 'H NMR after the first trituration showed some impurities and so
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product was triturated a second time to obtain 2 -1 1  (0.10 g, 66%) as a gray powder: R, = 
0.62, 10% ethyl acetate in CH2CI2; !H NMK (500 MHz, CDCIj) 8 9.42 (d, J = 8.5 Hz. 
1H, ArH), 8.11 (d, J = 7.7 Hz, 2H, Aril), 8.01-7.93 (m, 6H, Aril), 7.82-7.68 (m, 5H, 
Aril), 7.57-7.33 (in, 9H, ArH), 7.04 (d, J = 9.6 Hz, 1H, H,), 6.82 (d, J = 8.0 Hz, 1H, 114), 
5.56-5.53 (m, 1H, H3), 5.46-5.43 (in, 1H, H2); HR MS ealed for C,8H27BOfl 590.1901, 
found 590.1910.
Synthesis of l±)-3a.4l)-diacetoxv-lu.2ct-dih vdroxv-1,2.3.4- 
letrahvdrobcnzofi'lphenanthrene (2-12 )
QH
The boronate derivative 2-10 (0.075 g, 0.16 mmol) was dissolved in a minimum 
amount of a 1:2 mixture of EtOAc-acetone (13 mL). A 50% aqueous solution of 
hydrogen peroxide (0.15 mL, 5.2 mmol) was added, and the reaction was stirred at room 
temperature for 10 hours. The reaction mixture was diluted with ethyl acetate, washed 
sequentially with water, 10% aqueous ice-cold Na2S03 and water. The organic layer was 
dried over anhydrous Na2SC>4 and concentrated on a rotary evaporator. The crude 
product was passed through a plug of silica gel packed with CH2C12. The compound was 
dissolved in 10% acetone in CH2C12 and passed through this silica plug. Additional 10% 
acetone in CH2C12 was added until all of the compound was eluted. The resulting oil 
obtained by evaporation of the solvent was dissolved in a minimum amount of ether and 
precipitated in hexane. The precipitate was isolated by filtration and dried under vacuum 
to afford 2-12 (0.027 g, 44%) as a colorless powder: Rr (10% acetone in CH2CI2) = 0.34;
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*H NMR (500 MHz, CDCI3) 59.24 (d. J = 8.5 Hz, 1H, ArH), 7.97-7.45 (m, 7H, ArH). 
6.45 (brs, 1H, OH). 5.89 (br s, 1H. OH), 5.32-5.29 (m, 1H, H,), 4.55-4.41 (m, 1H, H4), 
4.20-4.18 (m, 1H, Hj), 3.73-3.71 (m, 1H, H2), 2.30 (s, 3H, OCOCHj), 2.13 (s, 3H, 
OCOCH3); MS-ESI 403.1 [M + Na]+, 783.1 [2M + Na]*.
Synthesis of (±)-3a.4B-dihenzovloxv-la.2a-dihvdroxv-1.2.3.4- 
telrahvdiobenzofclphenanthrenc (2-131
The boronate derivative 2-11 (0.10 g, 0.17 mmol) was dissolved in a minimum 
amount of a 1:2 mixture of EtOAc-acctone (14 mL). To this solution was added a 50% 
aqueous solution of hydrogen peroxide (0.15 mL, 5.2 mmol) in one portion, and the 
reaction was stirred at room temperature for 5 hours. The mixture was then diluted with 
ethyl acetate, washed sequentially with water, 10% aqueous ice-cold NajSC^ and rinsed 
with more water. The organic layer was dried over anhydrous NaiSOj and concentrated 
on a rotary evaporator. The resulting yellowish-gray solid was dissolved in 5% ethyl 
acetate in CH2CI2 and eluted through a plug of silica gel packed with CH2CI2, using 5% 
ethyl acetate in CH2CI2 as eluting solvent. The solution was concentrated on a rotary 
evaporator and dried on vacuum line. The crude product was dissolved in a minimum 
amount of ether and precipitated in hexane. The precipitate was isolated by filtration and 
dried under vacuum to afford a colorless solid. The impure solid was purified by Si02 
column chromatography eluting with 2% ethyl acetate in CH2CI2 to afford 2-13 (0.04 g, 
58%) as a yellowish-white solid: R, (5% ethyl acetate in CH2CI2) = 0.38; m.p. 102-104
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°C; 'H NMK (500 MHz, CDC13) 5 9.29 (br d, J = 8.5 Hz, 2H, H12 roaj(X minor isomel), 
8.23-8.21, 8.10-7.92, 7.83-7.42 (m, 34H. ArH minor™™). 7.09 (d, J = 4.7 Hz, 1H,
Hi minor isomer)* 6.76 (d, J = 2.6 Hz, 1H, H| major isomer)* 6.08~6.05 (m, 2H, IT4 major and minor
\
isomer). 5.84 (t, J — 3.7 Hz, 1H, H2 In)nor isomer), 5.65 (t, J — 3.2 Hz, 1H, H2 isomer), 4.74 
(br, 1H, H3mij„, isomer), 4.62 (br. 111, 1I3 minor isomer); MS-ESI 527.1 [M + Na]*, 1031.1 [2M 
+ Naf; HRMS ealed forC32H240 6 504.1573, found 504.1578.
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CHAPTER 3
COMPUTATIONAL EVALUATION OF DIASTEREOSELECTIVITY IN THE 
SYNTHESIS OF A KEY INTERMEDIATE LEADING TO NUCLEOSIDE ADDUCTS
OF BaP AND BePh
3.1 Introduction
As described in the introductory section, polycyclic aromatic hydrocarbons 
(PAHs) are ubiquitous environmental contaminants, which exhibit cytotoxic, mutagenic 
and carcinogenic activity through metabolic activation to diol epoxides.62 For more than 
six decades, scientists have been trying to probe the structural factors responsible for 
PAH carcinogenesis.121 Studies of a variety of diol epoxides have shown that factors 
contributing to carcinogenicity include reactivity, conformation adopted by molecules 
and absolute configuration in addition to the conformation.62 Metabolism and DNA 
binding of any PAH results in 16 possible nucleoside adducts, in which each diol epoxide 
reacts with dcoxyadenosinc or deoxyguanosine through cither a cis or trans oxirane bond 
scission.25 The extent to which diol epoxide isomers of PAHs react with DNA varies, 
and the reactivity of each diol is selective. Hence, for detailed structural and biological 
studies, it is necessary to generate diastereoselective syntheses of each diol epoxide- 
nucleoside lesion. En route to a diastereomericaliy pure diol derived from the 
dihydrodibenzoate of benzo[a]pyrene (BaP), an unexpected and interesting result was
61
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discovered.119 Catalytic OsCXi dihydroxylation of benzo[a]pyrcnc dihydrodibenzoate 3-1 
proceeds with reasonably high facial selection producing tetraol dibenzoatc BaPI as the 
major product (Scheme 1). A Narasaka dihydroxylalion using catalytic OsO,i and 
phenylboronic acid, PhB(OHb, however, produced the tetraol dibenzoate boronate 
BaPBl exclusively.11̂ This boronate, upon oxidation, provides the diastereomerically 




Scheme 3.1 Synthesis of tetraol dibenzoate and tetraol dibenzoate boronate derivatives 
of bcnzo[rr]pyrcne.
It is also of interest to apply the same set of reactions to the more sterically 
congested benzo[c]phenanthrene (BcPh) derivatives (Scheme 3.2). The question 
therefore was to find out if the dihydroxylation reaction could equally be applicable to 
BcPh. If the dihydroxylation reaction is applicable to BcPh, then by analogy to the Bal’ 
case the sequence outlined in Scheme 3.2 could occur. As shown in Scheme 3.2, 
subjecting (±)-/ran.v-3,4-dibenzoyloxy-3,4-dihydrobenzo[c]phcnanthrene 3-2 to Narasaka
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dihydroxylation could produce the isomers of the tetrahydrodiol dibenzoate boronate 
derivatives BcPBl and BcPB2. The boronate could then be oxidized to the isomers of 
3,4-bis(bcnzoy loxy)-1,2-dihydroxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene BcP 1 and 
BcP2. An interesting question that arose during these studies was: Can computational 
methods aid in understanding the diastereoselectivily of some of the reaction steps in the 
syntheses of BaP (Scheme 3.1) and BcP (Scheme 3.2) intermediates'? Such intermediates 
are then valuable precursors for the synthesis of nucleoside lesions.
...OCOPh
PhB(OH)2
, .. .. 'OCOPh-------------------------
















Scheme 3.2 Synthesis of tetraol dibenzoate and tetraol dibenzoate boronate derivatives 
of benzo[c]phenanthrene.
The computational techniques include drawing an initial structure of the 
molecule, and then applying both molecular mechanics (MM) and quantum mechanics 
(QM) methods; the computations can determine the physical properties of the molecules. 
The incorporation of conformational searching methods, such as Monte Carlo (MC), 
makes the treatment of large organic molecules with many degrees of freedom easier.
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MC conformational search using the MMFF94 force field determines the lowest-energy 
conformation of each isomer. Semi-empirical AMI quantum mechanical methods 
determine the equilibrium geometry and heats of formation for the isomers. Boltzmann 
weighting factors assess the relative probability or population of each isomer.
The flexible torsion angles for the MC and AMI geometries are measured and 
compared. Semi-empirical AMI calculations also provide thermodynamic quantities 
such as standard enthalpies and entropies. The solvation energies for the tetraol 
dibenzoate isomers are also obtained using the SM5.4 model of Cramer and Truhlar.1 ” 
Laali et al. have successfully carried out AMI scmi-cmpirical calculations to explain the 
selectivity in the synthesis of stereoisomers of chrysene.12'1 Recently, a computational 
investigation aimed at explaining the differences in stereochemical, structural, and 
thermodynamic stability between stercoisomeric bcnzo[a]pyrcne diol epoxides has been 
repotted.16 These workers investigated the origins of the stability of the stereoisomeric 
benzo[a]pyrene deoxyadenosine adducts in a DNA mutational hot spot sequence using a 
combination of molecular dynamics and molecular mechanics with Poisson-Boltzmann 
surface area methods to compute the free energy differences. Similar computational 
investigations have been repotted employing the (+)-lfl and (-)-l.V-fram «»ri-BcPh-/V’- 
guanosinc adducts, void of the sugar residues, as prototypes.87 Computational methods 
involved energy minimization aimed at investigating the benzylic ring conformation and 
fjord region twist using high-resolution NMR solution structures.
The isomeric derivatives of bcnzo[«]pyrenc (Figure 3.1) arc represented by BaPl 
and BaPBl for the anti isomers (major isomers) and BaP2 and BaPB2 for the syn isomers 
(minor isomers). The corresponding isomeric derivatives of benzofcjphenanthrene
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(Figure 3.2) are represented by BcPl and BePBl for anti isomers (major isomers) and 
BcP2 and BcPB2 for the syn isomers.
Figure 3.1 Isomeric boronates of BaP and BcPh with torsion angles.
OCOPh
(±)-BaP1
Figure 3.2 Isomeric tetraol dibenzoates of BaP and BcPh with torsion angles.
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The torsion angles measured are also defined and shown in Figures 3.1 and 3.2. 
Only the torsion angles at the point of difference in configuration of the isomers were to 
be considered. The goal of this chapter then is to elucidate the fundamental structural 
differences between the isomers that account for their difference in reactivity and to 
relate the results to experimental observations.
3.2 Methods
Starting structures were first built in 2 dimensions (2D), then converted to 3 
dimension (3D) in PC Spartan Pro (Wavefunction, Inc.). The structures were then 
refined by minimization with the Merck molecular mechanics force field (MMFF94). 
The stereochemistry of the refined starting geometry was assigned by choosing configure 
labels from the Model menu and checking chirality from the dialog that appeared. This 
way the chiral centers were labeled using the R, S configuration. The refined molecular 
structure was then subjected to a Monte Carlo (MC) conformational search to establish 
the best conformer (low-energy conformer) for the molecule. In the Setup calculation 
menu, conformer distribution and equilibrium geometry were chosen as the task to be 
accomplished. Molecular mechanics using MMFF94 force field was chosen as the type 
of calculation method. No constraints were applied and no frozen atoms were chosen. 
After establishing the best energy conformation (global minimum) or a structure close to 
it, AMI semi-empirical calculation was performed to establish the equilibrium geometry 
of this conformer. In setting up the quantum mechanical calculation, equilibrium 
geometry was chosen as the task to be performed while scini-cmpirica! AMI was chosen 
as the method. Again no constraints were applied and no frozen atoms chosen. In the 
compute menu, solvation energy was chosen for the tetraol dibenzoate isomers, but not
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for the boronate dibcnzoate isomers, because the method has not been parameterized for 
boron atom. Choosing the solvation energy in the compute menu enabled the calculation 
of the aqueous solvation energy using the SM5.4 procedure of Cramer el al.m  The 
solvation energies calculated are usually added to the gas-phase total energies obtained 
from AMI calculations. Because the SM5.4 procedure of Cramer el al. has not been 
parameterized for the carbon-boron bond, solvation energy option was not chosen for the 
boronate dibenzoate derivatives. Frequency was also checked in the compute menu 
ensuring the calculation of second derivatives of energy, which were used to calculate the 
zero-point vibrational energies. Calculation of an electron density surface as well as the 
electron density surface onto which the value of the electrostatic potential had been 
mapped was performed.
The incorporation of MC conformational search method in PC SPARTAN Pro 
was important particularly for the treatment of large and flexible organic molecules with 
large numbers of degrees of freedom. First, an initial geometry was produced using the 
Builder menu in PC Spartan Pro, and its structure was optimized by molecular mechanics 
energy minimization using the MMFF94 forecfield to obtain initial strain energy, This 
initial refined structure was then submitted to the MC conformational search that located 
all readily accessible conformations with the goal of attaining the global minimum. The 
resulting minimum energy conformcr was compared with previously found conformers to 
test for the possibility of duplication. If the newly generated conformer was a previously 
undiscovered conformer, then it was added to an accumulating list of unique conformers. 
The cycle was then repeated, and a new starting geometry was obtained and energy 
minimized. The search was terminated when new minima ceased to be found, and the
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lowest energy conformation was reported. Starting geometries were generated using 
random or pseudorandom variations of molecular geometry. Because no bonds were 
constrained the conformational search ran for a sufficiently long period of time covering 
all regions of conformational space. The probability of finding new conforincrs at any 
point in time depended upon the number of undiscovered conformers, in which case the 
number of new conformers decreased as the search progressed. The search began at an 
initial temperature of 5000 K, and this temperature was varied until the lowest energy 
conformation was found at 300 K.
At the end of the conformational search, similar molecules and high energy 
conformers were discarded, leaving only the best conformations (i.e., low energy 
conformations). The best conformations, a maximum of 100 conformations, were 
retained and displayed on a spreadsheet. By sorting these conformations, the spreadsheet 
arranged them according to their potential energies in keal/mol beginning with the lowest 
energy conformation. The lowest energy conformation was then saved in preparation for 
a semi-empirical AMI calculation to determine the equilibrium geometry.
The semi-empirical AMI calculation was used to obtain the heat of formation of 
the lowest energy conformer of one isomer relative to the other. In the AMI calculation, 
the following menus were chosen in the Calculations dialog: Equilibrium Geometry, 
Semi-empirical, AMI and MMFF conformer. The calculation was performed in the gas 
phase with a total molecular charge of 0 and spin multiplicity of 1 .
The strain energies were obtained from the molecular mechanics (MM) 
calculations, while the heats of formation were obtained from semi-empirical calculations 
using a restricted Hartree-Fock AMI (RHF/AM1) model. The zero-point vibrational
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energies were obtained by checking the vibrational modes in the setup calculation menu. 
Standard thermodynamic quantities obtained at 298.15 K and 1.00 atm included the 
translational, rotational, and vibrational enthalpies and entropies. The conformational 
enthalpies and entropies were calculated from the translational, rotational and vibrational 
enthalpies and entropies. The conformational free energies and Boltzmann weighting 
factors were determined using standard thermodynamic relationships.124
The Boltzmann weighting factor or fractional statistical weight, , of each 
isomer relative to the other was computed from the relationship
( 1)p  _  iL _ , ar-u u»t 
N, "
Where AE12 is the relative energy of the isomers in keal/mol; R is the universal gas 
constant in kcal mol'1 deg'1, and T is the temperature in kelvin. The free energy changes 
(AG) were then computed from the relationship
AG = AH - TAS (2)
The flexible torsion angles, at the point of difference, for each isomer were measured 
using the Geometry model in PC Spartan Pro.
3.3 Results
The potential energies of the lowest energy conformations obtained after the MC 
conformational searches for the tetraol dibenzoate and boronate isomers of 
benzo[a]pyrene and benzo[r)phenanthrene are shown in Table 3.1. The calculated 
Boltzmann weighting factors are also shown in Table 3.1. The flexible torsion angles for 
the lowest energy conformations after the MC conformational searches are given for the 
boronate isomers in Table 3.2 and for the tetraol dibenzoate isomers, in Table 3.3. Note 
that there are five torsion angles for each of the boronate isomers and two torsion angles
iced with permission of the copyright owner. Further reproduction prohibited without permission.
70
for each of the tetrao] dibenzoate isomers. Only those torsion angles at the point of 
reaction and where the isomers differ in absolute configuration are considered. The heats 
of formation by AMI semi-empirical method for the boronatc and tetraol dibenzoatc 
isomers of benzo[«]pyrene and benzole]phenanthrene are shown in Table 3.4. Also 
included are the energy differences between the isomers and the Boltzmann weighting 
factors.
Table 3.1 Lowest Potential Energy Conformations Obtained by MC Conformational Searches at 298.15 K.

















Table 3.2 Measured Torsion Angles for the Boronate Isomers (degrees).
Angle Atoms BaPBl BaPB2 BcPBl BcPB2
Yl C-C-B-O -37.85 -24.70 -42.61 -34.44
Y 2 C-B-O-C -107.21 119.06 -102.07 -98.21
Yr B-O-C-H -145.82 137.20 77.44 -151.87
Y* B-O-C-H 80.50 -75.94 -159.13 80.59
Y s C-B-O-C 132.10 -144.58 129.65 125.85
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Table 3.3 Measured Torsion Angles for the Tctraol Dibenzoatc Isomers (degrees).
Angle Atoms BaPl BaP2 BcPl BcP2
Ya H-O-C-H -73.22 73.81 66.38 -71.47
r# H-O-C-H -71.09 96.76 68.46 -97.82
Table 3.4 Heals of Formation by AMI Semi-empirical Calirulations.

















Tables 3.5 and 3.6 show the torsion angles measured for the AMI geometries of 
the boronatc isomers of BaP and BcP and tctraol dibenzoatc isomers, respectively. As in 
the case of the MC geometries, five torsion angles are reported for the boronatc isomers 
and two torsion angles for the tetraol dibenzoate isomers. The four atoms defining the 
torsion angles are also represented in the tables. For each isomer the same set of four 
atoms were picked so a comparison between the isomers could be made without 
ambiguity. The same symbol was used for the angles in both isomers. The torsion angles 
for the boronatc isomers are read in a clockwise direction.
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Tabic 3.5 Measured Torsion Angies for the Boronate Isomers of AMI Geometry (degrees).
Angle Atoms BaPBI BaPB2 BcPBl BcPB2
y i C-C-B-0 0.87 -5.62 -3.68 6.63
T! C-B-O-C -178.69 179.22 178.97 175.93
Y 3 B-O-C-U -118.94 121.00 116.67 -113.28
Y4 B-O-C-H 114.75 -112.43 -116.28 119.65
Ys C-B-O-C -178.61 176.36 179.12 -177.28
Table 3.6 Measured Torsion Angles for the Tetraol Dibenzoate Isomers of AM 1 Geometry (degrees).
Angle Atoms BaPl BaP2 BePl BcP2
Yu H-O-C-H -69.30 164.77 68.09 -170.03
Yp H-O-C-H -71.84 78.54 63.33 -59.95
The standard thermodynamic quantities computed at 298.15 K and 1.00 atm are 
shown in Table 3.7.
The energy due to solvation for the tetraol dibenzoate isomers calculated using the 
SM5.4 model of Cramer and Truhlar is shown in Table 3.8. The energy difference and 
Boltzmann weighting factors calculated are also provided.
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Tabic 3.7 Thermodynamic Quantities at 298.15 K and 1.00 atm.
Compound AG (kcal/mol) G (kcal/mol) 11 (kcal/mol) TS (kcal/mol)
BaPI 284.904 344.260 59.356
0.073
BaP2 284.977 344.275 59.298
BaPBt 322.049 396.141 67.092
1.211
BaPB2 330.261 396.279 66.018
BcPI 277.153 334.969 57.816
-0.026
BcP2 277.127 335.234 58.107
BcPBl 320.926 386.836 65.910
0.769
BcPB2 321.695 386.836 65.141
Tabic 3.8 Solvation Energies of Tclraol Dibenzoate Isomers.










The major and minor isomers of the tetraol dibenzoates of benzojujpyrene BaPI
and BaP2 differ by 1.091kcal/mol with the minor isomer BaP2 having a greater energy
(Table 3.1). The Boltzmann factor of the minor isomer BaP2 relative to the major isomer
BaPI is 0.159, and assuming that only these isomers are formed, then the Boltzmann
factor for the major isomer is 0.841. Then the population would be 15.9% for the minor
isomer BaP2 and 84.1% for the major isomer BaPI. The same trend is seen for the
energies of the lowest energy conformations of the major and minor isomers of the
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boronatc derivatives of bcnzo[a]pyrene BaPBl and BaPB2 where the major and minor 
isomers, BaPBl and BaPB2 respectively differ by 2,566 keal/mol with the minor isomer 
BaPB2 having a greater energy. The Boltzmann factor results in populations of 98.7% 
and 1.3% for the major isomer BaPBl and the minor isomer BaPB2 respectively. The 
lowest potential energy conformations of the tetraol dibenzoatc isomers of 
bcnzo[e]phenanthrenc BcPl and BcP2 differ by 3.393 keal/mol with the minor isomer 
BcP2 having a greater energy. The Boltzmann distribution gives a 99.7% to 0.3% of the 
major isomer BcPl relative to the minor isomer BcP2. The boronate isomers of 
bcnzo[c]phcnanthrcne, the major and minor isomers BcPBl and BcPB2 respectively, 
differ by 2.944 keal/mol, and again the minor isomer BcPB2 has a greater energy with 
Boltzmann ratio of 99.3% to 0.7%. From energy considerations, the higher the energy 
the less stable the conformation and vice versa; thus, it is reasonable to expect the minor 
isomer BcPB2 to have a higher energy.
Comparing the potential energies of conformations of BaP and BcP, the values for 
BcP are slightly larger and the Boltzmann factor for the more stable isomers arc greater. 
The trend is going from BaP to BcP, there is more major isomer than minor isomer. If 
one considers the geometry of both BaP, which is planar, and the more sterically 
congested BcP, which is non planar, one could infer that the slightly higher energies for 
BcP may be reasonable by virtue of its geometry. Looking at the torsion angles for the 
boronate isomers, Table 3.2, and comparing y'j and y’j for the major isomers (BaPBl and 
BcPBl), the smaller torsion angles for BcPBl may be due to the proximity to the 
congested fjord region of benzo[i']phenanthrcne. This tight geometry creates greater 
strain energy. The torsion angles for the tetraol dibenzoatc isomers, Table 3.3, also show
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a similar trend. Therefore, the more congested the geometry of a conformer, the larger its 
strain energy.
A more reliable evaluation of the stability of the isomeric compounds of BaP and 
BcP can be accomplished by semi-empirical quantum mechanics. From AMI, the heats 
of formation for the tetraol dibenzoate isomers of benzo[a]pyrene (BaPI and BaP2) 
indicate stability assuming that the entropic contributions to the energy are negligible 
(Table 3.4). The heats of formation of the major and minor isomers (BaPl and BaP2 
respectively) differ by 1.788 keal/mol with the heat of formation of the minor isomer 
(BaP2) being greater than that of the major isomer (BaPl). The Boltzmann factor gives a 
ratio of 95.1% to 4.9% for the major isomer relative to the minor isomer (Table 3.4). The 
heats of formation of the boronatc isomers of bcnzo|u]pyrcne (BaPBl and BaPB2) again 
indicate that the minor isomer (BaPB2) is greater than the major isomer (BaPBl) by 
1.158kcal/mol. The Boltzmann factor in this case gives a ratio of 85.8% to 14.2% for the 
major isomer (BaPBl) relative to the minor isomer (BaPB2). In Table 3.4, the heat of 
formation of the minor isomer of the tetraol dibenzoate derivative of 
benzo[c]phenanthrene (BcP2) is greater than the major isomer (BcPl) by 1.532 keal/mol, 
with the Boltzmann factor giving a ratio in percentage of 92.5% to 7.5% of the major 
isomer relative to the minor isomer. A much larger difference in the heats of formation 
in the boronate isomers of benzo[c]phenanthrcne, compared to the others, 3.573 keal/mol 
is observed for the major and minor isomer with the minor isomer (BePB2) having a 
greater energy than the major isomer (BcPBl). The major isomers all have lower heats 
of formation and, therefore, are more stable. For the tetraol dibenzoate and boronatc 
isomers, compared to the torsion angles of the MC geometries, the torsion angles of the
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AMI geometries are more symmetrical for the various isomers in which the angles are 
almost the same in magnitude but differ in direction (Tables 3.5 and 3.6).
Considering thermodynamic quantities (Table 3.7), except in the case of tctraol 
dibenzoate of bcnzo[e]phcnanthrenc (BcPI and BcP2), The results show that the 
computed free energies favor the major isomer just as heats of formation (Table 3.4). For 
the isomers BaPl and BaP2, the computed free energy favors the major isomer, BaPl, by 
0.073 kcal/mol. For the isomers BaPBl and BaPB2, the computed free energy favors the 
major isomer by 1.211 kcal/mol. For the BcPBl and BcPB2 isomers, the computed free 
energy favors the major isomer by 0.769 kcal/mol. The computed free energy favors the 
minor isomer in ease of the BcPI and BcP2 isomers by 0.026 kcal/mol. Computing free 
energy differences due to solute entropy, however, shows that only in the case of the 
BcPI and BcP2 isomers is the major isomer favored by 0.291 kcal/mol. The solvation 
energies (Table 3.8) favor the major isomers in both BaP and BcP. The Boltzmann factor 
of the isomers of BaPl and BaP2 show a ratio of 95.7% to 4.3% favoring the anti isomer 
(BaPl). Boltzmann ratio of 71% to 29% in the case of BcPI and BcP2 favors the anti 
isomer, BcPI, also. The heat of formation characterizes the stability of a molecule, with 
the most stable molecule having the lower heat of formation. Within reasonable margin 
of error, computational studies are in agreement with experimentally observed relative 
stabilities.
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3.5 Summary
To determine the difference in energy between two isomers, it is necessary to 
determine the lowest energy conformation or global minimum of each isomer. The 
MMFF molecular model can be used for assigning the lowest-cnergy conformation, while 
semi-empirical AMI quantum mechanical model can be used to obtain the best- 
optimized geometry for the conformcrs and to determine the heats of formation, the 
energies of solvation and other thermodynamic quantities. Geometry optimizations 
generally give structures of low energy. The use of MC conformational search facilitates 
easy treatment of large organic molecules having many degrees of freedom.
Experimental results have shown the predominance of BaPl, BaPBi, and BcPBI 
(major isomers) compared to BaP2, BaPB2, and BcPB2 (minor isomers). Experimental 
results in the case of BcPl and BcP2 have shown a mixture of products one case in a ratio 
of 60% to 40% and a second case in a ratio of 75% to 25%, but these were unoptimized 
and the isomers were not isolated. Thus experimental results for BcPl and BcP2 are 
inconclusive, and further experimentation is necessary. On the other hand the 
computational results in the BaP case arc a good match.
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CHAPTER 4
PALLADIUM-CATALYZED SYNTHESIS OF NUCLEOSIDE ADDUCTS 
CORRESPONDING TO T! IOSE RESULTING FROM THE BINDING OF 
BENZO[a]PYRENE RADICAL CATION TO 2 -DEOXYADENOSINE
4.1 Introduction
On the basis of the studies of polycyclic aromatic hydrocarbon (PAH) metabolism 
coupled with the catalytic property of cytochrome P-450, it has been hypothesized that 
PAHs arc mctabolically activated by single electron oxidation to form radical cations 
which are also implicated in the DNA-adduct formation.26 27 Single electron oxidation of 
PAHs produces radical cations that then react with a variety of nucleophilic sites in 
deoxyadenosine (dA) and deoxyguanosinc (dG) producing adducted nucleobascs and 
nucleosides. A range of adducts can be produced from radical cations. Among these 
adducts, /V7 adducts are labile and produce apurinic sites in DNA,26,27 Nl and /V5 adducts 
are also known.26'27 Reaction of radical cations at the cxocyclic amino groups of dA and 
dG can lead to stable lesions (Figure 4.1).26,27 Reactions of the radical cations with DNA 
could, therefore, produce covalently modified DNA. Errors in replication and 
deficiencies in repair of such alkylated DNA could then be the underlying basis for tumor 
production. Due to our interest in chemical carcinogenesis, we wanted to develop 
methods for the synthesis of nucleoside adducts of PAHs through both metabolic 
pathways (explained in Chapter 1).
78
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Adducts. when incorporated into identical DNA sequences, would allow for a 
detailed analysis of the structures and biological implications of each type of lesion. 
Such studies may enable the determination of the significance of one metabolic pathway 
over the other in the realm of chemical carcinogenesis induced by PAHs.
on
DB[a,/]P-10-N6 dA
Figure 4.1 Structures of nucleoside adducts from single electron oxidation of some PAHs.
Several approaches have been investigated to establish radical cations as key 
intermediates in the metabolic activation of PAH. Electrochemical oxidation of some 
PAHs in the presence of nucleosides has been used to generate PAH-nucleoside 
adducts.3'’ ”  130 In some cases, adducts have been obtained in which covalent binding
to DNA is mediated by enzymes such as horseradish peroxidase or rat liver microsomal 
cytochrome P-450.125,30133 An alternative approach for generating PAH radical cation- 
nucleoside adducts involve the use of Ij as the oxidant.b4 PAHs are oxidized by I2 to
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form radical cations that react readily with a variety of nucleophiles. The generation of 
PAH radical cation-nucleoside adducts involving the use of MnfOAch as oxidant has 
also been reported.115 Whatever method is employed to generate radical cations, two 
important features of these intermediates arc their low oxidation potentials making them 
readily oxidizable, and their charge localization that allows for efficient and specific 
reactivity towards nucleophiles.136
Because of the pioneering effort of the Lakshman group in the use of palladium 
catalysis for nucleoside modification, we became interested in evaluating a rapid 
synthesis of nucleoside adducts produced by single electron oxidation of benzo[a]pyrcnc 
(BoP). Using various combinations of palladium catalyst, base and ligand, a library of 
suitable reagent combination and solvent for the synthesis of nucleoside adducts has been 
developed. In this chapter, evidence is presented that stable adducts at the exocyclic 
amino groups of nucleosides produced by single electron oxidation of PAIIs can be 
synthesized via a palladium-catalyzed carbon-nitrogen bond formation (Scheme 4.1).
TBDMSO.
OTBDMS






Scheme 4.1 Palladium-catalyzed carbon-nitrogen bond formation.
Adduct structure determination was accomplished by using UV, NMR, and high 
resolution mass spectrometry. This is the first evidence for the palladium-catalyzed
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synthesis of adducts corresponding to the binding of polycyclic aromatic hydrocarbon 
radical cations to nucleosides. This method avoids the use of electrochemical apparatus 
which is not readily available in most organic laboratories and is thus more convenient.
4.2 Synthesis
The last few years have seen a tremendous growth in palladium-catalyzed C-N 
bond formation largely due to the efforts of Buchwald,| 17'n9Hartwigl4<M42and Koie141. 
Lakshman el al. have demonstrated that palladium catalysts is a powerful technique for 
the introduction of aryl groups at the exocyclic amino group in dA.144 More recently, a 
similar methodology was applied for dG modification.143 A retrosynthetic analysis of the 
synthetic strategy for preparing single electron oxidation adducts is shown in Scheme 4.2.
6-Amino-BaP 6-Bromo-BaP
Scheme 4.2 Retrosynthetic analysis for the synthesis of single electron oxidation adducts. 
As shown in the retrosynthetic analysis (Scheme 4.2), two possible alternatives exist for 
the palladium-catalyzed arylation of dA and dG.144 These are: (a) Nucleoside is the amine 
donor, which is reacted with a bromoaromatic compound, and (b) Aromatic amine is 
reacted with a bromonuclcosidc.
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In their recent work on palladium catalysis, Lakshman el al.'u  have demonstrated 
that alternative (a) which involves reaction of a protected nucleoside with a 
bromoaromatic was not viable with simple aromatic systems. Subsequently, Johnson and 
coworkers demonstrated that option (a) is useful when the aromatic residue contains the 
highly electron-withdrawing nitro group. 146 In the present study, particular interest was 
geared towards ascertaining whether both options (a) and (b) arc usable when the aryl 
residue is an extended aromatic system such as pyrene and ben/.o(«]pyrenc. It was also 
important to evaluate which of the two combinations was superior for preparing 1 
pyrenyl and 6-benzo[a]pyrenyl adducted dA.
Several factors needed investigation with each pair of coupling partners to 
ascertain the viability of both approaches. For initial experimentation, the simpler 
systems 1-bromopyrene and l-aminopyrcne were chosen, both of which are 
commercially available. The nucleosides can be easily synthesized following literature 
procedure.144 The factors that could influence the reaction include palladium catalysts, 
ligands, base and solvent, all of which are commercially available. Systematic studies 
with palladium species, ligand, base and solvent as variables is important in designing a 
protocol for palladium catalyzed synthesis of the nucleoside adducts. Identification of 
optimal conditions with respect to the variables will then lead to the synthesis of the 
nucleoside adducts.
iced with permission of the copyright owner. Further reproduction prohibited without permission.
83
Table 4.1 Palladium Species. Bases and Solvents Used in the C-N Coupling.
Pd species Pd2(dba)3 Pd(OAc)2
Bases CS2CO3 K3PO4 t-BuONa
Solvents PhMe DME Dioxane THF
E F G H
Figure 4.2 Some commercially available ligands for Pd-catalyzed C-N reactions. 
A: 2-(dicyclohexylphosphino)-2’-(ACV-dimethylamino)-1,1 ’-biphenyl.
B: (±)-2.2’-bis-(diphcnylphosphino)-1,1 ’-binaphthyl (BINAP).
C: 2-(dicyclohexylphosphino)-l,l'-biphcnyl.
I): 2-(di-/ert-butylphosphino)-l, 1 ’-biphenyl.
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The palladium species, bases and solvents that were employed in the synthesis arc 
shown in Table 4.1 while some new ligands for palladium catalyzed C-N bond formation 
are shown in Figure 4.2. To determine adducts formed in biological systems, it is 
important to efficiently synthesize and characterize adducts that can serve as reference 
standards.
4.2.1 Synthesis of Pvrenvl Adduct of Deoxvadenosine (dA)
Both alternatives (a) and (b) shown in Scheme 4.2 were investigated in the 
synthesis of the pyrcnyl adducts of dA. For alternative (a), the influence of various 
palladium catalysts, ligands and bases on the course of the reaction between 3’,5’-bis-0- 
(/er/-bulyldimethylsiiyl)-2’-dcoxyadcnosme (4-1) and 1-bromopyrene (4-2) was studied 
(Scheme 4.3).
Scheme 4.3 Pd-catalyzed synthesis of an N6-pyrenyI adduct from 1-bromopyrene.
The amine (4-1) was coupled with 1-bromopyrene (4-2) in the presence of a 
palladium catalyst, base, and ligand in an organic solvent resulting in the adduct 4-3 
(Scheme 4.3). Among the commercially available ligands, A, B, C, and D (Figure 4.2) 
were chosen based on the use of these ligands in palladium-catalyzed coupling reactions 
as reported in the literature. Table 4.2 shows the results from the optimization studies. 
Best results were obtained with Pd(OAc)2, BINAP and CS2CO3 (entry 3). As is amply 
evident from Table 4.2 choice of the right combination of catalyst, ligand, and base is
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critical. The reaction was cautiously carried out at a temperature not to exceed the 
boiling point of the solvent. Reactions were monitored by TLC and purified by column 
chromatography. The choice of solvent toluene was determined by both the solubility of 
the reagents as well as its use in amination chemistry.
Table 4.2 Variables and Results for the Coupling of 4-1 and 4-2.
Entry Pd species" Ligand* Base Temp (°C) 
Time (li)
Results'"
1 Pd2(dba)3 A k 3po4 90, 20 41%, pyrene byproduct
2 Pd2(dba)3 A t-BuONa 90, 20 24%, pyrene byproduct
3 Pd(OAc)2 B Cs2C 03 90,4 90%
4 Pd(OAc)2 C t-BuONa 90, 20 No product formation
5 Pd(OAc)2 C k ,po 4 90,21 No product formation
6 Pd(OAc)j I) t-BuONa 90,21 No product formation
7 PdfOAch I) k 3po 4 90,21 No product formation
“ All palladium species were used in 10 mole %. "The following mole % of the ligands 
were used A (30%), B (15%), C (20%), 1) (20%). 1 All reactions were carried out in 
PhMe. Ligands: A: 2-(dicyclohexylphosphino)-2’-(A,,/V-dimethylamino)-l, 1 '-biphenyl.
B: (±)-2,2’-bis-(diphenylphosphino)-l,l’-binaphthyl. C: 2-(dicyclohcxylphosphino)-l,l’- 
biphcnyl. I): 2-(di-tm-butylphosphino)-l,r-biphenyl.
From Table 4.2, use of tris(dibenzylideneacetone)dipalladium [Pdafdba)^], in
combination with 2-(dicyclohexylphosphino)-2’-(N,Ar-dimethylamino)-1,1'-biphenyl 
ligand A, gave the desired product with either K3P04 (Entry 1) or sodium ferf-butoxide 
(Entry 2). In both cases, more catalyst was added after 18 hours, and the reaction 
continued for two more hours. Low to modest yields, however, were obtained along with 
the formation of pyrene as a byproduct. Although the products were isolated
iced with permission of the copyright owner. Further reproduction prohibited without permission.
86
chromatographically from the byproducts, ‘H NMR still showed inseparable and 
uncharactcrizcd impurities. It is evident from Table 4.2 that the combination of ligand B. 
Pd(OAc)j, and CsjCOj (Entry 3) was superior to all other combinations investigated both 
in yield and reaction time, resulting in a 90% isolated yield of 4-3 with reaction complete 
in 4 hours. To investigate the idea that no single variable will promote coupling but the 
right combination of variables, the palladium catalyst Pd(OAc)i was used with different 
ligands and bases. Interestingly, use of Pd(OAch in combination with other ligands and 
bases resulted in little or no product formation (Entries 4-7, Table 4.2). Reaction 
mixtures in these cases were checked by TEC and were shown to contain substantial 
amounts of 1-bromopyrene.
To test option (b), 6-bromo-9[2-deoxy-3,5-bis-<9-(fe«-butyldimcthylsilyl)-P-D- 
erythro-pcntofuranosyllpurinc144 (4-4) was reacted with 1-aminopyrcne (4-5) and the 
influence of palladium species, ligand, and base on the outcome of the reaction 
investigated (Scheme 4.4).
Scheme 4.4 Pd-catalyzed synthesis of pyrenyl adduct from l-aminopyrene.
In this case, ligands A and B that were shown to be superior to the other ligands 
for alternative (a), were used. The choice of base was also limited to C.S2CO3 and K.3PO4. 
The solvent used was 1,2-dimethoxyethanc (DME) because this solvent had previously 
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the C-6 position of dcoxynucleosides as reported by Lakshman et al. Two different 
reaction conditions (Entries 1 and 2, Table 4.3) were used. Compared to option (a), the 
reaction times here were generally shorter.
Table 4.3 Variables and Results for the Coupling of 4-4 and 4-5.
Entry Pd species" Ligand*’ Base Temp (°C) 
Time (h)
Resullsr
1 Pd2(dba)3 A K3PO4 80,2 52%, clean product
2 Pd(OAc)2 B CSjCO^ 80, 1 73%, somewhat impure
were used A (30%), B (30%). ' All reactions were carried out in DME.
Ligands: A: 2-(dicyelohexylphosphino)-2'-(/V./V-dimcthyUmino)-1,1'-biphenyl.
B: (±)-2,2’-bis-(diphcnylphosphino)-1,1 '-binaphthyl.
As in the previous case, the use of Pd(OAc)2 and BINAP with Cs2CC>3 gave a
better result but this was somewhat impure compared to the Pd2(dba)3, ligand A, and 
K3PO4 combination. The product obtained from the Pd>(dba)3, ligand A, and K3PO4 
combination was pure after column chromatography. However, the product in the case of 
Pd(OAe)2, ligand B, and CS1CO3 combination contained some uncharacterized impurities 
as evident by 'H NMR. Efforts to vigorously purify the product by column 
chromatography were unsuccessful.
4.2.2 Synthesis of Benzofalpvrenvl Adduct of Dco.wadenosine (dA)
Once the reaction was successfully established and worked well for the simpler 
pyrene system, this methodology was extended to the biologically relevant hydrocarbon 
benzofajpyrene. The requisite PAH precursors, 6-bromobenzo[a]pyrcnc (4-6) and 6- 
aminobcnzo[a]pyrcnc (4-8) were prodided by our collaborators, but can be prepared by
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an NBS bromination and a nitration-reduction respectively.147 Both alternatives (a) and 
(b) as shown in Scheme 4.2 were investigated.
For alternative (a), the influence of various palladium catalysts, ligands and bases 
on the course of the reaction between 6-bromobenzo[a]pyrcne (4-6) and 3’,5’-bis-0-(/ert- 
butyldimethylsilyl)-2'-dcoxyadcnosinc (4-1) was investigated. Reaction of 4-6 with 4-1 
in the presence of palladium catalyst, base and ligand results in the formation of 4-7 
(Scheme 4.5).
Scheme 4.5 Pd-catalyzcd synthesis of benzo[«]pyrenyl adduct from 6-bromo- 
benzo[a]pyrenc
Table 4.4 lists the experimental results. The solubility played a critical role in the 
reactions, and unlike in the case of pyrenyl adducts, the reactions were not 
straightforward.
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Tabic 4.4 Variables ami Results for the Coupling of 4-1 and 4-6.
Entry Base Solvent Temp (°C) 
Time (h)
Results"
1 CS2CO3 PhMe 100,24 Largely incomplete reaction
2 CS2CO3 DME 80.24 Largely incomplete reaction
3 CS2CO3 dioxane 100, 43 12% isolated, incomplete
4 I-BuONa dioxane 100,43 Largely incomplete reaction
5 CS2CO3 PhMe/THF 1:1 100, 72 Largely incomplete reaction
" The palladium species used was Pd(OAc)2 in 10 mole %, and ligand B was used in 15 
mole %.
As seen on Table 4.4, option (a) of Scheme 4.2 was not successful in the synthesis 
of N6-bcnzo[a]pyrcnyl adduct. Entry 1 (Table 4.4), Pd(OAc)2, ligand B, CS2CO3, and 
PhMe combination was used, which is identical to the combination that had given the 
best result in the case of pyrcnyl adduct (Entry 3, Table 4.2). In the present case the 
reaction mixture was heated at 100 °C and after 24 hours, the reaction was monitored by 
thin layer chromatography (TLC). TLC revealed that a substantial amount of starting 
material was still present. In Entry 2, same catalyst, ligand and base were used but this 
time the solvent was changed to a lower-boiling solvent 1 ,2 -dimcthoxycthanc (the solvent 
used in C-N bond-forming reactions).144 However, this solvent change did not lead to 
progress of the reaction to completion as TLC revealed a substantial amount of starting 
material still present after 24 hours.
I11 Entry 3, PdfOAcE, ligand B, and CS1CO3 combination was used but with the 
lower-boiling 1,2-dimcthoxyethanc (DME) replaced with a higher-boiling 1,4-dioxane. 
In this case, some amount of product (12%) was isolated which was impure. Although 
this reaction was allowed to run much longer, 43 hours, TLC still showed the presence of
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starting material, in Entry 4, Pd(OAe);, ligand 1$, and 1,4-dioxane combination was used 
but this time the milder base CsiCCL was replaced with a much stronger base tert- 
BuONa. The reaction mixture was heated at 100 °C and stirred continuously for 43 
hours. The mixture was monitored by TLC and was shown to contain no product but a 
substantial amount of starting material. In Entry 5, PdfOAcB, ligand B, and Cs^COj 
combination was used with a 1:1 solvent mixture of PhMe/THF. The reaction mixture 
was heated at 100 °C and stirred continuously for 72 hours. No product formation was 
noticed upon monitoring by TLC but rather a substantial amount of starting material was 
present.
To test option (b), 6-bromo-9|2-dcoxy-3,5-bis-0-(/er/-butyldimethylsilyl)-P-r>- 
erythro-pcntofuranosylipurine (4-4) was reacted with 6-aminobenzo[a]pyrene (4-8) to 
obtain 4-7 (Scheme 4.6).
4-4 4-8 4-7
| R = H. = Mono-Adduct 
R = dA, m Bis-Adduct
Scheme 4.6 Pd-calalyzed synthesis of benzo[«]pyrcnyl adduct from 6 
aminobenzofajpyrene.
iced with permission of the copyright owner. Further reproduction prohibited without permission.
91
Table 4.5 Variables and Results for the Coupling of 4-4 and 4-8.
Entry Pd species" Ligand" Base Solvent Temp (°C) 
Time (h)
Results
1 Pd(OAch B Cs2CO, DME 80. 18 30%/22% mono-/bis-adduct
2 Pd.(dba), A K,PO< DME 80, 18 39%/10% mono-Zbis-adducl
3 Pd(OAc) 2 B CsjCO) PhMe 80, 16 20%/26% mono-/bis-adduct
4 Pd(OAc); B C s j C O j dioxanc 100,5.5 51%/15% mono-/bis-adduct
5 Pd(OAc)2 B CS2CO3 PhMc/THF
1:1
7  ™— i r ^ r
1 0 0 , 2 1 16%>/25% mono-/bis-adduct
“ All palladium species were used in 10 mole %. l' The ligands were used in 30 mole %. 
Ligands: A: 2-(dicyclohexylphosphino)-2'-(iV,/V-dimethylamino)-1,1 ’-biphenyl.
B: (±)-2,2’-bis-(diphcnylphosphino)-1,1 ’-binaphthyl.
The influence of palladium species, ligand, and base on the outcome of the
reaction was investigated (Table 4.5).
Two points worth mentioning from the table (Table 4.5) arc the fact that solubility 
plays a critical role, and the reaction is not straightforward because two products were 
isolated. Based on 'H NMR and high resolution mass spectrometry, the two products 
were identified as the desired adduct (mono-adduct) and a bis-adduct. As can be seen on 
Table 4.5, there seem to be a correlation between solvent effect and the ratio of the 
products. It is worthy of note that in all the entries, product formation was observed.
In Entry 1, PdtOAch, ligand B, and Cs>CO;i combination was used with 1.2- 
dimethoxyethanc (DME) as solvent. The reaction mixture was stirred at 80 °C for 18 
hours leading to product formation as determined by TLC. Two products were isolated 
by column chromatography, and based on 'H NMR and high resolution mass 
spectrometry, these were identified as the mono-adduct and bis-adduct (structures are 
shown in the experimental section). The products were obtained in a ratio of 30% to 22%
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of the mono- to bis-adduct. Because the desired product could be isolated by column 
chromatography, the next step was to investigate what experimental variables lead to 
more of the desired product in a reasonable yield. Following earlier work,144 it had been 
shown that Pdj(dba)j, ligand A, K3PO4, and 1,2-dimcthoxyethanc (DME) combination 
was highly effective for C-N bond formation at the C-6 position in deoxynucleosidcs. 
The difference between this combination and the combination in Entry 1 is the nature of 
the palladium catalyst and the base. As shown in Entry 2, this combination was applied 
to synthesize the bcnzo[a]pyrenyl adduct. The reaction mixture was heated and stirred 
continuously at 80 °C for 18 hours leading to product formation. Interestingly enough, 
more of the mono-adduct was formed as the two products isolated were in a ratio of 39% 
to 10% of mono- to bis-adduct. Although the desired adduct was obtained in only a 
modest 39% yield, it was encouraging to investigate other variables of the reaction. The 
effect of solvent on the product ratio was then investigated.
In Entry 3, Pd(OAc)2, ligand B, CS2CO3, and PhMe combination was used. The 
reaction mixture was heated at 80 °C for 16 hours leading to product formation as 
determined by TLC. Two products were isolated in a ratio of 20% to 26% of mono- to 
bis-adduct. Only an overall yield of 46% was obtained, with more of the undesired 
product (bis-adduct) being formed. The best result was obtained in Entry 4 (Table 4.5) 
both in terms of reaction time and yield of the desired product. The system Pd(OAc)i, 
ligand B, CS2CO3, and dioxane was quite effective, with a relatively short reaction time, 
and an overall product yield of 66% with the ratio of mono- to bis-adduct being 51% to 
15%. Next, a solvent mixture was used. In Entry 5, Pd(OAc)2, ligand B, and CS2CO3 
combination was used as in entry 1 but instead a 1:1 mixture of PhMe and THF was
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employed as the solvent system. The reaction mixture was heated and stirred 
continuously at 100 °C lor 21 hours leading to the formation of two products. The two 
products isolated were in a ratio of 16% to 25% of mono- to bis-adduct. The use of 
solvent mixture in this case was not successful in biasing the reaction towards formation 
of more of the desired product (mono-adduct).
4.3 Summary
The applicability of palladium-catalyzed cross coupling methodology in the 
synthesis of nucleoside adducts arising from single electron oxidation of PAHs has been 
demonstrated for the first time. The synthesis of nucleoside adducts have been 
accomplished in both the case of a simpler aromatic system pyrene and a more extended 
aromatic system benzo(a]pyrene. A case by case analysis of suitable coupling partners 
has been performed. Unlike in the case of pyrenyl adduct where only one product was 
isolated, reaction in the case of bcnzo[u]pyrcnyI adduct was not straightforward as two 
products were typically isolated. Also, solubility played a critical role in the reaction. 
For the benzo[u]pyrenyl adduct there seemed to be a solvent dependence of the ratio of 
the mono- and bis-adduct. Both bromo-aromatic and arylamines seem potentially useable 
but these reactions need case by case evaluation and no generalizations can be made. 
Evidence for the structure of the adducts was obtained by NMR, high resolution mass 
spectrometry and UV. The synthesized adducts can be incorporated into DNA to produce 
oligomers containing single electron oxidation adducts for biological, biochemical and 
physical studies as well as for comparisons with the diol epoxide adducts.
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4.4 Experimental
Palladium(ll)acetate [Pd(OAc)2j, tris(dibenzylideneacetonc)dipalladium 
[Pd2(dba).i], l-bromopyrcne 4-2, l-aminopyrcne 4-5, ligands A-D, CS2CO3, K3 PO4 , tert- 
BuONa, toluene, and 1,2-dinicthoxycthane (1,2-DME) were purchased from commercial 
sources and were used without further purification. The catalysts and ligands were stored 
under a nitrogen atmosphere in a dessicator at 0 °C and the bases were stored in a 
dessicator at room temperature. THE was distilled from LiAHj, and 1,4-dioxane was 
distilled from NaBH4. The benzo[a]pyrcnc derivatives, 6-bromobenzo[ajpyrenc 4-6 and 
6-aminoben/.o|«|pyrene 4-8 were provided by our collaborators. The bromonucleoside 
4-4 was synthesized as described.144
Reactions were monitored by TLC on glass-backed Whatman TLC plates 
prccoatcd with silica gel 60 (250pm layer thickness). Column chromatography was 
performed using 200-300 mesh silica gel. Proton nuclear magnetic resonance ( 'll NMR) 
and homonuclear two-dimensional chemical shift correlation spectroscopy (COSY) 
spectra were recorded in deuterated solvents on a Bruker AVANCE-500 (500 MHz) 
spectrometer. Chemical shifts (8) are reported in parts per million (ppm). 'H NMR 
splitting patterns are designated as singlet (s), doublet (d), triplet (t), quartet (q), or 
quintet (quint). All first order splitting patterns are assigned based on the appearance of 
the multiple!. Splitting patterns that are not easily visualized arc designated as multiple! 
(m). Coupling constants (7) arc reported in Hertz (Hz). High resolution mass spectra 
(HRMS) were determined on an AX505 spectrometer. UV absorbance spectra were 
recorded on a Beckman DU-640 spectrophotometer in methanol (Figures 19A-21A, 
Appendix A).
ced with permission of the copyright owner. Further reproduction prohibited without permission.
95
Synthesis of Pvrcnvl Adduct of Dcoxvadenosine (4-3)
4-3
In an oven-dried, screw-cap vial containing a stirring bar were placed Pd(OAc)2 
(1.5 mg, 6.68 pmol), (±)-2,2’-bis-(diphenylphosphino)-1,1 ’-binaphthyl (6.3 mg, 10.1 
pmol), and anhydrous toluene (0.68 mL). The mixture was then flushed with nitrogen 
and stirred at room temperature for 5 minutes. This was necessary to preform the 
palladium-ligand complex. To the resulting solution was added the amine 3’,5’-bis-0- 
(tert-butyldimethylsilyl)-2’-deoxyadenosine 4-1 (49 mg, 0.102 mmol), 1-bromopyrene 4- 
2 (19.1 mg, 0.068 mmol), and CS2CO3 (31 mg, 0.095 mmol). The vial was Hushed with 
nitrogen, sealed with a Teflon-lined cap, and placed in a sand bath that was maintained at 
90 °C. The reaction was monitored by TLC and was complete after 4 hours. The 
reaction mixture was cooled to room temperature, diluted with ethyl acetate and extracted 
twice with water. The organic layers were dried over anhydrous Na2SOj and 
concentrated on a rotary evaporator. The crude product was purified by column 
chromatography using CH2CI2, followed by 5% acetone in CH2CI2 to obtain 90% of 4-3 
as a pale yellow solid: Rr (5% acetone in CH2CI2) = 0.37: UV. X„,a,(nm) 238, 275, 341 
(methanol); *11 N\1R (500 MHz, CDCI3) 5 8.62 (d, J = 8.3 Hz, 1H. ArH), 8.50 (s, 1H. 
Il8), 8.30-8.00 (m, 10H, 8ArH, NH & 1H2), 6.54 (t, J = 6 5 Hz, 1H, H, ), 4.67 (m, 1H, 
H30, 4.07 (app q, = 3.1 Hz, 1H, H4 ), 3.93 (dd, J = 11.2, 4.1 Hz, 1H, H5 ), 3.82 (dd, J
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= 1 1 .1 ,3.0 Ilz, 111, Hj.), 2.73 (appquint, J,„ = 6.6 Hz, 111, Hr). 2.50 (Odd, /  = 13.0, 6.1,
4.1 Hz, 1H, H2), 0.96, 0.94 (2s. I8H, ten-Bu), 0.14 (s. 12H, SiCH,); HRMS ni/z, [M + 
1]* CMH,gN}0 3Si2 call'd 680.3452, found 680.3454.
In an oven-dried, screw-cap vial containing a stirring bar were placed Pd(OAc); 
(2.065 mg, 9.20 pmol), (±)-2,2’-bis-(diphenylphosphino)-l,r-binaphthyl (17.18 mg, 
27.6 pmol), and 1,4-dioxanc (1 mL). The mixture was stirred at room temperature for 5 
minutes after flushing with nitrogen. This was necessary to preform the palladium-ligand 
complex. To the resulting solution was added 6-aminobenzo[a]pyrene 4-8 (49.2 mg,
0.184 mmol), 6-bromo-9-[2-dcoxy-3,5-bis-0 -(/<.'/7-butyldimcthylsilyI)-|)-D-erythro- 
pentofuranosyljpunne 4-4 (0.05 g. 0.092 mmol), CsjCO.i (44.95 mg, 0.138 mmol), and 
additional 1,4-dioxanc (0.84 mL). The vial was flushed with nitrogen, sealed with a 
Teflon-lined cap, and placed in a sand bath that was maintained at 100 °C. The reaction 
was monitored by TLC and was complete after 5.5 hours. The reaction mixture was 
cooled to room temperature, diluted with ethyl acetate and extracted twice with water. 
The organic layers were dried over anhydrous NaiSCL and concentrated on a rotary 
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followed by 2% acetone in CHjCli. Two fractions were collected in 51% and 24% and 
were identified as the mono- and bis-adduct respectively.
Mono-Adduct: This was obtained in 51% yield as a yellow solid: Rf (2% acetone 
in CH2CI2) = 0.51; L'V. Ainal(nm) 256, 265, 287, 299, 372, 392 (methanol); 'l l  NMR (500 
MHz, CDCIj) 6 9.10 (d, J = 8.4 Hz, 1H, ArH), 9.07 (d, J = 9.6 Hz, 111, ArH), 8.45 (d, J =
8.2 Hz, HI, ArH), 8.36 (d superimposed on broad singlet, J = 9.1 Hz, 2H, ArH), 8.23 (d, 
J = 7.8 Hz, 1H, ArH), 8.22 (br s, 1H), 8.14 (d, J = 9.0 Hz, IH, Aril), 8.06 (d, J = 7.2 Hz, 
IH. ArH), 7.96 (m, 2H, ArH), 7.88 (d, J = 9.0Hz, 1H, ArH), 7.83 (t, J = 7.2 Hz, 1H, 
ArH), 7.72 (t, J = 7.2 Hz. IH, ArH), 6.53 (br, HI. Hr). 4.69 (br, IH, Hv), 4.07 (br, IH, 
Hr), 3.95 (br, IH, Hs ), 3.84 (br d, J = 9.0 Hz, IH, Hy), 2.79 (m, IH, Hr ), 2.50 (m, HI. 
Hr), 0.94 (br s, 18H, rerr-Bu), 0.14 (br s, 12H. SiCHj): HRMS m/z, [M + H+ 
C^HsiNsOjSij ealed 730.3609, found 730.3607.
Bis-Adduct: This was obtained in 24% yield as a pale yellow solid: R( (2% 
acetone in CH2CI2) = 0.30; UV, U n m )  255, 265, 288, 300, 377, 398 (methanol); Ml 
NMR (500 MHz, CDCb) 6 9.14-9.11 (m, 2H, ArH), 8.50 (s, IH, Aril), 8.49 (s, IH, 
ArH), 8.46 (d, J = 9.0 Hz, IH, ArH), 8.34 (d, J = 9.0 Hz. IH, ArH), 8.22 (d, J = 7.8 Hz, 
HI, ArH), 8.19 (d, J = 9.6 Hz, IH, ArH), 8.00 (d, 7 = 6.6 Hz, IH, ArH12), 7.93 (t,7 = 7.2 
Hz, IH, ArH), 7.87 (s, 2H, ArH). 7.78 (d, J = 9.0 Hz, IH, ArH), 7.75 (t, J = 7.8 Hz, HI, 
ArH), 7.59 (t, J = 7.2 Hz, IH, ArH), 6.45 (2t, J = 6.6 and 6.6 Hz, 2H, Hr), 4.59 (m, 211, 
Hy), 4.00 (m, 2H, Hr), 3.78 (dd, J = 10.9, 5.0 Hz, 2H, H5 ), 3.72 (dd, J = 11.2, 3.7 Hz, 
2H, Hv), 2.69 (m, 2H, H2 ), 2.40-2.36 (m, 2H, Hr), 0.91,0.81 (2s, 36H, rert-Bu), 0.10, 
-0.031, -0.038, -0.070, -0.076 (5s, 24H, SiCHj); HRMS m/z, [M + 1]+ C„4HwN<)0 ,,Si4 
ealed 1192.6091, found 1192.6066.
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CHAPTER 5
SYNTHESIS OF UNUSUAL NUCLEOSIDE ANALOGS 
5.1 Introduction
Nucleosides are organic compounds consisting of a nitrogen-containing 
heterocyclic base linked to a sugar. The sugar unit can either be ribosc or deoxyribosc 
while the base can be derived from two heterocyclic ring systems referred to as punne 
and pyrimidine (Figure 5.1 ).148 In each nucleoside, a glycosidic bond is formed between 
C-l of the sugar and cither N-l of pyrimidine or N-9 of purine.
Figure 5.1 The sugar unit and base structure of nucleosides.
Nucleotides are compounds that contain a phosphate group in addition to the 
nucleoside components. Considerable interest has been drawn to the chemistry of 
nucleosides and nucleotides because these compounds form the building blocks of 
nucleic acids, DNA and RNA, which are at the center of life processes. They also 
function as activated intermediates for biosynthesis, energy stores, components of 
cocnzymes, and metabolic regulators.149
98
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Analogs of nucleosides and nucleotides arc widespread in nature, and a variety of 
synthetic derivatives have been made that exhibit varying degrees of biological activity. 
Synthetic analogs have been critical in the understanding of DNA, RNA, protein
analogs of purine and pyrimidine nucleosides have proven to be efficient as antibacterial, 
antiviral, and anticancer or antitumor agents, as a result of their functions as enzyme 
inhibitors and antagonists.151 Antibiotic effect is exhibited primarily through inhibition 
of the synthesis of nucleic acid precursors or by interfering with peptide-chain elongation 
in the ribosome. As a result of the biological activity of nucleosides and their modified 
analogs, interest has been geared towards the synthesis of modified nucleosides for more 
than four decades.152 The structures of natural nucleosides are shown in Figure 5.2.
Figure 5.2 Structures of natural nucleosides.
In recent times, the finding that nucleoside derivatives such as 2’,3’- 
dideoxycytidine, 2',3'-didcoxyinosine, and 3’-azido-3’-deoxythymidine (AZT) are 
potentially effective therapeutic agents for the treatment of diseases such as acquired
synthesis, and the regulation of biosynthesis of nucleic acid precursors.150 Natural
OH OH OH OH OH OH OH OH
Adenosine Guanosine Cytidine Uridine
OH OH OH OH
Deoxyadenosine Deoxyguanoslne Deoxycytidino Deoxythymidlno
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immune deficiency syndrome (AIDS) has triggered explosive new developments in the 
synthetic chemistry of nucleosides.153 Purine nucleosides containing aryl substituents at 
the C-2 and C-6 positions could have potential pharmacological activity and could be 
used to probe the effect of such substituents on DNA structure and stability.154 O6- 
Substituted derivatives of 2'-deoxyguanosine (dG) have interesting biological activity.'55 
For example 0° alkylation of dG has been proposed to reduce the number of hydrogen 
bonding sites in the guanine moiety.156 As a result, the formation of (/'-alkyl guanine 
derivatives has been established as a potent mutagenic and carcinogenic modification.157 
In particular, ( / ’-methyl dG has been shown to produce mutations and misinformation 
during replication.155
Several methods have been reported in the literature for the synthesis of 
nucleoside derivatives with the hope of obtaining therapeutically useful agents. Among 
these methods, we have reported facile synthesis of ( / ’-alkyl-, ( / ’-aryl-, and 
diaminopurinc nucleosides from 2’-deoxyguanosinc.158 The application of Suzuki- 
Miyaura cross-coupling has also been reported for the synthesis of nucleoside 
derivatives.154 The methods for the synthesis of nucleoside derivatives, reported by our 
group, are simple and convenient and offer advantages over other methods. The research 
idea was accomplished through team effort of the Lakshman group, with contributions 
from the author to this effort. In this chapter therefore, the synthesis of certain nucleoside 
derivatives based upon new methods is presented.
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5.2 Synthesis
The synthesis of nucleoside derivatives necessitates the use of reagents and 
reaction conditions that will be tolerant to the hydroxyl protecting group on the sugar 
moiety and will not destabilize the glycosidic linkage. The synthesis of unusual 
nucleosides from natural nucleosides has been studied extensively.150 Modification of 
naturally occurring nucleosides is quite attractive because the starting materials, the 
natural nucleosides, can be obtained commercially and when the analogs are not 
commercially available such as the halonuclcosidcs, their synthesis can readily be 
accomplished in an efficient manner. The synthetic approach we have explored involves 
modification of the purine base while keeping the sugar structure constant. The hydroxyl 
groups of the sugar moiety are conveniently protected. Analogs of two naturally 
occurring nucleosides, dcoxyadenosine (dA) and dcoxyguanosine (dG), have been used 
for the synthesis of nucleoside derivatives. For the synthesis of the dG derivatives, the 
goal was to obtain modified nucleosides in which the N1 of the purine base remains 
unprotected.
5.2.1 Synthesis of f/-Alkvl Nucleosides
Reaction at the Ob position of dG is well known. Jones,157 Reese159160 and 
Plata161'162 have reported the synthesis of 0 6-sulfonyl derivatives of dG. Jones and 
Gaffney have reported the displacement of the sulfonate group at the Ob position of dG in 
the presence of trimethylamine leading to 0 6-alkyl ethers.157 An intermediate quaternary 
ammonium salt is formed which is then trapped with alcohol to give the desired ether. 
The method of Jones and Gaffney, however, involved protection of the sugar hydroxyls 
and N2 of the purine base by acylation. Noyori el al. have reported the synthesis of Ob-
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allyl 3 ',5’-bis-(?-/f77-butyldimethylsilyl-2'-deoxyguanosine from an (/-sulfonate 
precursor using allyl alcohol as solvent.164 Although the (/-sulfonate is not protected at 
the N2 position, the use of alcohols as solvents could be problematic.158 A common 
feature among these synthetic methods is the use of highly volatile nitrogen nucleophiles 
such as trimethylamine (bp 3 °C) for displacement of the sulfonate. Such volatile 
nucleophiles on a large scale may not be convenient to handle due to toxicity and their 
unpleasant odor.165
An effective route for the synthesis of 6-substituted dG derivatives using 
trifluoroacctic anhydride/pyridinc has been reported/''’ This method, although efficient in 
synthetic application, has a shortcoming in that the use of sodium alkoxidcs as base could 
be incompatible with silyl protecting groups. The synthesis of (/-alkyl dG derivatives, 
in which the purine N2 is unprotected, by the Milsunobu reaction condition has been 
reported.167168 The reaction conditions arc compatible with silyl protecting groups but 
product separation is tedious from residual reactants and byproducts. The case of 
displacements at the C-6 position of purines by the use of l,4-diazabicyclo[2.2.2)octane 
(DABCO) as leaving group has been reported.165,169 The displacement of chloride from 
the C-6 position of purines has also been reported.169 However, because chlorination of 
deoxyguanosinc (dG) proceeds in low yields,155 chlorinated dG was not considered a 
good starting point for our synthesis. Based on the disadvantages of other synthetic 
approaches in the literature, it would be useful to develop a convenient and simple 
procedure for the synthesis of purine nucleoside derivatives from 2’-deoxyguanosine. 
Goals included the synthesis of 3’,5'-0-disilyl nucleoside derivatives in which the purine 
N2 is unprotected, the use of highly volatile trimethylamine is avoided, and the
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development of a procedure in which a variety of compounds can be synthesized from a 
single precursor.158
The synthesis of Of,-a!kyl derivatives was accomplished as a one-pot, two-step 
reaction stalling from 3’,5'-bis-0-TBDMS (/-mcsitylenesulfonate of dG 5-1 (Scheme 
5.1).
1 1,2-DME, DABCO, DBU 
2. R-OH, rt
R = CH3 = 5-2 
R » (CH3)2CH = 5-3
Scheme 5.1 Synthesis of 0 6-alkyl 2'-dcoxyguanosine 5-2 and 5-3.
When treated with l,4-diazabicyclo[2.2.2]octane (DABCO), and 1,8- 
diazabicyclo-[5.4.0]unde-7-ene (DBU) in 1,2-DME, 5-1 undergoes facile displacement in 
the presence of a primary or secondary alcohol to afford 5-2 or 5-3. With both primary 
and secondary alcohols, product formation was observed, but the reaction with secondary 
alcohol gave low yield. Table 5.1 below summarizes the yield and reaction time while 
details of the synthesis arc given in the experimental section.
Table 5.1 Yields and Reaction Times for the Synthesis of (/-Alkyl 2’-dG Derivatives.
ROH Reaction time/h Product Yield (%)
CH3OH 24 5-2 80
(CHj)2CHOH 72 5-3 15
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The rationale for the mechanism of the formation of ( / ’-alkyl 2'-dG derivatives is 
shown in Scheme 5.2. The reaction may proceed through the intermediary of the 
expected ammonium salt which is not isolated 5-la. This intermediate ammonium salt is 
then displaced by the various alcohols in the presence of DBU to afford the desired 
products. Evidence of this mechanism has been reported.158
5-1*
Scheme 5.2 Mechanism for the synthesis of 0 6-alkyl 2 ’-deoxyguanosinc analogs.
5.2.2 Synthesis of A^-Substiluted Diaminopurinc Nucleosides 
Based on the success of the synthetic methodology for the synthesis of 0°-alkyl 
nucleoside derivatives, we thought a simple route to the A^-substiluted diaminopurinc 
nucleosides might involve a direct SNAr displacement of the sulfonate 5-1 by amines. In 
the case of the amines, however, higher temperature was required for the reactions to 
proceed to yield the desired products.158 Both primary and secondary amines were used
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and in all cases, the yields were generally good to excellent. Unlike reactions with 
alcohols, reactions with amines did not require an additional tertiary amine or base such 
as DABCO and DBU respectively.
Reaction of benzylaminc with 3',5’-bis-0-TBDMS O^-mcsitylenesulfonatc of dG 








Scheme 5.3 Synthesis of ,V’-bcnzyl-2,6-diaminopurinc nucleoside analog 5-4.
Reaction of allylaminc with 3’,5’-bis-0-TBDMS f / ’-mesitylenesulfonate of dG 5- 







N NH2 CH2=CHCH2NH2, Et3N 
1,2-DME, 50 “C *  
77%
HN
Scheme 5.4 Synthesis of Ar-allyl-2-aminopurine nucleoside analog 5-5.
The reaction with secondary amines was efficient and products were obtained in 
good to excellent yields. This contrasts with the reactions of the alcohols where 
secondary alcohols gave poor yields.
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Reaction of a solution of A'.A'-dimethylamine in tetrahydrofuran (THF) with 3',5’- 
bis-O-TBDMS 0 6-mesitylenesulfonate of dG 5-1 in 1,2-DME and triethylaminc afforded 
5-6 in 86% yield (Scheme 5.5).
Scheme 5.5 Synthesis of A^uV'-dimethylamino^-aminopurine nucleoside analog 5-6.
Reaction of morpholine with 3’,5’-bis-0-TBDMS O^mesitylenesulfonate of dG 
5-1 in 1,2-DME and triethylaminc afforded 5-7 in 94% yield (Scheme 5.6).
Scheme 5.6 Synthesis of 6-morpholino-2-aminopurine nucleoside analog 5-7.
The products were purified by column chromatography and characterized by 'H 
NMR and high resolution mass spectrometry. Details of the synthetic procedure and 
results from characterization are given in the experimental section.
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5.2.3 Synthesis of Hydrophobic C-6 Arvl 2'-Dcoxvnucleosidc 
Prompted by interest in palladium catalyzed nucleoside modification, the utility of 
Suzuki-Miyaura cross-coupling170 was explored for the synthesis of C-6 aryl 2’- 
dcoxynucleosides.154 A detailed comparison of the utility of C-6 chloro- and C-6 
bromopurine nucleosides in Suzuki-Miyaura cross-coupling reactions has also been 
reported.154 The coupling of 6-bromo-9[2-dcoxy-3,5-bis-0-(/erv-butyldimcthylsilyl)-[l-D- 
erylhro-pentofurunosyl]purine 5-8 with 3-methoxyphcnylboronic acid 5-9 in the presence 
of Pd(OAc):, 2-(dicyclohexylphosphino)biphenyl (L-l), and KiP04 in anhydrous 1,4- 
dioxanc afforded 6-(3-mcthoxyphcnyl)-3’,5’ bis-0-(rerf-butyldimcthyl-silyl)-2’- 
deoxynebularine 5-10 in 73% yield (Scheme 5.7).
o c h 3
5-9
B(OH)j
Pd(OAc)2, L-1, K3 PO4 
1,4-dloxane, 100”C, 1h 
73%
5-10
Scheme 5.7 Synthesis of 5,10.
The compound was purified by column chromatography and characterized by 'H 
NMR and high resolution mass spectrometry. Details of the synthesis and 
characterization arc given in the experimental section.
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5.3 Summary
A convenient and concise strategy for the synthesis of ( / ’-alkyl and / / ’-substituted 
diuminopurinc nucleosides from 2’-dcoxyguanosinc has been demonstrated. In reactions 
with a primary and secondary alcohol, good yield was obtained using the primary alcohol 
while the secondary alcohol gave a poor yield. In contrast, reactions proceeded smoothly 
with both primary and secondary amines giving diamino nucleosides in very good to 
excellent yields. While reactions with the alcohols proceeded at room temperature, 
reactions with the amines were carried out at 50 °C. The reactions were generally 
complete within 24 hours for primary alcohols as well as for primary and secondary 
amines. Because a wide variety of compounds can be obtained from a single precursor, 
this chemistry can be applicable in combinatorial technology or automated parallel 
synthesis.
The utility of Suzuki-Miyaura cross-coupling for deoxynucleoside modification 
has also been reported for the first time. The result presented in this chapter on the use of 
palladium catalysis in nucleoside modification is part of a larger project. The Lakshman 
group has carried out a detailed and systematic study on the applicability of Suzuki- 
Miyaura cross-coupling for deoxynucleoside modification. In particular, studies geared 
towards understanding the catalytic systems and the generality of the approach have been 
earned out. This methodology permits the synthesis of unusual nucleosides that are not 
readily synthesized by other methods.
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5.4 Experimental
The arylborome acid, palladium(ll)acetate [PdfOAch], 1,2-DME, DABCO, DBU, 
2-(dicyclohcxylphosphino)-biphcnyl (L-l), K3 PO4 , alcohols and amines were purchased 
from commercial sources and were used without further purification. The catalyst and 
ligand were stored under N2 in a desiccator at 0 °C and the base was stored in a desiccator 
at room temperature. For the cross-coupling reaction, 1,4-dioxanc was distilled from 
NaBHj just before starting the reaction. Compound 5-1 was synthesized as 
dcscribed.l7land compound 5-8 was synthesized as described.144
Thin-layer chromatography (TLC) was performed on glass-backed Analtcch TLC 
plates precoatcd with silica gel (250 pm layer thickness). Column chromatographic 
purifications were performed on Nalland 200-300 mesh silica gel. ’H NMR were 
recorded at 500 MHz in deacidificd CDCI3 (for (/-alkyl and /V6-substituted 
diaminopurinc nucleoside products), and regular CDCI3 for the C-6 aryl 2’- 
dcoxynucleosidc product. Deacidification was performed by percolating the solvent 
through a bed of solid NaHCC>3 and basic alumina. Chemical shifts (8) are reported in 
parts per million (ppm). All first order splitting patterns are assigned based on the 
appearance of the multiple!. Splitting patterns that are not easily visualized arc 
designated as multiple! (m). Coupling constants (J) are reported in Hertz (Hz). High 
resolution mass spectra (11RMS) were determined on an AX505 spectrometer, at the 
University of Oklahoma.
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Synthesis of Oll-Mcthvl-3'.5'-bis-<’,>-rt'n-bulvldimclhvlsilvl-2’-dcoxvguanosine (5-2)
To a solution of 3’,5'-bis-0-TBDMS 0 6-mesitylcncsulfonate of <JG 5-1 (100 mg. 
0.147 mmol) in 1,2-DME (1.47 ml.) were added DABCO (33.1 mg, 0.295 mmol). 4 A 
molecular sieves, and methanol (30 jiL, 0.741 pmol). After allowing the mixture to stir 
at room temperature for 30 minutes DBU (33 nL, 0.221 /xmol) was added. The mixture 
was stirred at room temperature for 24 hours. Completion of the reaction was monitored 
by TLC. The mixture was diluted with ethyl acetate and subjected to aqueous extraction. 
The organic layer was dried in anhydrous NaiSO-r, concentrated on a rotary evaporator 
and dried further under vacuum. The crude product was purified by column 
chromatography using CH2CI2 to load compound and 2% methanol in CH2CI2 to elute the 
product. Concentration of fractions afforded 60 mg of 5-2 (80% yield) as a white solid: 
Rr (silica/CH2Cl2) = 0.38; ‘H NMR (500 MHz, deacidified CDCI3) 8 7.92 (s, 1H. H„), 
6.33 (t, J = 6.5 Hz, 1H, H, ). 4.84 (s, 2H, NH2). 4.60 (m, 1H, Hr), 4.07 (s. 3H, OCHj), 
3.98 (app q, Jm  = 3.9 Hz, 1H, Re), 3.82 (dd, 7=11.1, 4.3 Hz. 1H, Hr). 3.76 (dd, J = 
11.1, 3.2 Hz, IH, H5 ), 2.58 (app quint, 7app = 6.8 Hz, IH, Hr), 2.36 (ddd, J = 13.0, 6.1, 
3.8 Hz, IH. Hr). 0.92 (s, 18H, tert-Bu), 0.11, 0.09. 0.08 (3s. 12H, SiCllj); HRMS m/z, 
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Synthesis of ('/-lsopropvl-3’.5’-bis-Q-/m-butvldimcthvlsilvl-2’-deoxvguanosine (5-3)
OTBDMS
5-3
To a solution of 3’,5’-bis-0-TBDMS 0 6-mesitylencsulfonatc of dG 5-1 (50 mg, 
0.074 mmol) in 1,2-DME (0.75 mL) were added DABCO (16.5 mg, 0.147 mmol), 4 A 
molecular sieves, and isopropanol (28.2 /tL, 0.368 /imol). After allowing the mixture to 
stir at room temperature for 30 minutes DBU (16.5 /tL, 0.11 /imol) was added. The 
mixture was stirred at room temperature for 48 hours. No product formation was 
observed as judged by TLC Another 5 equivalents of isopropanol were added and the 
reaction mixture stirred at room temperature for another 24 hours. After a total of 72 
hours, product formation was observed but the reaction was incomplete. With the hope 
of driving the reaction to completion, the mixture was stirred at 50 °C for 2 hours, but 
TLC still showed some starting material present. The mixture was diluted with ethyl 
acetate and subjected to aqueous extraction. The organic layer was dried in anhydrous 
NajSOj, concentrated on a rotary evaporator and dried further under vacuum. The crude 
product was purified by column chromatography using CII2CI2 to load the compound and 
2% methanol in CH2CI2 to elute the product. Concentration of fractions afforded 6 mg of 
5-3 (15% yield) as colorless oil: Rf (silica/CH2Cl2) = 0.75; ‘H NMR (500 MHz, 
dcacidificd CDCIj) 5 7.80 (s, IH. H„), 6.23 (t, J = 6.4 Hz, III, II,-). 5.46 (sept, J = 6.2 Hz, 
1H, OCH), 4.71 (s, 211, NH2), 4.51 (m, IH, Hj ), 3.87 (app q, Jm  = 3.3 Hz, IH, H4), 3.74 
(dd,y= 11.1, 4.3 Hz, IH, Hy), 3.65 (dd,7= 11.1,3.2 Hz, IH, Hs ), 2.46 (app quint, Jm  =
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6.1 Hz, 1H, H2 ), 2.24 (ddd, J = 13.1, 6.0, 3.6 Hz, 111, Hr). 1.32 (d, J = 6.2 Hz, 6H, CH3), 
0.82, 0.81 (2s, 18H, ten-Bu), 0.04-0.01 (3s, 12H, SiCll3); HRMS m/z, [M + 1]* 
CjjHagNjOgSij calcd 538.3245, found 538.3242.
Synthesis of 2-Amino-6-(henzvlamino)-9-l2-deoxv-3.5-bis-0-(ffr/-butvldimethvlsilvl)-B- 
D-pm/iro-pentofuranosvIlpurinc (5-4)
To a solution of 3’,5’-bis-0-TBDMS 0 6-mesitylenesulfonatc of dO 5-1 (100 mg, 
0.147 mmol) in 1,2-DME (1.50 mL) were added EtjN (103 gL, 0.739 gmol), 4 A 
molecular sieves, and bcnzylamine (80.1 pL, 0.733 pmol). The mixture was stirred at 50 
°C for 24 hours. Completion of the reaction was monitored by TLC. The mixture was 
diluted with ethyl acetate and filtered. This was followed by sequential extractions with 
10% aqueous citric acid and saturated NaHC03. The organic layer was dried in 
anhydrous Na2SO.», concentrated on a rotary evaporator and dried further under vacuum. 
The crude product was purified by column chromatography using CHjCIj to load the 
compound and 2% methanol in ClfCI2 to elute the product. Concentration of fractions 
afforded 69 mg of 5-4 (80% yield) as a white powder: R( (silica/3% MeOH in CH2CI2) = 
0.49; *H NMR (500 MHz, deacidificd CDCI3) 6 7.76 (s, 1H. Hg), 7.33 (m, 511, ArH), 
6.31 (l. J = 6.6 Hz, 1H, Hr). 5.83 (s, 1H, NH), 4.79 (s, 2H, NH-), 4.70 (s, 2H, NCH2), 
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Hs ), 3.76 (dd, J  = 11.1.3.4 Hz, IH. Hs ), 2.59 (app quinl, 7a(>p = 6.1 Hz, 1H, Hr). 2.35 
(ddd. J = 13.0, 6.0. 3.7 Hz, 1H, Hr). 0.92 (2s. 1811, tm-Bu), 0.11, 0.08, 0.08 (3s, 12H, 
SiCHj); HRMS ni/z, [M + N af C..9H44N(,Na0 3SiJ calcd 607.3224, found 607.3233. 
Synthesis of 2-Amino-6-(allvlaminot-9-l2-dco\v-3.5 bis-CM/err-bulvldimcthvIsilvD-B-D- 
ent/iro-oentofuranosvIlpurine (5-51
To a solution of 3’,5’-bis-0-TBDMS (Amesitylenesulfonalc of dG 5-1 (100 mg, 
0.147 mmol) in 1,2-DME (1.50 mL) were added EtjN (103 pL, 0.739 pmol), 4 A 
molecular sieves, and allylaminc (0.042 mg, 0.737 pmol). The mixture was stirred at 50 
°C for 24 hours. Completion of the reaction was monitored by TLC. The mixture was 
diluted with ethyl acetate, filtered, and subjected to aqueous extraction. The organic 
layer was dried in anhydrous Na2SO.i, concentrated on a rotary evaporator and dried 
further under vacuum. The crude product was purified by column chromatography using 
CH2CI2 to load the compound and 2% methanol in CH2CI2 to elute the product. 
Concentration of column fractions afforded 61 mg of 5-5 (77% yield) as light yellowish 
powder: R, (silica/3% McOH in CH2CI2) = 0.24; ' l l  NMR (500 MHz, dcacidificd 
CDCI3) 6 7.77 (s, 1H, H8), 6.30 (t, J = 6.8 Hz, 1H, Hr ), 5.87 (tdd, J = 17.0, 10.3, 6.0 Hz, 
1H,=CH), 5.58 (brs.NH), 5.28 (dd,7= 17.0, 1.2 Hz, IH, =CHua„s), 5.16 (d. J = 10.3, 1.2 




ced with permission of the copyright owner Further reproduction prohibited without permission.
114
(appq, Jw  = 3.5 Hz, lH.Ha), 3.82 (dd,7 = 11.0, 4.5 Hz, 111, H5 ), 3.76 (dd,7 = 11.0, 3.3 
Hz, 1H, H5), 2.60 (app quint, yapp = 7.0 Hz, 1H, Hr ), 2.34 (ddd, J  = 12.9, 5.9, 3.5 Hz, 
1H, H; ), 0.92 (2s, 18H, tert-Bu). 0.11,0.09,0.OS (3s, 12H, SiCHj); HRMS ni/z, [M + l]" 
C25H47N60 3Si2 cak'd 535.3248, found 535.3262.
Synthesis of 2-Amino-6-fdimethvlamino)-9-l2-deoxv-3.5-bis-0-trerr-buivldimethvlsilvl)- 
B D (’n ’t/iro-Dcntofuianosyllpurine (5-61
H3C ,ch3
N
To a solution of 3’,5’-bis-0-TBDMS 0 6-nicsitylcnesulfonate of dG 5-1 (100 mg, 
0.147 mmol) in 1,2-DME (1.13 mL) were added IitjN (103 11L, 0.739 /tmol), 4 A 
molecular sieves, and dimethylaminc (2 M solution in THF, 0.37 mL, 0.7 mmol). The 
mixture was stirred at 50 °C for 24 hours. Completion of the reaction was monitored by 
TLC. The mixture was diluted with ethyl acetate, filtered, and subjected to aqueous 
extraction. The organic layer was dried in anhydrous Na^SO*. concentrated on a rotary 
evaporator and dried further under vacuum. The crude product was purified by column 
chromatography using CH2CI2 to load the compound and 2% methanol in CH2CI2 to elute 
the product. Concentration of column fractions afforded 66 mg of 5-6 (86% yield) as a 
white powder: Rr (silica/3% McOH in CH2CI2) = 0.47; *11 NMR (500 MHz, dcacidified 
CDCIj) 8 7.71 (s, 1H, H„), 6.33 (t, 7 = 6.1 Hz, 1H, Hr ), 4.58 (s, 2H, NH2), 4.58 (m, 1H, 
Hy), 3.98 (app q, 7jpp = 4.0 Hz, 1H, Ha ), 3.78 (dd, 7=11.1, 4.6 Hz, III, Hs ), 3.75 (dd, J
OTBDMS
5-6
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= 11.1, 3.8 Hz. 1H. Hs ), 3.45 (s, 6H. NCH3), 2.57 (app quint, Jm  = 6.6 Hz, 1H, Hr). 
2.34 (ddd, J  = 13.1,6.0, 3.4 Hz, IH, Hr). 0.92, 0.91 (2s, 18H, tert-Bu). 0.11, 0.08, 0.07 
(3s, 12H, SiCHj); IIRMS m/z. [M + 11* C:4H.7N0O,Sh calcd 523.3248, found 523.3224. 
Synthesis of 2-Amino-6-mofpholino-9-f 2-deox v-3.5-bis-6>-trprt-butvldimethvlsilvl)-B-D- 
(’rvr/uvr-pcmofuranosvl ipurine (5-7)
To a solution of 3',5’-bis-0-TBDMS (/-mesitylenesulfonate of dG 5-1 (100 mg, 
0.147 mmol) in 1,2 DMH (1.50 mL) were added Et3N (103 pL, 0.739 pmol), 4 A 
molecular sieves, and morpholine (64.3 pL, 0.737 pmol). The mixture was stirred at 50 
°C for 24 hours. Completion of the reaction was monitored by TLC. The mixture was 
diluted with ethyl acetate, filtered, and subjected to aqueous extraction. The organic 
layer was dried in anhydrous Na2SOr, concentrated on a rotary evaporator and dried 
further under vacuum. The crude product was purified by column chromatography using 
CH2C12 to load the compound and 2% methanol in CH2C12 to elute the product. 
Concentration of column fractions afforded 78 mg of 5-7 (94 % yield) as a while powder: 
Rr (silica/3% McOH in CH2C12) = 0.27; *11 NMR (500 MHz. dcacidifted CDCIj) 8 7.73 
(s. IH, H»), 6.33 (t, 7 = 6.7 Hz, 1H. Hr ).4.61 (s, 2H, NH2),4.58 (m, IH, Hr), 4.23 (br s, 
411, NCH2), 3.97 (app q, 7W = 4.1 Hz, IH, Hr), 3.80 (t, J = 4.9 Hz, 4H, OCH2), 3.78 (dd, 
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Hz, 1H, Hr ), 2.34 (ddd, J = 13.0, 6.0, 3.4 Hz, IH, H2). 0.92, 0.91 (2s, 18H, /ert-Bu), 
0.10, 0.08, 0.07 (3s, 12H, S1CH3); HR MS h i/ ; ,  [M + I f  CssHwNsC^Sij ealcd 565.3354, 
found 565.3377.




In an oven-dried, screw-cap vial containing a stilting bar were placed Pd(OAc): 
(2.00 mg, 8.91 jtmol), 2-(dicyclohexylphosphino)biphcnyl (4.80 mg, 0.014 mmol), 3- 
mcthoxyphcnylboronic acid (21 mg, 0.138 mmol), and KjPOj (39 mg, 0.184 mmol). 
Finally, the bromonucleosidc 5-8 (50 mg, 0.092 mmol) was added followed by freshly 
distilled, dried 1,4-dioxane (0.6 mL). The vial was flushed with nitrogen, scaled with a 
Teflon-lined cap, and placed in a sand bath that was maintained at 100 °C. The reaction 
was monitored by TLC and was complete after 1 hour. The reaction mixture was cooled 
to room temperature and filtered through Celite. The residue was washed with CHiCb 
and the filtrate evaporated to dryness. The crude product was purified by column 
chromatography eluting with CII2CI2. Fractions containing the product were combined, 
evaporated and dried under vacuum to afford 38 mg of 5-10 (73% yield) as a yellow oil: 
Rr (CH2CI2) = 0.38; 'l l  NMR (500 MHz, CDCIj) 5 9.01 (s, IH, purine-H), 8.44 (s, 1H, 
purine-H) overlaps with (br d, IH, Ar-H, J -  7.0 Hz), 8.36 (br s, IH, Ar-H), 7.49 (t, J =
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8.0 Hz. 1H, Ar-H). 7.09 fdd, J = 8.2, 2.7 Hz, 1H, Ar-H), 6.59 (t, J = 6.5 Hz, 1H. Hr ), 
4.67 (m, IH, Hr ), 4.07 (app q, 7lpp = 3.5 Hz, 1H, H< ), 3.95 (s, 3H, OCHj), 3.90 (dd, J =
11.2,4.1 Hz, 1H, H5 ), 3.81 (dd,/  = 11.2, 3.2 Hz, 1H, H5 ), 2.72 (app quint, Jm  = 6.3 Hz, 
1H. H2-). 2.51 (ddd, J = 13.0, 5.9. 3.8 Hz, 111, H: ). 0.94. 0.91 (2s, 18H, lert-Bu), 0.13, 
0.10, (2s. 12H, SiCHj); HRMS m/z. (M + Naj* C2vH4,,N404Si:Na calcd 593.2955. found 
593.2957.
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CHAPTER 1
OVERVIEW
1.1 Brief Summary of Research Goal
The functions of numerous biological systems depend on peptides and proteins. 
The conformation adopted by peptides and proteins therefore is extremely important in 
light of their functions in biological systems. Most natural peptides are oligomers of a- 
amino acids (a-peptides) and arc conformationally flexible which makes them unsuitable 
for design purposes. Oligomers of P-amino acids (P-pcptides), however, provide a 
greater opportunity for conformational rigidity making them much more suitable for 
design purposes. Naturally occurring a-amino acids have been shown to adopt defined 
stable conformations, giving rise to regular secondary structure in natural (a-) peptides. 
Synthetic oligomers of p-amino acids (p-pcptidcs) can also fold into compact, stable and 
well-defined secondary structures, but compatibility between a- and P-peptide secondary 
structures remains largely uninvcstigalcd.
Heterogeneous backbone oligomers are oligomers containing both u- and p-amino 
acid residues in an alternating sequence. No information is available in the current 
literature concerning the structure of such heterogeneous backbone oligomers. The goal 
herein is the synthesis of heterogeneous backbone oligomers and the investigation of 
folding propensity. Also of interest is the investigation of whether a potentially folded
119
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structure complies with (3-pcptidc folding rules, and how the overall folding is perturbed 
by varying the a-amino acid. The determination of what structural role is played by each 
kind of residue in the conformation adopted by the oligomers is of equal importance. In 
the field of foldamers, the focus is on the search for non-natural oligomer backbones with 
an increased tendency to adopt compact, stable, and specific conformations in solution.1
1.2 Foldamers
Foldamers are unnatural oligomers that fold into specific, compact and well- 
defined conformations in solution,1,2 The complex activities of biological 
macromolecules, such as proteins and RNA, are due to stably folded structures resulting 
from non-covalent interactions.3 Two main classes of foldamers are known based on if 
folding is accompanied by association.1 One of these classes of foldamers that only fold 
arc single-stranded foldamers such as peptidomimetics and their non-biological 
analogues. Another class of foldamers is the multiple-stranded foldamers which both 
fold and associate and examples of which are nucleotidomimetics and their non- 
biological analogues. In the development of foldamers, three distinct goals have been 
identified.2 These goals include the design of novel oligomers with the propensity to fold 
in a predictable manner, an efficient synthesis of monomers and oligomers, and the 
search for potential chemical applications. The principles underlying these goals arc 
elaborated in the subsequent paragraphs.
A variety of low-resolution and high-resolution spectroscopic techniques can be 
used for the identification of novel folded conformations of non-natural oligomer 
backbones. Examples of low resolution spectroscopic techniques include one- 
dimensional nuclear magnetic resonance, amide proton-deuterium exchange, circular
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dichroism, and infrared spectroscopy. High-resolution spectroscopic techniques such as 
two-dimensional nuclear magnetic resonance (2-D NMR) can provide information on the 
specific backbone orientation of foldamers in solution. X-ray crystallography can 
provide information on the specific orientation or spatial arrangement of the folded 
structure in the solid state.
The design of efficient methods for the synthesis of monomers in 
stcrcochcmically pure form is extremely important in the development of foldamers. An 
efficient monomer synthesis and optimization of oligomer synthesis will allow a quick 
evaluation of foldamers for potential biological applications.
The most important goal in foldamcr development is the search for interesting 
biological applications. The design of efficient synthesis must therefore take into account 
particular properties of the foldamers that confer important chemical functions.
In recent years, several research groups have reported various types of foldamers 
that mimic the major secondary structures found in nature such as helices, sheets, and 
turns. For most oligomers, backbone conformation is specified by hydrogen bonding 
while others do not rely on hydrogen bonding to stabilize secondary structures. Figure
1.1 shows examples of hydrogen-bonded and non-hydrogen-bonded foldamer backbones.
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The most thoroughly studied foldamers arc oligomers of P-amino acids (P-pcptidcs). The 
major secondary structures in proteins have also been reported to be found in P-peptidcs. 
Before discussing p-peptides, it will be important to briefly review the main secondary 
structures in oligomers and proteins.
1.3 Review of Protein Structure
Peptides and proteins are comprised of amino acid units (residues) joined by 
amide bonds between the carboxyl group of one amino acid and the amino group of the 
other. The function of a particular protein depends on its three-dimensional structure. 
There arc generally four levels of protein structure.4 The sequence of amino acids, 
stabilized by peptide bonds, is known as the “primary structure.” The “secondary 
structure” is defined in terms of the way in which the amide backbone (dihedral torsion 
angles) folds locally. The classification of “secondary structure” includes descriptions 
such as helices, sheets, and reverse turns. The spatial relationship between the various 
components of secondary structure gives rise to the “tertiary structure." The last level of 
protein structure is the quaternary structure which arises from the association of protein 
subunits stabilized by non-covalcnt interactions such as hydrophobic forces, hydrogen 
bonds, and salt bridges. This review will focus on secondary structure because among 
synthetic oligomers reported in the literature, the prominence of secondary-type 
structures has been confirmed experimentally.
There are three main classes of secondary structure conformations based on either 
local or non-local (non-covalcnt) interactions between residues in sequence. Among the 
regular secondary structures arising from non-local interactions arc u-helices and ()- 
sheets. Local interactions on the other hand are due to torsional preference of the peptide
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backbone and examples of secondary structures in this category are reverse turns. 
Peptide segments in a protein that are not characterized by any regular or repeating 
conformation are referred to as "random-coil'' regions.
The a-helix is the most common form of secondary structure in proteins, in which 
the polypeptide chain is coiled into a helix. The helical structure is held in place by weak 
hydrogen bonds between the i1* and (i+4)'h residues of the helix. An a-hclix takes a 
cylindrical form in which the hydrogen-bonds all point in the same direction and are 
approximately parallel to the helical axis. The hydrogen-bond directionality confers a net 
dipole with a partial positive charge at the N terminus and a partial negative charge at the 
C-terminus. The side chains of the amino acid residues form the surface of the helix. 
The helix is right-handed in nature and contains 3.6 residues per tum of the helix with a 
translation along the helix axis of 1.5 A per residue/
In P-sheets, adjacent strands of extended polypeptide chains are arranged in either 
a parallel or antiparallel orientation. Compared to helices, a typical p-sheet involves non­
local interactions between amino acid residues that arc sequentially distant 
(intramolecular) or that are from different molecules (intcnnolecular). The p-sheet 
structure resembles a twisted plane, unlike the rod-like cylinder of the a-helix. The twist 
of the P-shect is generally right-handed in orientation, regardless of whether the strands 
of the sheet are oriented parallel or antiparallcl to one another.4 In the sheet 
conformation, a network of hydrogen bonds forms in the plane of the sheet. The side 
chains of the amino acids are oriented above and below the plane of the sheet. 
Sometimes a P-shcct occurs on the surface of a protein with the side chains directed away 
from the protein being predominantly hydrophilic, and the side chains directed towards
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the protein being predominantly hydrophobic. This alternation between hydrophilic and 
hydrophobic nature of the side chains between the two faces of a jJ-sheet, results in an 
amphiphilic character for the sheet. In a parallel p-sheet the adjacent P-strands have 
identical N- to C-terminus orientation, while the N- to C-terminus directionality of 
adjacent strands alternates in an antiparallel p-sheet (Figure 1.2).5
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Figure 1.2 Two-dimensional projections of parallel and antiparallel P-strands. The arrows 
indicate the directionality (from N- to C-terminus) of the p-strands. Hydrogen bonds are 
indicated with dashed lines.
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Reverse turns, also known as loops, arc strictly local in nature.'1 The turns reverse 
the directionality of the peptide backbone spatially. Different types of reverse turns exist
turn is a P-tum which consists of lour residues at positions i to i + J (Figure 1.3). 
Another type of reverse turn structure, the y-tum,6a consists of three residues at positions i 
to i + 2. Generally each type of reverse turn is defined in terms of the <> and v  torsion 
angles of the central residues, a y-tum contains one central residue and a p-tum contains 
two central residues. Typically, a hydrogen bond is formed between the carbonyl oxygen 
of the first residue in the turn and the amide proton of the third residue (y-tum) or fourth 
residue (P-tum). The presence of hydrogen bond, although observed in most reverse 
turns, is not a necessary requirement for the classification of p-tum.'’1’ Reverse turns have 
also been implicated in the development of small p-sheet models such as p-hairpins. 
Most of the classic y-tums are known to occur at the ends of P-hairpins.
Figure 1.3 Example of a p-tum peptide structure. Residues R j, i  and R,,: form the loop. 
Classification based on 0 and q/ of loop residues. Dashed line indicates potential H-bond.
depending on the number of residues considered to define the turns.4 The most eommon
R i*3  O
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P-Hairpins are anliparallcl hydrogen-bonded strands of p-shcet that arc adjacent in 
sequence.6'1 The loop of a reverse turn refers to the residues not involved in hydrogen 
bonding.
1.4 P-Peptides
Like natural peptides and proteins, p-peptides can adopt folded conformations 
including common secondary structures such as helices,7 10 turns,11'12 and sheets.1’ 
Compared to natural peptides, P-peptides have the advantage of increased conformational 
stability in an aqueous environment.114 The p-peptide backbone compared to natural 
peptides is resistant to protease degradation and has the potential for a great variety of 
substitution patterns.15 In addition P-peptides form more stable helices in solution 
compared to a-peptides.16 P-Peptides can form stable secondary structures with as few as 
four to six residues in solution,10 compared to over 20 residues needed for stability of the 
natural analogs. P-Peptidcs can also readily form cyclic compounds that stack into tube 
structures.17 This stability, important for biological activity, makes p-peptides good 
candidates for useful drugs.12 P-Peptides have thus been reported with a variety of 
biological activities.18'22 As a result of the importance of P-peptides, the paragraphs that 
follow will review some early studies on p-amino acids and their conformations.
1.4.1 Early Studies on 11-Amino Acids
Early attempts at realizing ordered peptide structures with P-amino acids date 
from the end of the 1960s and were continued in the 1970s.2125 In 1994, Dado and 
Gcllman studied the intramolecular hydrogen bonding properties of p- and y-amino acid 
derivatives.26 They hypothesized that the formation of secondary structures by oligomers 
of ct-amino acids is due in part because formation of short range hydrogen bonds, such as
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intramolecular 5- or 7-membcred hydrogen bonded rings, is energetically unfavorable 
among a-amino acid oligomers (Figure 1.4). Based on their hypothesis. Dado and 
Gcllman reasoned that other oligomers in which formation of short range hydrogen bonds 
is unfavorable might also be predisposed to form secondary structures. To test this 
hypothesis further. Dado synthesized various derivatives of P-alaninc as well as y- 
isobutyric acid and using IR spectroscopy, examined the intramolecular hydrogen 
bonding of these molecules. The results demonstrated that while short range hydrogen 
bonds (7- and 9-membered rings) were common among the diamides of y-aminobutyric 
acid, the same was not true for diamides of P-amino acids (Figure 1.4). Therefore, based 
on these studies, Dado and Gellman concluded that oligomers of p-amino acids (P- 
peptides) could potentially form stable secondary structures. The studies carried out by 
Dado and Gellman did not take into account substitution on a-, P-, or y-carbons which 
could potentially have some constraining effects.
5-membered ring 8-membered ring 7-membered ring
7-membered ring 6*membered ring 9-mombered ring
Figure 1.4 Favorable and non-favorable intramolecular hydrogen bonding in a-, p-, and y- 
amino acid peptides.
Although predicted that P-pcptides are capable of forming stable and compact 
secondary structures, investigations of the NV1R solution structures of poly-P-alaninc 
indicated that the polymer had no folded conformation.25 In contrast, IR data in the solid
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stale indicated the formation of sheets.”  Various research groups have studied polymers 
of a-isobutyl-L-aspartatc by X-ray diffraction, CD, and IR spectroscopy. In 1978, Yuki 
et al. reported that the polymer of a-isobutyl-L-aspartatc formed extended sheets with 
hydrogen bonding between the strands.*3 In the mid 1980s, Femandez-Santln and co­
workers reported that in the solid state, the polymer of a-isobulyl-L-aspartate formed two 
helical conformations characterized by intramolecular 16- and 20-mcmbered hydrogen 
bonded rings.2<>1" In 1995, Ldpez-Carrasquero et al. contrasted initial reports by 
Fcmandez-Santin and co-workers and instead proposed that the helical conformations 
formed by the polymer of a-isobutyl-L-aspartatc was characterized by 14- and 18- 
membered hydrogen bonded rings.11
The biggest breakthrough in the synthesis (J-pcptides of defined sequence that 
allowed crystallographic and high-resolution NMR data to be obtained was achieved by 
the research groups of Gellman7 '0'138'14 and Secbach.12'16 1712 Gellman and co-workers 
have synthesized and characterized oligomers of /ra/i,v-2-aminocyclopcntanecarboxylic 
acid (ACPC),8 mj/w-2-aminocyclohcxanecarboxylic acid (ACHC),9 and trans-3- 
aminopyrrolidinc-4-carboxylic acid (AGP).14 Gellman et al. showed that while ACHC 
adopted a 14-helical conformation in organic solvent, ACPC adopted a 12-helical 
conformation. Oligomers containing both ACPC and ACP residues were also shown to 
form 12-hclical conformations in aqueous solution.14 Sccbach and co-workers showed 
dial p-peplides composed of acyclic residues with side chains derived from a-amino acids 
also formed 14-helical conformations in organic solvent.'6
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1.4.2 Helix Nomenclature
Helical conformations have been described using several different conventions in 
the literature. However, the best convention is that which describes the helix based on 
the number of atoms involved in the hydrogen bonded ring formed. This convention is 
capable of describing all helices reported in the literature this far.
1.4.2.1 14-Helix
A 14-hclical conformation consist of a 14-mcmbcred hydrogen-bonded ring 
between a carbonyl oxygen in the i,,' position and an amide proton in the (i + 2)r  position 
towards the N-terminus.9 The helix dipole is thus negatively charged at the N-tcrminus 
and positively charged at the C-tcrminus. This orientation is opposite to what is observed 
in naturally occurring a-helices. The 14-helix is more stable compared to the u-helix.
1.4.2.2 12 Helix
A 12-helical conformation consist of a 12-membered hydrogen-bonded ring 
between a carbonyl oxygen in the f '  position and an amide proton in the (i + 3)"1 position 
towards the C-terminus.8 The helical dipole points in the same direction as the a-helix, 
but in opposite direction compared to the 14 helix.
1.4.2.3 Other Helices
Other helices include the 10-helix and the 10/12 helix. The 10-helical 
conformation consist of a 10-mcmbcrcd hydrogen-bonded ring between the amide proton 
of the i"' residue and the carbonyl oxygen of the (i + i f  residue. The 10/12 helical 
conformation on the other hand is characterized by 10- and 12-membcrcd hydrogen- 
bonded rings.'1 The directionality of the 10-mcmbcrcd hydrogen-bonded ring is almost
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perpendicular lo the helical axis, while the 12-membered hydrogen-bonded ring is 
parallel to the helical axis.
1.4.3 6-Amino Acid Conformation
In polypeptides of a-amino acids, the backbone conformations are defined by 
three sets of torsion angles Q, xp, and to (Figure 1.5).33 Generally in peptides and proteins, 
the torsion angle about the peptide bond is restricted to a Irons geometry (to = 180). 
Backbone conformation of ()-amino acid residues in peptides is determined by four main 
chain torsional variables b, 0, \|/, and to, using the convention of Balaram (Figure 1.5).33
H H
Figure 1.5 Backbone conformation of P-amino acid.
By this convention, the backbone conformation is read sequentially from the N- to 
the C-terminus with the torsional variables defined as 0 (N- Ce), 0 (C^-C0), v  ( C“-C'), 
and u) (C'-N) (Figure 1.5). In p-amino acids, the torsion angle about the C-C bond (0) 
can lie close to the gauche (0 = ± 60°) and irons (0 = 180°) conformations.33 A 
predominance of gauche conformations can easily lead to the formation of folded 
structures.
1.5 Factors Affecting Oligomer Structure
In the design of non-natural secondary structures, a number of factors must be 
taking into consideration. These factors affect the overall conformation and the nature of 
folding of oligomers. The conformation of a folded oligomer is defined by noncovalent
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interactions between non-adjacent monomer units. The folding of oligomers is 
considered in solution, which means solvent is critical in folding.
1.5.1 Intramolecular Interactions
The creation of a defined oligomer secondary structure necessitates restricting the 
oligomer to adopt only specific conformations. Intramolecular interactions play an 
important role in directing the formation of secondary structure. Attempts at using 
donor-acceptor interactions of aromatic rings to control the conformation of aedamers 
(aromatic oligomers with stacking propensities) has been reported.34 The formation of 
intramolecular donor-acceptor complexes in aedamers was ascertained by nuclear 
magnetic resonance (NMR), and ultraviolet (UV) spectroscopy.
1.5.2 Conformational ControI and Hydrogen Bonding 
Oligomer secondary structures can also be obtained by limiting the accessible 
oligomer backbone conformations. The formation of oligomer secondary structure often 
incorporates intramolecular hydrogen bonds, which are weak attractive forces. A 
common approach in the design of oligomer structure is to favor hydrogen bonding 
formation, while eonformationully restricting the monomers. Evidence for the formation 
of intramolecular hydrogen bonds in vinylogous peptides have been reported by Hagihara 
ct al:'s Gcnnari and co-workers have reported the importance of carbon-carbon double 
bonds, sulfonamides, and hydrogen bonding in the structures adopted by vinylogous 
sulfonamidopeptide.s.'’<’■'’, An extended conformation was maintained by the double bond, 
while the sulfonamides imposed a turn in the oligomeric backbone. Based on TR data, an 
intramolecular 14-mcmbered hydrogen bonded ring was proposed, while crystal structure 
instead indicated an intramolecular 12-membered hydrogen bonded ring.
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The contribution of aromatic ring substitution pattern and intramolecular 
hydrogen bonds to the conformation of oligoanthranilamidcs has been reported. ’8 It was 
found that while ortho substitution favored a linear extended conformation, meta 
substitution favored a helical conformation. The incorporation of chiral centers into side 
chains have been reported to favor helical conformations in peptoids.3l)
1.5,3 Solvent Effects
The interactions between oligomers and solvent can affect the conformations 
adopted by oligomers. The ability for an oligomer to fold can be favored or disfavored 
by such solvent properties as dielectric constant, solubility, and hydrogen bonding 
capability. Solvent effects on the conformations of phcnylaectylene oligomers have been 
reported by Nelson and co-workers.'10 Based on NMR and UV spectroscopic studies, they 
concluded that a well-ordered conformation was observed in deuterated acetonitrile, but 
not in deuterated chloroform. The difference in behavior of the oligomer in the different 
solvents could be a result of difference in solubility. The oligomer was found to be 
completely soluble in chloroform irrespective of the number of residues and had many 
conformations. In acetonitrile, however, the oligomer became less soluble as the chain 
length increased resulting in a single, well-defined conformation.
1.6 Methods for Conformational Analysis 
Several different analytical techniques exist to probe the secondary structure of 
peptides in different solvents. Among the techniques applicable for the research in this 
thesis are one- and two-dimensional NMR, molecular modeling, and circular dichroism 
(CD).
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There exist a number of one-dimensional and two-dimensional NMR techniques 
to probe peptides for solution conformations.
Some useful information can be derived from one-dimensional 'H NMR 
techniques. For example, the occurrence of aggregation can be investigated by 
concentration dependent one-dimensional NMR. Monomeric peptides are usually 
characterized by sharp, and well-resolved resonances. When peptides associate 
intermolecularly with increasing concentration, broaden lines with decreased intensity are 
formed. Another technique is the exchange between the amide-protons of peptides or 
proteins and the solvent protons which occurs in dynamic equilibrium. If the pseudo 
first-order exchange rate is delayed, then some kind of steric or chemical hindrance, such 
as hydrogen bonds is implicated.
In two-dimensional NMR spectroscopy, proton resonances or chemical shifts arc 
assigned to the respective protons by experiments that can be divided into two general 
classes: experiments that measure through-bond interactions, and experiments that 
measure through-space interactions. Through-bond interactions arise through nuclei that 
are coupled, or covalently connected through one or more bonds to each other. Through- 
space interactions result from dipolar relaxation mechanisms between nuclei that are not 
necessarily close in a covalent sense, but arc close to one another in space.41 Two- 
dimensional experiments effectively spread out the resonances making it easier to assign 
protons and observe interactions, that would otherwise be difficult to observe by one- 
dimensional experiments due to resonance overlap. A general outline of the information 
that can be obtained from the various experiments is presented below.
1.6.1 One- and Two-Dimensional NMR
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1.6.1.1 COSY and TOCSY
Both COSY and TOCSY experiments examine the through-bond (J-couplcd) 
interactions between nuclei that are directly connected through covalent bonds. The 
homonuclear 'H NMR COSY (correlated spectroscopy) experiment generates cross peaks 
for protons connected to each other and separated by two or three bonds (2J or 3J).43 
TOCSY (total correlated spectroscopy) experiment generates cross peaks between a 
nucleus and all other nuclei in its spin system.42 A spin system refers to all the protons 
that are either directly coupled to one another, or coupled through intervening protons. 
This magnetization, however, docs not pass through quaternary carbons, such as the 
carbonyl carbon of the peptide backbone. The TOCSY experiment is very useful for 
peptides, since each amino acid residue forms a spin system, separated from the spin 
systems of other residues by the carbonyl carbon of the amide bond. A model system to 
illustrate the interaction between cross peaks is shown in Figure 1.6. A standard COSY 
spectrum would show cross peaks between the following proton pairs: H|-Hp, and 
(Figure 1.6). In a TOCSY spectrum, Hi would show cross peaks to Hp and H„, but not to 
Hj, which is isolated from the spin system of H|-Ha by the intervening quaternary 
carbonyl carbon (Figure 1.6).
Figure 1.6 Model to illustrate 'H NMR J-couplcd and dipolar relaxation interactions.
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Both techniques are based on through-space dipolar interactions. Dipolar 
interactions between two nuclei can generate a Nuclear Overhauscr Enhancement 
(NOE).45 The magnitude of the dipolar interaction and NOE is modulated by a l/r° 
dependence on distance. This means an observable NOE is generated only between 
protons that are relatively close to one another, typically within 5 A of each other. NOE 
experiments are generally used to determine the three-dimensional structure of peptides 
in solution. Both short-range and long-range NOEs are used to characterize the solution 
conformation of peptides and proteins. The definition of short-range refers to nuclei that 
are close in a through-bond sense (Hi and Hp in Figure 1.6), while long-range refers to 
nuclei separated by many bonds (Hi and fy. Figure 1.6). Generally, information from 
NOESY (Nuclear Overhauscr Effect Spectroscopy)44 and ROESY (Rotational 
Overhauscr Effect Spectroscopy)45 experiments arc used together to generate NOEs that 
reflect the real extent of through-space interactions between protons. While the NOESY 
experiment is based on the NOE signal, the ROESY experiment is based on the ROE 
(Rotational Overhauscr Effect) signal. Both NOE and ROE intensities have 1 / / ’ distance 
dependence.
1.6.2 Computational Methods
Molecular modeling can be used in conjunction with NMR data to determine 
three-dimensional solution structure of peptides. Experimental information from NMR 
such as NOE and coupling constant data can be incorporated into a computational 
method for accurate prediction of solution conformations. The general strategy for 
computational modeling of peptides that has been reported in the literature involves
1.6.1.2 NOESY and ROESY
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building and modeling dipeptidc units. Peptides have been studied by both ab initio and 
molecular mechanics methods.46 Molecular dynamics methods have been applied to 
predict the folding patterns of P-pcptidcs.47"w'l3b Molecular mechanics force fields were 
used in the simulations, and promising results have been obtained. Appclla el al. 
predicted the 14-helical conformation of (5-peptides made of trans-ACHC by 
computational methods,47 and this was consequently confirmed by experiment.50 Yun- 
Dong and De-Ping have carried out ab initio quantum mechanics studies on P-pcptidc 
models.40,51 Their theoretical studies was based on locating low-energy conformations 
and conformations associated with (he formation of secondary structures using dipeptidc 
models. Their theoretical calculations gave results in agreement with experimental 
observations.
1.6.3 Circular Dichroism
Circular dichroism (CD) is a spectroscopic method that measures the differential 
absorbance of left- and righl-circularly polarized light by a compound in solution. The 
differential absorbance is expressed as molar ellipticity, and arises as a result of the 
intrinsic chirality of the chromophore or when the chromophorc is placed in a chiral 
environment.4 In the case of peptides, the amide chromophore absorbs strong signals due 
to the backbone peptide conformation in the far UV region (240-180 nm) of the CD 
spectrum. The CD spectrum in the near UV region (320-260 nm) reflects the 
environments of the aromatic amino acid side chains. The peptide CD spectrum is 
sensitive to the solution conformation of the peptide as a result of the difference in 
absorbance.4 CD has been widely used to detect regular secondary structural features in 
peptides and proteins, such as u-hclix and |)-shcet.52
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The CD signals for a-helix, p-sheet and random coil structures of peptides and 
proteins arc well characterized. The CD spectra of a-helices are characterized by minima 
around 208 nm and 222 nm, and a maximum around 192 nm. In comparison, p-shects 
are characterized by CD spectra consisting of a minimum around 218 nm and a maximum 
between 195-200 nm. The CD spectra of random coils consist of a strongly negative 
signal near 200 nm and a weak maximum close to 220 nm.
Different characteristic CD signals are observed for each type of turn in p~ 
turns,53'5'1 making it considerably more difficult to predict a general characteristic of such 
CD signals. The CD spectra of P-hairpins are difficult to analyze, since p-hairpins arc a 
combination of p-strand and P-tum, and only the contribution of p-tum to CD is 
characterized. The CD signals of antiparallel P-hairpins, however, have been 
qualitatively observed to resemble that of p-sheets.52
As mentioned earlier, compatibility between a- and P-peptide secondary 
structures remains largely uninvestigated. It will be interesting to synthesize oligomers 
containing a- and P-amino acids in an alternating sequence and then check for the ability 
of such oligomers to fold. The synthesis and characterization of heterogeneous 
oligomers, the main focus of this part (Part II), is described in chapter two. Chapter three 
provides all the experimental details from chapter two. In chapter four, attempts at 
modeling heterogeneous oligomers to predict experimental results are presented. Finally 
in chapter five, computational simulations of linkers between u- and P-peptide helices are 
presented.
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CHAPTER 2
SYNTHESIS AND CHARACTERIZATION OF HETEROGENEOUS OLIGOMERS
2.1 Inlroduction
Heterogeneous oligomers of alternating frwi.v-2-aminocyclohexanecarboxylic 
acid (ACHC) with various a-amino acids were designed and synthesized to study their 
conformational properties. Heterogeneous oligomers arc synthesized by both solution 
phase and solid phase methods. Standard coupling reagents are used with the coupling 
proceeding from the C-tcrminus towards the N-terminus. For efficient coupling to be 
effected, it is desirable to obtain the monomer in a pure form. It is also important to use 
protective groups that are tolerant to reaction conditions. For solution phase synthesis, 
tcrt-butyloxycarbony! (Boc) group is used for N“ protection while the benzyl group is 
used for protection of the C-terminus. The a-amino acids are obtained commercially and 
are used without further purification. The desired a-amino acids for solution phase 
synthesis arc those protected with the Boc group at the N-tcrminus with a free carboxylic 
terminus. For solid phase synthesis, the desired a-amino acids are those protected with 9- 
fluorenylmethyloxycarbonyl (Fmoc) at the N-terminus. The side chains of those a-amino 
acids containing reactive groups were also protected to prevent side or unwanted 
reactions. The p-amino acids required for coupling, tran.v-2-aminocyclohcxanc- 
carboxylic acid (ACHC), and Fmoc-piperidine carboxylic acid are
138
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synthesized and purified. The optical rotation is checked to make sure the monomer is 
pure enough for coupling.
The advantage of efficient monomer and oligomer syntheses is that rapid analysis 
for structural characterization is ensured. Oligomer synthesis consists of three main 
steps: (1) activation of a-carboxyl group. (2) coupling with an amino component, and (3) 
deprotection.55 In the synthesis of peptides, it is extremely important to maintain the 
chirality of the constituted amino acids to avoid racemization.56 An efficient oligomer 
synthesis necessitates, solubility of the constituent amino acid monomers in organic 
solvents, complete exclusion of racemization at every step of the synthesis, and a 
quantitative yield of product at every coupling step.55
Protecting groups are selected that can be easily removed, leaving the peptide 
bond and the various side chain functions unaffected and generating only relatively 
harmless by-products. The major difference between solid phase synthesis and solution 
phase synthesis is protection of the C-terminus. In solid phase synthesis, the insoluble 
polymeric support may be considered to be the C-terminus protecting group, while in 
solution phase synthesis, more conventional protecting groups are used.56 Most 
commonly, the C-terminus is protected as an alkyl or aryl ester. Both sequential 
elongation and segment condensation strategics may be employed in solution phase 
synthesis of oligomers. Sequential elongation is effective for the synthesis of small 
peptides and preparation of peptide segments in the construction of larger peptides and 
proteins.56 The use of carbodiimidc derivatives for the activation of the carboxyl group in 
the synthesis of peptides was first reported by Sheehan and Hess.57 Carbodiimide 
derivatives are now the most widely used coupling reagents for both solid phase and
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solution phase synthesis of peptides.5'’58 It is now common to use the carbodiimide 
coupling reagents in the presence of additives, to suppress racemization and accelerate 
aminolysis.59'60,61 The synthesis of p-amino acid monomers for oligomer coupling are 
presented in the paragraphs that follow.
2.2 Synthesis of A,-(9-Fluorenylmethyloxy)-/ran.s-ACHC by Enzymatic Resolution 
The synthesis of iV-(9f!uoicnylmethyloxyearbonyl)-/ra/i.v-ACHC was 
accomplished stalling from the commercially available anhydride, compound 2-1 , which 
was quantitatively converted to the diester 2-2  by refluxing in methanol and thionyl 
chloride. The symmetric dicster was subsequently converted to the monoester 2-3 by 
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Scheme 2.1 Synthesis of Carbamate Ester 2-4.
Precedence for this enzymatic reaction was first reported by Ohno and co­
workers,62 and subsequently adapted by Gellman group 63 Ohno and co-workers reported 
that the enzyme pig liver esterase selectively hydrolyzes one of the two methyl ester 
groups of 2-2 to afford 2-3 in high enantiomeric excess.62 No diacid formation was 
observed as had been reported and the enantioselective hydrolysis of the diester by pig
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liver esterase generally terminated at the monoestcr stage.62 An explanation to this is 
probably because the initially formed monoester exists as a carboxylate anion in weakly 
alkaline buffer-media, and may be too polar to be incoiporated into the hydrophobic 
binding site of the enzyme.62 This implies that the enzymatic reaction can continue until 
all the diester is consumed. In addition, Olino and co-workers62 also developed 
conditions for obtaining 2-4 from 2-3 by a Curtius rearrangement (Scheme 2.1). Thus the 
monoestcr 2-3 was reacted with ethyl chloroformate and triethylamine in acetone and 
then sodium azide in water was added to the reaction mixture. The resulting acyl azide 
solution was subjected to thermal rearrangement in benzene and treated with benzyl 
alcohol to afford the p-aminocstcr derivative 2-4 (Scheme 2.1). An excess of benzyl 
alcohol is needed in this reaction for the efficient trapping of the resulting isocyanate to 
form a Cbz-protectcd amino group. Appclla el al., of the Gcllman group, have 
reproduced these results but in their case, 2-4 could not be purified from benzyl alcohol.03 
Similar to the work of Appclla et al., the above procedures were reproduced and yet the 
carbamate 2-4, could not be separated from benzyl alcohol. The mixture was however 
carried on in subsequent synthetic steps.
Reduction of the alkcne and removal of the Cbz protecting group in 2-4 was 
accomplished by catalytic hydrogenation (Scheme 2.2). Thus the protected (3-aminocster 
2-4 was subjected to hydrogenation of the carbon-carbon double bond and 
hydrogenolysis of the benzyloxycarbonylamino group by treatment with catalytic Pd/C 
under a hydrogen atmosphere. After reduction and deprotection of 2-4, the benzyl 
alcohol was easily separated from the amine product by acid-base extraction. The 
resulting |i-aminocstcr, free from benzyl alcohol, was then reacted with di-/ert-butyl
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dicarbonate (B0C2O) and potassium carbonate to afford 2-5 (Scheme 2.2). An alternative 
route to 2-5 involved a one pot reaction in which hydrogenation, hydrogenolysis, and 
Boc-proteclion were carried out in one step.
Scheme 2.2 Synthesis of Boc-ACHC-OBn 2-8.
Epimerization of the protected [1-aminoester 2-5 with NaOMe in refluxing MeOH 
yielded the trails isomer 2-6, which was contaminated with a small amount of the cis 
isomer 2-5. Rccrystallization in 11-heptane provided pure 2-6 (Scheme 2.2). The methyl 
ester was hydrolyzed to provide Boc-ACHC 2-7, whose optical rotation was comparable 
to the same compound synthesized and reported by Appclla el a/."'1 The C-tcrminus of the 
Boc-prolected free acid was protected with a benzyl group to afford 2-8 (Scheme 2.2), 
that was used as an intermediate for solution phase synthesis of oligomers.
To obtain the required monomer for solid phase synthesis, Fmoc-protection was 
necessary since it has been demonstrated that in the solid phase synthesis of oligomers, 
Fmoc-bascd protection strategy is most facile.58 The desired monomer for solid phase 
synthesis 2-9, was obtained from the corresponding Boc-protected free acid 2-7 by 
deprotection of the amino group followed by rcprotection with the Fmoc group as shown 
in Scheme 2.3. Two different synthetic methods were used to synthesize 2-9 from the 
corresponding Boc-protected free acid. The first method involved the use of an organic
NHCbz .NHBOC NaOMe. MeOH
.NHBoc LiUn. M2U2 
Aq MeOH
OH H Oja,’COOMo♦ BnOH 2. Boc20 , K2C 03 
80%
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base DIEA in acetonitrile while the second method involved the use of weak inorganic 
base sodium bicarbonate in acetone/watcr. Both methods yielded the desired Fmoc- 
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Scheme 2.3 Synthesis of (K,K)-Fmoc-ACHC 2-9.
The synthetic routes that have been described above (based on enzymatic 
hydrolysis) enabled the synthesis of benzyl (IK. 2K)-At-/er/-butyloxycarbonyl-/ru«v-2- 
aminocyclohexanecarboxylate 2-8, for solution phase synthesis, and (lK,2K)-Fmoc- 
ACHC 2-9 for solid phase synthesis. Although the monomers, 2-8 and 2-9, were 
obtained in quantitative yield, the major drawback was that the synthetic routes only 
provided access to one enantiomer (R,R). The method does not allow the synthesis of 
(S,S)-Fmoc-ACHC, which will be required for the synthesis of oligomers incorporating 
natural a-amino acids (L-configuration). Also several column chromatographic steps 
were involved, which is generally not convenient when dealing with large amount of 
material. The search for an alternative and more efficient synthetic route to the (1-amino 
acid monomers should be based on overcoming the shortcomings of the use of pig liver 
esterase. An efficient synthetic route to the monomers, therefore, should be one that can
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give access to both enantiomers, ami can afford quantitative amount of the pure 
monomers with little or no column chromatography involved. Towards this end. the 
synthesis of the P-amino acid monomers by reductive animation presented in the next two 
sections is an efficient synthesis that precludes the use of column chromatography and 
enables both enantiomers to be synthesized. This chemistry was developed by the 
Gcllman group64 and successfully implemented.
2.3 Synthesis of P-Amino Acid Monomers by Reductive Animation 
Reductive amination methodology for the synthesis of cither enantiomer of trans- 
3-aminopyrrolidinc-4-carboxylic acid (APC), and fra/r.s-2-amino cyclopcntanecarboxylic 
acid (ACPC) respectively had been previously reported by the Gellman group.65'66 Both 
synthetic routes were inspired by the chemistry developed by Bartoli and co-workers.67 
Bartoli and co-workers demonstrated that sodium inetal reduction of cyclic p-enamino 
ester 2-10  will result in the formation of the trans y-amino alcohol in high 
diastereoselectivity and excellent yield (Scheme 2.4).
2%
2-12
Scheme 2.4 Diastereosclective reduction of p-amino ester by Bartoli and co-workers.07
Based on this chemistry, the Gellman group66 hypothesized that replacement of 
the benzylamine with an optically pure cc-methyl benzyl amine would allow reduction to 
produce predominantly the most stable diastcrcomeric alcohol, which could be separated 
and after purification carried on to give optically pure Fmoc-ACPC.
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The synthesis to either enantiomer of ACPC was successfully accomplished.66 
The synthetic route, however, suffered from low yields at the reduction stage, and overall 
low yields were obtained when the reaction was carried out on a larger scale. A different 
approach was taken that led to the successful reductive amination of P-ketoestcr 2-13 to 
p-aminocster 2-14 in the synthesis of APC derivatives (Scheme 2.5).65
Scheme 2.5 Diastercoselective reduction reported by the Gellman group.65
Inspired by their success in APC synthesis,65 the Gellman group modified their 
synthetic route to Fmoc-ACPC. 66 P-Ketoester 2-15 was subjected to reductive amination 
conditions followed by saponification, dcprotcction and protection to afford Fmoc-ACPC 
2-17 (Scheme 2.6).
fT ^ r  nh2






NH2 C02Et 1. LiOH FmocHN_ C02H
2. H2, Pd/C 1— (
3. Fmoc-OSu
2-16 2-17
Scheme 2.6 Synthesis of 2-17 by reductive amination, reported by the Gellman group.6
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The synthetic routes developed,05'66 although efficient, reproducibility became a 
problem in the Gellman group. Purification of the final product by recrystallization 
seemed almost impossible, and an inseparable impurity (observed by HPLC) of mass unit 
corresponding to a product due to incomplete hydrogenolysis of the chiral auxiliary was 
observed in oligomers containing the Fmoc-ACPC monomer.08 Investigation into the 
difficulty in reproducibility revealed that the impurity that could not be separated from 
the monomer upon recrystallization was due to the presence of dibenzylfulvenyl alcohol, 
a decomposition product from the use of Fmoc-OSu in excess at the final protection 
step.08 The impurity observed in the oligomers containing Fmoc-ACPC monomers could 
be due to contamination of the monomer by a tertiary carbamate that could be 
incorporated into a part of the oligomer.68
These problems were addressed by a modification of the initial synthetic route.66 
Complete removal of the chiral amine was ensured by carrying out transfer 
hydrogenation instead of simple hydrogenation, and the number of equivalents of Fmoc- 
OSu was reduced making it the limiting reagent.08 The results of the modification were 
the reproducibility of the synthetic methodology, and the formation of pure enantiomers 
in very good yields. This methodology has been adapted for the synthesis of monomers 
of ACHC,64 and has been implemented for the synthesis of Fmoc-ACHC, and 4-/V-(9- 
Fluorcnylmcthyloxycarbonyl)-l-fert-butyloxyearbonyl-!raiu-pipcridine carboxylic acid 
which are presented in the proceeding sections.
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2.3.1 Synthesis of nfl,2fl)-2-(9//-Fluorei)-9-vlmeilivloxvcarbonvlamino)- 
Cvclohcxanecarhoxvlic Acid hv Reductive Aminalion 
The results of the synthetic route leading to the synthesis of Fmoc-(/f,/f) ACHC 
arc summarized in Scheme 2.7. The key step involves the reductive animation of the (3- 
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Scheme 2.7 Route to Ftnoc-(R.R) ACHC 2-9 based on reductive amination.
The synthetic route (Scheme 2.7) was inspired by earlier work in the Gellman 
group,65'66 and the asymmetric synthesis of eis-2-aminocyclohexanccarboxylic acid 
reported by Xu el al.w The (3-kctoester 2-18 is allowed to react with (R)-a- 
methylbcnzylamine in refluxing benzene with catalytic tolucncsulfonic acid and 
continuous removal of water using a Dean-Stark trap. The resulting cnamine 2-19 is 
isolated as a pale yellow oil by distillation at reduced pressure. Xu et al.1'9 had reported 
that NaBHj/acid reduction of the enamine 2-19 resulted in four diastereomeric (i- 
aminocstcrs. The diastcrcoselectivity and cis/trans selectivity were found to depend on 
the carboxylic acid, co-solvent, ratio of aeid/substratc, and the reaction temperature.
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Assignment of the diastcreomers was based on their respective 'H NMR spectra.60 
When the enamine 2-19 dissolved in toluene was added to a mixture of sodium 
borohydridc and isobutyric acid at 0 °C, the enamine was reduced only to two 
diastcreomers (both cis, no traits) with a 94% diastcrcomeric excess. The diastereomeric 
product was then subjected to epimerization using sodium in absolute ethanol. Following 
cpimcrization, the crude product was purified by a two-step crystallization protocol that 
allows isolation of the hydrochloride salt 2-20 in diastereomcrically pure form. Thus, the 
crude product from epimerization reaction was dissolved in ethyl acetate and converted to 
a mixture of hydrochloride salts by treatment with 4N HC1 in dioxane. Rccrystallizalion 
from acetonitrile yielded pure 2-20 (>99% tie) in 51% overall yield from 2-19. The 'H 
NMR spectrum of the purified P-aminoester 2-21 was identical to the spectrum for the 
same diastereomcr that was reported by Xu et til69 Thus the diastereoselectivity was 
determined by proton NMR.
The synthetic route was completed by alkaline ester hydrolysis, reductive removal 
of the chiral auxiliary (a-mcthylbcnzylaminc), and Fmoc protection of the resulting 
amino group using Fmoc-OSu and sodium bicarbonate in aqueous acetone. The crude 
product was purified by recrystallization in n-hexane/chloroform to afford 2-9 in 76% 
overall yield. The optical rotation was determined and compound 2-9 was found to have 
the same optical rotation as the reference compound synthesized by enzymatic resolution. 
This synthetic route is efficient and leads to the formation of either enantiomer of Fmoc- 
ACHC with no chromatography involved.
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2.3.2 Synthesis of(3A‘.4ff i-1-(/V-tcit-BulvloxN carbon vl)-3-hvdrox vcarbonvl-4- 
l9//-fluorcn-9-vl-mcthvloxvcarbonvlamino)-Pipcndine by Reductive Amination 
Reductive amination methodology was also applied for the large scale synthesis 
of the enantiomeric derivatives of piperidine (Scheme 2.8).
pn' '̂NH P n ^ 'N H  HCI
I . C 0 2Et 1. Pd/C, HC02NH4 X ,  cO jE t X  ..-COjEt
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Scheme 2.8 Synthesis of 2-26.
The benzyl group was removed from the piperidine carboxylate salt 2-22 by 
transfer hydrogenation followed by protection with a ferf-butyloxycarbonyl (Boc) group. 
The Boc-protected P-ketoester was then subjected to reductive amination using (fl)-a- 
mcthylbenzylaminc in refluxing benzene with catalytic tolucnesulfonic acid and removal 
of water by a Dean-Stark trap to afford 72% of the enamine 2-23 after silica gel flash 
column chromatography.
The resulting enamine 2-23 was reduced in situ with sodium borohydride and 
isobutyric acid. This reduction produced a mixture of two diastereomeric Boc-prolcctcd 
P-aminoeslcrs, all cis and no trans isomers. The cis diastercomcrs were obtained in a 7:1 
(major to minor isomer) ratio based on proton NMR, after column chromatography.
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Epimcrization of the cis isomeric mixture in sodium and absolute ethanol afforded the 
crude trans mixture. The crude P-aminoestcr mixture was dissolved in ethyl acetate and 
converted to a mixture of hydrochloride salts by treatment with 4N IICI in dioxane. A 
single trans isomer crystallized in relatively pure form (>95% cle), with some 
contamination from the other trans isomer. After recrystallization from acetonitrile, the 
pure product 2-24 was obtained in 22% overall yield from 2-23. A small amount of 2-24 
was subjected to a base wash to obtain 2-25. of which the diastereomeric excess upon 
proton NMR was shown to be >99%. Hydrolysis of the ester group, followed by removal 
of the chiral auxiliary from 2-24 and protection of the resulting amino group afforded the 
crude product. The crude product was purified by crystallization from n-hexane and 
chloroform to afford 53% of 2-26.
2.4 Solution Phase Synthesis of Heterogeneous Oligomers 
Oligomers were synthesized in solution by conventional peptide coupling 
methods with A',/V-dimethylaminopropyl-3-ethylcarbodiimide hydrochloride salt (HDC1) 
as the coupling reagent, and 1-hydroxybcnzotriazolc hydrate (HOBt) as additive to 
suppress raccmization and accelerate aminolysis. Coupling was designed to proceed 
from the C- towards the N-terminus. Protecting groups were needed for the amino and 
carboxy groups. A tm-butyloxycarbonyl (Boc) protecting group, which is easily 
removed under acidic conditions, was chosen for the amino group, and a benzyl group 
(Bn), which is removed by hydrogenolysis, was chosen to protect the carboxy group. A 
retrosynthetic analysis for solution phase coupling is shown in Scheme 2.9. A sequential 
coupling strategy was employed starting with the synthesis of the dimeric backbone. 
The synthesized P-amino acid monomers had the R.K configuration and for compatibility
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in the synthesis, it was desirable to use unnatural a-amino acids having the D- 
configuration. Several different reaction conditions were tried to synthesize the dimeric 
backbone and the best condition was obtained with EDCl/HOBt as coupling reagents, 
diisopropylcthylamine (DLEA) as base, and N,/V-dimcthylformamidc (DMF) as solvent. 
The same combination of reagents was subsequently applied for the synthesis of trimers, 
tctramcrs and higher oligomers.
Scheme 2.9 Rclrosynthetic analysis for solution phase oligomer synthesis. R is the amino 
acid side chain.
2.4.1 Synthesis of Dimers
The synthesis of dimers was accomplished starting with the Boc-protected free a- 
amino acid as the electrophile. The (l-amino acid protected by a Boc group at the N- 
terminus and a benzyl group at the C-tcrminus was first dcprotected at the N-terminus to 
form a free amine that would serve as the nucleophile. Standard dcprolcelion methods 
involving the use of 4N HCI in dioxane to deprotecl the Boc group was earned out as 
shown in Scheme 2.10. Once the Boc group was deprotcctcd, the free amine was then 
coupled to the free acid using standard coupling reagents (Scheme 2.10).
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Scheme 2.10 Dimerization of ACIIC with a-amino acids.
Dimer couplings generally went lor an average of 4S hours and the yields were 
usually very good to excellent even after column chromatography. The dimers were 
characterized by 'H NMR and MS-ESI. The structures of the various dimers that were 
synthesized and their yields are shown Figure 2.1. Synthetic details are given in chapter
3.
Figure 2.1 Structures and yields of heterogeneous dimers (In all cases, stereochemistry of 
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2.4.1 Synthesis of Trimcrs. Tctramers, and Higher Oligomers 
A sequential or stepwise coupling from the dimer was employed to synthesize 
oligomers with three or more residues. A general synthetic route leading to oligomers 
beyond the dimer is shown in Scheme 2.11.
Boc-AA-ACHC-OBn or Boc-ACHC-OBn











Scheme 2.11 Synthetic route to oligomers with more than two residues; AA = a-amino 
acid.
Synthesis was successful to the level of the tctramers but beyond the tctramers, 
solubility became a problem. An attempt was made to synthesize the hexamer containing 
Ala which unfortunately did not yield any good results. Poor solubility of the compounds 
in organic solvents was a major issue and the reaction was messy. Observation of the 
spectra obtained by MALD1 and electrospray ionization mass spectrometry indicated the 
mass of the desired product, but other uncharacterized impurities were more abundant. 
Although the original idea was to make oligomers of u- and [3-amirio acids in alternating
uced with permission of the copyright owner. Further reproduction prohibited without permission.
154
sequence, another design was tried in which some oligomers were synthesized having a- 
amino acids but with [i-amino acids at the N- and C-termini. The idea was to investigate 
the effect of terminal P-amino acids on the conformation of a chain of a-amino acids. 
The trimers and letramers were purified by column chromatography, and when it was not 
possible to carry out chromatography due to low solubility, repeated precipitation was 
used to purify the oligomers. The oligomers were characterized by MS-ES1 and low 
resolution 'll NMR. Conformational and structural analysis was not carried out with 
these solution phase oligomers because a more purified form of the oligomers is needed 
for such studies. Purified samples for conformational analysis by CD and NMR could 
only be obtained from HPLC, and because of solubility problems HPLC grade samples 
could not be obtained. The structures of the various oligomers synthesized and their 
yields are shown in Figures 2.2 and 2.3. Trimer and tetramer refer to oligomers 
containing three and four residues respectively. Synthetic details arc given in chapter 3.
The yields reported are based on recovered product upon column chromatography 
or repeated precipitation. The mass spectra were usually clean after column 
chromatography and repeated precipitation with the peak corresponding to the molecular 
mass of the oligomers being the most significant peak. Purity check by HPLC, however, 
was not performed to make sure the oligomers were clean enough for analysis due to the 
oligomers being insoluble in HPLC solvent systems.

















Figure 2.2 Structures and yields of heterogeneous trimcrs (In all cases, stereochemistry of 
the a-amino acid is D while the |3-amino acid is R.R).
The heterogeneous dimer (dipeptide) 2-28 was /V-dcprotected with 4N HCI in 
dioxanc, and coupled with the Boc-a-amino acid (Boc-Val-OH) to give the 
heterogeneous trimer (tnpeptidc) 2-30 in 85% yield. The heterogeneous dimer 2-28 was 
iV-dcprotectcd with 4N HCI in dioxane, and coupled with the Boc-P-amino acid (Boc- 
ACHC-OIi) to afford the heterogeneous trimer 2-31 in 52% yield. The heterogeneous 
dimer 2-29 was /V-dcprotectcd with 4N HCI in dioxanc, and coupled with the Boc-P- 
amino acid (Boc-ACHC-OH) to give the heterogeneous trimer 2-32 in 62% yield. The 
heterogeneous dimer 2-29 was A'-deprotectcd with 4N HCI in dioxane, and coupled with 
the Boc-a-amino acid (Boc-Lys-OH) to obtain the heterogeneous trimer 2-33 in 84% 
yield.
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Figure 2.3 Structures and yields of heterogeneous tetramers (In all cases, stereochemistry 
of the ct-amino acid is l) while the p-amino acid is R,R)-
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The heterogeneous letramer 2-34 was synthesized from two heterogeneous dimers 
of 2-27. Thus, the heterogeneous dimer 2-27 was deprotected on the C-terminus by 
hydrogenolysis (H2, Pd/C) and then coupled with the corresponding iV-dcprotcctcd (using 
4N HCI in dioxane) heterogeneous ditner 2-27 to give the heterogeneous letramer 
(tetrapeptide) 2-34 in 75% yield. In a similar manner, the heterogeneous letramer 2-35 
was synthesized from two heterogeneous dimers of 2-28 The heterogeneous dimer 2-28 
was deprotected on the C-tcrminus by hydrogenolysis (H2, Pd/C) and then coupled with 
the corresponding /V-deprotectcd heterogeneous dimer 2-28 to give the heterogeneous 
letramer (tetrapeptide) 2-35 in 72% yield. The heterogeneous tetramer 2-36 was also 
synthesized from two heterogeneous dimers of 2-29. Therefore, the heterogeneous dimer 
2-29 was deprotected on the C-terminus by hydrogenolysis and then coupled with the 
corresponding /V-dcprotccled heterogeneous dimer 2-29 to afford the heterogeneous 
tetramer (tetrapeptide) 2-36 in 80% yield (Figure 2.3).
The heterogeneous tetramers 2-37, 2-38, and 2-39 were synthesized by coupling a 
tripeptidc with an a- or p-amino acid. For the preparation of the heterogeneous tetramer 
2-37, the tripeptidc 2-30 was /V-deprotccted, using 4N HCI in dioxane, and coupled with 
the Boc-a-amino acid (Boc-Lys-OH) to obtain 2-37 in 60% yield. The heterogeneous 
tetramer 2-38 was prepared by deprotection of the trimer 2-32 at the N-terminus, using 
4N HCI in dioxane, and coupling with the Boc-u-amino acid (Boc-Lys-OH) to yield 90% 
of 2-38. Finally, the heterogeneous tetramer 2-39 was synthesized from the 
heterogeneous trimer 2-33, that was /V-deprotectcd, and the corresponding Boc-P-amino 
acid (Boc-ACHC-OH). By coupling /V-deprotcctcd 2-33 with Boc-ACHC-OH, 2-39 was 
obtained in 75% yield. Full experimental details are given in chapter 3.
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2.5 Solid Phase Synthesis of Heterogeneous Oligomers 
Oligomers were synthesized following the general protocol for solid phase 
synthesis from the C- towards the N-terminus.70 The general protocol involves 
deprotection, activation, and coupling (Scheme 2.12).
o
Acid Labile 
Linker -N H 2
Fmoc-Alpha Amino Acid 
HBTU, DIEA, H03t, DMF O Acid Labile Linker —N H NHFmoc
1. 20% Piperidine in DMF
2. Fmoc-ACHC. HBTU 
DIEA. HOBT. DMF
NHFmoc Elongation




1. 20% P'pendine in DMF










Scheme 2.12 Generalized route for solid phase synthesis.
Extended deprotection, extended coupling and extended flushes were employed to 
ensure that synthesis was complete. The columns in the synthesizer were loaded with 
three-fold excess of amino acid that is sufficient for coupling, iV, /V-Dimcthylformamidc 
was used as solvent while HBTU and DIEA reagents served as the activators. The 
purpose of the activators was to convert the carboxyl group to an active ester which then 
reacts with the deproteeted a-amino acid. The use of llOBt as an additive was necessary 
to suppress any possible racemization and accelerate aminolysis. Piperidine and DMF 
served to deprotcct the Fmoc-protected a-amino group on the peptide resin in preparation
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for coupling. THF was used as the secondary solvent to clean the column of primary 
solvent after synthesis. At the end of the synthesis, the oligomers (peptides) were 
acctylatcd and rinsed. The peptides were then cleaved from the resin by a protocol 
involving the use of 95:2.5:2.5 TFA:ethancdithiol:H20  and stirring for about 5 hours. 
The peptides (Figures 2.4 & 2.5) were precipitated by evaporation of the deprotection 
solution, followed by addition of methanol to solubilize the peptides, and addition of 












Figure 2.4 Heterogeneous hexamers synthesized by solid phase method.
The crude peptides were obtained in good yields (calculation based on the initial 
loading of the resin) and high purity as determined by analytical HPLC. The peptides 
were further purified by reverse phase HPLC, characterized by MALDI-TOF mass 
spectrometry, and the correct structure verified by high resolution 'H NMR spectroscopy. 
The purified peptides were used for structural characterization (conformational analysis) 
by CD and NMR spectroscopy.





Figure 2.5 Heterogeneous octamers synthesized by solid phase method.
2.6 Characterization of Oligomers
The characterization of oligomers reported in this section is based on 
conformational analysis. Several spectroscopic techniques arc available for 
conformational analysis of peptides. Two of these techniques, CD and NMR 
spectroscopy were used for conformational analysis of the heterogeneous oligomers 2-40, 
2-41, 2-42, and 2-43.
2.6.1 One- and Two-Dimensional Nuclear Magnetic Resonance 
One- and two-dimensional NMR spectroscopic measurements were carried out by 
Margaret Schmitt (Gcllman group. University of Wisconsin-Madison). High-resolution 
ID data were collected on all heterogeneous oligomers 2-40, 2-41, 2-42, and 2-43, in 
order to determine the proper temperature for 2D experiments. The proper temperature
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was determined based on the dispersion of significant protons at various temperatures. 
Proton chemical shifts vary slightly depending on temperature, and adjustments in 
temperature may result in better dispersion for more complete 2D assignment and 
analysis. Resonance assignments were made based upon COSY and TOCSY data, as 
well as sequential ROES from ROESY data. Data were collected at either 4, 14 or 24 °C. 
as necessary for the best resolution of spectra overlap. Unfortunately, a complete 2D 
assignment could not be made (no observed long-range NOEs or ROEs) for the 
heterogeneous oligomers 2-40, 2-41, 2-42, and 2-43, due to significant spectral or 
resonance overlap.
2.6.2 Circular Diehroism
Circular diehroism (CD) has been extensively used to obtain information on the 
secondary structure of peptides and proteins in solution. The CD patterns for a-peptides 
and proteins have been characterized for common secondary structures such as a-helix 
and P-shect. However, for p-peptides, the correlation between CD patterns and types of 
secondary structure is an ongoing research. No CD information is available for structural 
characterization of heterogeneous oligomers. For proper estimation of the secondary 
structure content of a peptide or protein from CD it is essential to accurately know the 
concentration of the sample.5*’ The concentrations of the oligomers were determined by 
measurements of rijvo calibrated by reference to tyrosine. Because the physical details of 
absorption of circularly polarized light are not well understood, CD prediction of a new 
type of secondary structure is often difficult and must be used in conjunction with other 
methods of characterization. CD as a structural technique, however, plays an important
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role in complementing higher resolution structural approaches of X-ray crystallography 
and NMR.5'  The CD spectra of an oligomer can provide insight into its conformation.
The CD spectra of the hcxamcr 2-41. and octamer 2-42 arc presented in Figure 2.6. The 
CD spectra were recorded in Tris buffer.
Figure 2.6 CD of hexamer 2-41 (less intense) and octamer 2-42 (more intense) in Tris 
buffer.
Both hexamer 2-41 and octamer 2-42 are composed of (/f,tf)-ACHC, but while 
hexamer 2-41 is composed of (X)-a-amino acids, octamer 2-42 is composed of {R)-a- 
amino acids. Thus the CD spectrum of the hexamer is inverted relative to the CD 
spectrum of the octamer since the a-amino acids have an enantiomeric relationship. The 
CD spectrum of the octamer 2-42 shows a positive band at about 216 nm. and negative 
bands at 199 nm and 229 nm (Figure 2.6). This spectrum may indicate some form of 
secondary structure. The hexamer 2-41 is characterized by maxima at 212 and 230 nm.
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and a minimum at 220 nm. The CD bands of the hexamcr arc less intense than the longer 
octamcr. A qualitative interpretation for the increase in intensity of the CD bands for the 
octamer 2-42 compared to the hexamcr 2-41, could be that a more organized structure is 
formed with increase in number of residues.
2.7 Summary
An enzymatic approach has been applied to synthesize optically active trans-2- 
aminocyclohcxanccarboxylic acid (ACHC). This methodology is advantageous in that 
the reaction can be carried out on multihundred gram scale to afford enantiomerically 
pure ACHC from readily available starting materials. This method, however, only offers 
one enantiomer of Fmoc-ACHC. The method does not allow the synthesis of (S,S)- 
Fmoc-ACHC, which is required for the synthesis of oligomers incorporating a-amino 
acids with the (S) stereochemistry. The synthetic route was adapted from published 
procedures.61
An alternative synthetic approach, based on reductive amination, has been 
successfully applied for the synthesis of Fmoc-ACHC and Fmoc-piperidinc carboxylic 
acid. This synthetic route is advantageous in that it is simple, practical, scalable, and 
allows the preparation of multi-gram quantities of the monomers without the need for 
chromatography, especially in the case of Fmoc-ACHC. The reductive amination 
methodology is applicable for the synthesis of cither enantiomer of Fmoc-ACHC and 
Fnioc-piperidine carboxylic acid from a (3-ketoester, which makes the method more 
advantageous compared to the enzymatic approach. The key step that makes this 
methodology more practical is the diastcrcomeric enrichment through HCI salt 
crystallization. This new methodology was adapted by Schinnerl el ul.M of the Gellman
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group and have been successfully implemented to synthesize the (3-amino acid monomers 
for oligomer synthesis.
Heterogeneous oligomers, containing a- and p-amino acids in an alternating 
sequence, have been synthesized for the first time. A systematic approach was employed 
to select the right combination of coupling reagents, base, and solvent. Strategies in 
protection and deprotection were also successfully applied in the synthesis as this is 
critical in coupling reactions. Both solution phase and solid phase methodologies were 
applied in the synthesis of oligomers. All oligomers were characterized by mass 
spectrometry and nuclear magnetic resonance (’H NMR). The characterization of 
oligomers based on conformational analysis using high resolution one- and two- 
dimensional NMR, and CD was attempted. The correct structure of the oligomers was 
verified by one-dimensional ‘H NMR, but complete two-dimensional structural 
information could not be obtained due to extensive resonance or spectra overlap. From a 
qualitative interpretation of the CD spectra, it could be concluded that oligomers form 
some kind of ordered conformation in solution.
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CHAPTER 3
EXPERIMENTAL
3.1 Solution Phase Oligomer Synthesis
The following general procedures were carried for solution phase oligomer 
synthesis. Melting points (m.p.) were obtained on a Thomas Hoover Capillary Melting 
Point Apparatus and arc uncorrectcd. Optical rotations were measured on a Perkin-Elmer 
241 digital polarimeler using sodium light (D line, 589.3 nm) and are reported in degrees; 
concentrations (c) are reported in g/100 mL. Proton nuclear magnetic resonance (*H 
NMR) was recorded in deuterated solvents on a Brukcr AC-300 (300 MHz) spectrometer. 
Chemical shifts are reported in parts per million (ppm, 8) relative to tetramethysilane (8 
0.00). In the absence of tetramcthylsilanc in the deuterated solvent, the standard 
chemical shift of the solvent is referenced ( C D C I i ,  8 7.26; GDjOD, 8 3.30). For mixed 
solutions of CDCL and C D 3 O D ,  C D C I 3  is referenced. ‘H NMR splitting patterns arc 
designated as singlet (s), doublet (d), triplet (t), quartet (q), or quintet (quint). All first 
order splitting patterns are assigned based on the appearance of the multiples For those 
, splitting patterns that could not be easily visualized or interpreted, a designation of
multiplet (m) or broad (br) was used. Coupling constants arc reported in Hertz (Hz). 
Carbon nuclear magnetic resonance (l3C NMR) spectra were recorded on a Brukcr AC- 
300 spectrometer. Chemical shifts are reported in ppm (8) relative to the central line of 
the C D C I 3  triplet (8 77.0), or the CD3OD septet (8 49.0).
165
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Carbon NMR data were assigned using distortionless enhancement by 
polarization transfer (DEPT) spectra obtained with a phase angle of 135°: (C) not 
observed; (CH) positive; (ClI>) negative; (Cl[ 3 )  positive. Electrospray ionization (ESI) 
mass spectra were determined on a Kratos MS-80 mass spectrometer. Dry ethanol was 
prepared by distillation from diethyl phthalatc and sodium. Dry methanol was prepared 
by distillation from Mg(OMc)2 (Mg turnings (5 g), 12 (0.5 g), methanol (100 mL)). 
Benzene was freshly distilled from Na/bcnzophenone kctyl and stored under N2. 
Methylene chloride was distilled from CaHj. Hexane was distilled at atmospheric 
pressure. Diisopropylcthylamine (DIEA) was distilled from Call;. Unless otherwise 
noted, all other commercially available reagents and solvents were used without further 
purification. All commercially available reagents and solvents, unless stated otherwise, 
were purchased from Aldrich, except for 4 N MCI in dioxanc, which was purchased from 
Pierce. Analytical thin-layer chromatography (TLC) was curried out on Whatman TLC 
plates precoated with silica gel 60 (250 pm layer thickness). Visualization was 
accomplished using cither a UV lamp, potassium permanganate stain (2 g of KMnOj,
13.3 g of K2COj, 3.3 mL of 5% (w/w) NaOH, 200 mL of HjO), ninhydrin slain (0.5 g of 
ninhydrin, 150 mL of n-butanol, 5 mL of glacial acetic acid), or phosphomolybdic acid in 
ethanol. Column chromatography was performed on EM Science silica gel 60 (230-400 
mesh). Solvent mixtures used for TLC and column chromatography are reported in v/v 
ratios. All glassware were dried in an oven at 120°C.
ced with permission of the copyright owner Further reproduction prohibited without permission.
167
3.2 Solid Phase Oligomer Synthesis
In solid phase methodology, the oligomer is synthesized and then purified by 
HPLC. The general procedures for solid phase synthesis and purification arc presented in 
the sections that follow.
3.2.1 Oligomer Synthesis
Solid phase oligomer synthesis was earned out using the automated peptide 
synthesizers Synergy or Pioneer, Applied Biosystems Model 432A (Foster City, CA). N- 
9-Fluorenylmcthyloxycarbonyl amino acids and 2,4-dimethoxybenzhydrylamine resin 
(Rink Amide) cartridges were obtained from E.I. du Pont de Nemours & Co., Inc. 
(Boston, MA) or Novabiochem (San Diego, CA) and advanced Chcmtech (Louisville, 
KY). Peptide synthesis reagents such as DMF, piperidine, TFA, 1,2-cthanedithiol, 
thioanisolc, l-hydroxy-7-azabenzotriazole (HOAT), 0-(7-azabenzotriazol-l-yl)- 
N,N,N’,N’-trimcthyluronium hexafluorophosphate (HATU), were all purchased from 
Aldrich Chemical Company (Milwaukee, Wl) and were used without further purification. 
HBTU, HOBt, DIEA were purchased from Applied Biosystems (Foster City, CA).
Standard solid phase techniques with N“-Fmoc-protected amino acids70 using 
2,4-dimethoxybenzhydrylaminc resin (Rink Amide AM) cartridges on a 25 pmole scale 
were applied. The resins were either preloaded with the C-tcrminal amino acid or acid- 
labile amine. Synthesis proceeded from the C-terminal to N-terminal direction. Each 
coupling reaction was carried out at room temperature in DMF with three equivalents of 
amino acid. Coupling reactions were monitored by the conductivity of the solution. 
Reaction times were doubled to ensure that coupling was complete. The coupling 
reagents used were I1BTU and DIEA as activators with HOBt as the additive. In each
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step of the coupling, the chemicals were delivered at a scale of 75 pmoles which is three 
fold excess relative to the estimated resin capacity. For amino acids with reactive groups 
on their side chains, protection of the reactive groups was ensured to prevent unwanted 
side reactions. Notably the tyrosine and lysine side chains were protected with the icrt- 
butyl and Boc-protected groups respectively.
At the end of each coupling reaction, the N-tcrminul Fmoc-protectcd amine was 
dcprotccted by applying 20% piperidine in DMF at room temperature for about 60 
minutes. Fmoc deprotection reactions were also monitored by the solution conductivity. 
Upon addition of the last residue, the resin, still in the peptide synthesis column, was 
rinsed with methanol or methylene chloride and dried under a stream of nitrogen. The 
dried resin was transferred into a 10 mL round-bottom flask for the cleavage reaction.
To cleave the peptides from the resin, a solution consisting of 2.5% Milliporc 
water and 2.5% ethanedithiol in TFA was used. The solution and resin were stirred at 
room temperature for approximately 5 to 6 hours. The resin beads were filtered off using 
a plug of glass wool and rinsed two to three times with additional TFA. TFA was blown 
off under a gentle stream of nitrogen. The peptides were isolated via precipitation. A 
minimal amount of MeOH was added to dissolve the peptides, and diethyl ether (10 mL) 
was added to form a while precipitate. The mixture was cooled in an acctonc/dry ice bath 
for 5 minutes, and centrifuged at 3000-4000 rpm until the precipitate formed a pellet at 
the bottom of the centrifuge tube. The ether was decanted, and the pellet was 
resuspended in cold ether (10 mL) and centrifuged again; the process was repeated three 
times. During the final wash 10 mL of Millipore water was added to 10 mL of cold ether 
and the mixture was centrifuged again. The ether was decanted and the aqueous layer,
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containing the crude peptide was transferred to a round bottom flask for lyophilization. 
Crude yields for peptide synthesis were usually around 90%.
3.2.2 Oligomer Purification
1IPLC purification was performed on an Hewlett Packard-1050 HPLC using a 
semi-preparative Cis column (Vydac) with a flow rate of 3 ml-/minute. Analytical HPLC 
was carried out using a Cis column (Vydac) with a flow rate of 1 mL/minute. Gradient 
elution was used with the following solvent systems: solvent A = 0.1% TFA in water, 
solvent B = 80:20 CfLCN / 0.1% TFA in water. Peptides were purified by reverse phase 
semipreparative HPLC with a Cl 8-silica column (5 pm, 10 x 250 mm; Vydac, Hesperia, 
CA). Purity of peptides was monitored by reverse phase analytical HPLC with a C 18- 
silica column (5 pm, 4 x 250 mm; Vydac, Hesperia, CA). Peptide chromatograms were 
monitored at 220 nm, which corresponds to the absorption of the amide chromophorc. 
Crude peptides were dissolved in Milliporc water at a concentration of 0.2 mg/mL and 
passed through a 0.45 pm polyvinylidene difluoride syringe filter to remove particulate 
material. Each injection typically contained a ca. 1.5 mg of peptide. The shape of the 
chromatograph was analyzed to ensure good resolution and peak shape. The injection 
volume was typically decreased if poor resolution or separation was noticed. Gradient 
conditions were adjusted to about 0.5% of Cl LCN/HiO/TFA (80:20:0.01) per minute.
Peptide homogeneity was assured by analytical HPLC using a C18-silica 
analytical column (5 pm, 4 x 250 mm; Vydac, Hesperia, CA) and CH3CN/H2O/TFA 
eluents at a flow rate of 1 mL/min. The peptides were generally >95% pure, based on 
analytical HPLC. Peptide identity was initially confirmed by matrix-assisted laser
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desorption time-of-flight mass spectroscopy (MALD1-TOF-MS), and subsequently by 
high resolution 'H NMR analysis.
3.3 Analytical Methods
Analytical methods such as nuclear magnetic resonance (NMR) spectroscopy, 
circular dichroism (CD) spectroscopy, and MALD1-TOF mass spectrometry were used to 
characterize the oligomers. Both one- and two-dimensional NMR techniques were used 
for characterization. Sample preparation for low resolution one-dimensional NMR 
follows the same general protocol for all solution phase synthesis, which is conventional 
and so will not be considered in this section. Sample preparation for high resolution onc- 
and two-dimensional NMR, however, is not straightforward as the concentration of the 
sample is important, and this is reported in the paragraph that follows.
3.3.1 NMR Spectroscopy
Samples were prepared by dissolving the peptide in deuterated methanol 
(CDjOH) to a concentration of approximately 3 mM. A trace amount of 2,2-dimethyl-2- 
silapentanc-5-sulfonatc (DSS) was added for referencing. Samples were syringe-filtered 
into 5 mM NMR tubes and sonicated to ensure homogeneity. Data were collected on a 
VARIAN lnova-600 spectrometer in the chemistry information center (Department of 
Chemistry University of Wisconsin-Madison, supported by N1H and NSF). High- 
resolution one-dimensional NMR data were gathered on all samples to determine proper 
temperature for two-dimensional NMR experiments, based on the dispersion of 
significant protons at various temperatures. Resonance assignments were made based 
upon COSY andTOCSY data, as well as sequential ROEs from ROESY data. Data were 
cither collected at 4, 14 or 24 °C, as necessary for best resolution of spectral overlap.
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3.3.2 CD Spectroscopy
A 2 mg/mL slock solution of each peptide in Millipore water (concentration 
determined by muss of freshly lyophtlizcd peptide) was mixed with aqueous Tris- 
buf'fcrcd saline to give aqueous solutions of 0.2 mg/mL peptide in 10 mM Tris, 150 mM 
NaCI, pH 7.2. The final concentration of the peptides in each aqueous Tris-buffcred 
saline solution was calculated from the UV absorbance of the 2 mg/mL stock solution. 
The extinction coefficient of each peptide was assumed to be 1420 cm'1 M'1 at 275 nm, 
the wavelength of a-tyrosinc.71 All CD spectra were obtained on an AVIV 62A-DS CD 
spcctropolarimcter using 1 nm bandwidth, 1 nm resolution, 10 seconds averaging time, 1 
scan per second, 0 second delay, and a path length of 0.1 cm or 1 mm. The temperature 
of the sample was maintained at 25 °C, unless otherwise stated. Data were obtained in 
both methanol and Tris buffer. Data were obtained at high concentration (typically 1-2 
mM) and low concentration 0.1 mM. Scans usually ranged from 260 nm to 190 nm but 
with a high peptide concentration, the increased in dynode voltage prevented the 
detection of signal below 200 nm. Baseline spectra were subtracted from the raw data to 
obtain the real CD spectra. Data were converted to cllipticity, [0] in deg cm2 dmol1, 
according to the equation:
[01 = \|/*Mr / 100*f*c
where t|/ is the CD signal in degrees, Mr is the molecular weight divided by the number of 
chromophores. / is the pathlcngth in dm, and c is the concentration in g/mL.
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3.3.3 MALD1-TOF Muss Spectrometry
Mass spectra of all peptides were obtained using Bruker Reflex II MALDI-TOF 
Mass Spectrometer with a 337 nm laser. Spectra were resolved to the mass unit of the 
peptides. MALDI-TOF data were obtained for all HPLC purified samples of the 
peptides. For MALDI experiments, a matrix of a-cyano-4-hydroxycinnamic acid was 
used. The instrument was calibrated to a standard mixture of leu5-cnkcphalin (M+H* = 
556.28), angiotensin I (M+FT = 1296.7) and neurotensin (M+H* = 1672.9). The mass of 
the pure peptides matched the theoretical mass of the peptide within a very narrow 
margin of error.
Abbreviations Used: EDCEHCI = /V,A-dimethylaminopropyl-3-
ethylcarbodiimidc hydrochloride salt, DMF = ALV-dimcthylformamide, TFA = 
trifluoroacctic acid, DlEA = diisopropylethylaminc, MOAT = l-hydroxy-7- 
azabcnzotriazolc, HOBt = 1-hydroxybenzotriazole hydrate, IIBTU = O-bcnzotriazolyl-1- 
yl-AjV.A’^ ’-tctramethyluronium hexafluorophosphate, 1IATU = 0-(7-azabenzotriazol-
l-yl)-AUV,,ty\/V’-trimethyIuronium hexafluorophosphate, TFE = trifluorocthanol, Boc;0  = 
di-rert-butyl dicarbonatc, Z = bcnzyloxycarbonyl group.
3.4 Synthetic Details
Details of the synthesis of |)-amino acid monomers and heterogeneous oligomers 
that were reported in chapter 2 arc presented in the sections that follow. The molecular 
structures are also presented. The p-amino acid monomer Fmoe-ACHC and derivatives 
were synthesized by enzymatic resolution and reductive animation methodology. The 
Fmoc-piperidine monomer was synthesized by reductive amination methodology. The
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heterogeneous oligomers were synthesized by both solution phase and solid phase 
methods.




The compound 2-2 was prepared from the phthalic anhydride 2-1 following 
procedure developed by the Gellman group.'1' To the anhydride (35.0 g, 230 mmol) was 
added methanol (200 mL) and the mixture was refluxed for 4.5 hours. The mixture was 
subsequently cooled to room temperature and then 0 °C in an ice bath followed by drop 
wise addition of thionyl chloride during a 30 minute period. The mixture was stirred 
allowing temperature to rise gradually from 0 X  to room temperature for 8 hours. The 
reaction mixture was concentrated on a rotary evaporator and dried further under vacuum 
to obtain 45.1 g (99%) of 2-2 as a pale yellow oil: Ky = 0.67. 1:1 hexane/ethyl acetate; 'l l  
NMR (300 MHz. CDCI,): 6 5.66 (m, 1H, HOC'H), 3.68 (s. 3H. OCH3). 3.04 (m, 1H. 
CHCOOCH,), 2.60-2.49 (m, IH, CTTCHCOOCH,), 2.39-2.29 (m, 1H,
CHjCHCOOCHj); UC NMR (75 MHz, CDCI,): 8 177.4 (C), 122.3 (CH), 50.7 (CH,). 
39.0 (CH), 24.6 (CH2); MS-ESI m/z 199.2 [M + H f, 221.2 (M + Na]+, 419.4 [2M + 
Na]+.
Synthesis of UK. 65')-6-Mcthoxvcarboi)vl-3-cvelohcxene-l-carboxylic acid (2-3)
COOH
i  X
^ ^ C O O M e
2-3
Compound 2-3 was prepared following the procedure of Ohno and co-workers,62 
that had been successfully applied by the Gellman group.63 Precaution was taken to make
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sure all glassware was clean. All glassware was washed in acid bath and rinsed twice 
with Millipore water. To Millipore water (2.6 L) was added KH1PO4 (61.79 g, 454 
mmol) and the pH of the resulting solution adjusted to 8 by adding a prepared solution of
2.5 M NaOH and using a pH meter calibrated at pH 4 and pH 10. The diester 2-2 (45 g, 
227 mmol) was dissolved in reagent grade acetone (131 mL) and this solution added to 
the aqueous KH1PO4 solution. Pig liver esterase (10.5 mL. 48189 units) was added, and 
the resulting solution was stirred for 24 hours. The reaction was monitored by TLC (1:1 
hexane:ethyl acetate, R, (2-2) = 0.67, Rf (2-3) = 0.24). After ascertaining that reaction 
was complete, the enzyme was filtered off through cclite in a fritted glass funnel. The 
resulting solution was then acidified with 1M 11C1 to a pH about 2 and then extracted 
three times with ethyl acetate (1200 mL total). The organic extracts were dried over 
MgS04, concentrated, and dried under vacuum overnight to afford 38 g (91 %) of 2-3 as 
a thick yellow oil: 'l l  NMR (300 MHz, CDClj): 5 11.24 (br s, 111, OH), 5.68 (in, 211, 
HC=CH), 3.70 (s, 3H, OCHO, 3.07 (m. 2H, CHCOOCH, and CHCOOH), 2.62 -  2.54 
(m, 2H, CH;CHCOOCH3 or CJTCHCOOH), 2.41 -  2.32 (m. 2H. CHjCHCOOCHj or 
CHiCHCOOH); ,JC NMR (75 MHz, CDCI3): 8 179.6 (C), 173.5 (C), 125.0 (CH), 124.8 
(CH), 51.7 (CHj), 39.4 (CH), 39.2 (CH), 25.5 (CHi), 25.3 (Cli2); MS-ESI m/z 207,1 [M 
+ Na]*.
Synthesis of Methyl (1,5. 6/0-6-Bcnz.vloxvcarbonylaminocvclohcx-3-cnccai'bo.\vlatc (2-
41
NHCbz
f  T  + BnOH 
^ X O O M a  
2-4
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Compound 2-4 was prepared according to the procedure of Ohno and co- 
workers,62 that was successfully adapted by Appclla el al.63 of the Gellman group. The 
monoestcr 2-3 (7.08 g, 38.4 mmol) was dissolved in acetone (125 mL) and the resulting 
solution cooled to 0 °C. To this solution was added litiN (7.0 mL. 50.2 mmol), followed 
by slow addition of ethyl chloroformate (4.77 mL. 49.9 mmol). Mixture was stirred at 0 
°C for 15 minutes. In a separate flask, NaN, (4.01 g, 61.7 mmol) was dissolved in 
Millipore water (35 mL), and this solution added to the reaction flask. The temperature 
was gradually raised to room temperature and stirring continued for 3 hours. The 
reaction mixture was diluted with water (123 mL) and the resulting solution extracted 
three times with diethyl ether (900 mL total). The organic extracts were dried over 
MgSOi, concentrated without heating, and put under vacuum for a few minutes to afford 
yellow oil. To this oil was added anhydrous benzene (97 mL), and the resulting solution 
refluxed under a nitrogen atmosphere for 3 hours. The solution was cooled to room 
temperature followed by the addition of benzyl alcohol (13.9 mL, 133.8 mmol). The 
resulting solution was refluxed under an atmosphere of nitrogen for 22 hours. A yellow 
solution containing droplets of another liquid on the bottom of the flask was formed. The 
solution was cooled to room temperature, and the solvent was then removed on a rotary 
evaporator to afford 22.1 g (82% yield of 2-4 based on ' l l  NMR) of yellow liquid being a 
mixture of 2-4 and benzyl alcohol: 'l l  NMR (300 MHz, CDCIj): 5 7.39-7.22 (m, ArH of
2-4 and BnOH), 5.67 (m, 2H. HC=CH), 5.45 (br d, J = 9 Hz, 1H, NH), 5.06 (s, 2H, 
ArCHj) 4.64 (s, ArCH> of BnOH), 4.23 (m, 111, CHNHCbz), 3.66 (s, 3H, OCH,), 2.80 
(m, 1H, CHCOOCHj), 2.57 -  2.43 (m, 1H), 2.42 -  2.25 (m, 2H), 2.23 -  2.10 (m. 111).
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Synthesis of Mclhvl (JS. 67?)-b-/e/'/-buttloxvcarbonvlaminocvclohcxancearboxvlate (2-5)
^ . N H B o c
^•'"'XOOM e
2-5
Compound 2-5 was prepared by two methods.
Method I
Methanol (25 mL) was added to a mixture of 2-4 and benzyl alcohol (3.81 g), 
followed by 10% Pd-C (0.10 g) under nitrogen. The solution was shaken on a Parr 
apparatus underHj (50 psi) for 46 hours. The solution was then filtered through a plug of 
glass wool, concentrated, and dried under vacuum to obtain a yellow liquid. Water (5 
inL) was added to the liquid, and then 2 M HCI was added to the solution until a pH of 2 
was obtained. The resulting solution was extracted with diethyl ether three times (75 mL 
total) to remove benzyl alcohol. To the resulting aqueous solution was added 10% 
K;COj portion wise until a pH of 9 was obtained. Dioxune (10 mL) was added, followed 
by BociO (1.76 g, 8.1 mmol). The resulting solution was stirred for 33 hours. The 
solution was then transferred to a separatory funnel, water (10 mL) was added, and the 
solution extracted three times with ethyl acetate (150 mL total). The combined organic 
extracts w’erc dried over MgSOi, concentrated, and dried under vacuum overnight to 
obtain a viscous yellow liquid. The crude product was purified by Si02 flash column 
chromatography, eluting with 6:1 hcxane:ethyl acetate (Rr = 0.26) to afford 2-5 us a 
colorless oil (2.37 g, 70%).
Method 2
A mixture of 2-4 and benzyl alcohol (4.95 g) was dissolved in methanol (25 mL) 
and transferred to a hydrogenation flask. This was followed by the addition of 10% Pd-C
iced with permission of the copyright owner. Further reproduction prohibited without permission.
(0.85 g) and Boc;0 (4.5 g, 20.5 mmol) under Ni. The solution was shaken on a Pan- 
apparatus under H2 (50 psi) for 24 hours. The solution was then passed through a plug of 
silica gel and cclite, concentrated, and dried further under vacuum overnight to obtain 
pale yellow oil. The crude product was purified through a slurry-packed SiC>2 column 
eluting with 4:1 hexane:ethyl acetate (Rr = 0.41). The product eluted in fractions 8-21 
(15 mL fractions collected) to afford 3.5 g (80% yield) of 2-5 as a colorless oil: 'll NMR 
(300 MHz. CDCI3): 8 5.32 (br, HI. Nil), 3.85 (m. 111, CHNHBoc). 3.69 (s, 3H, OCH,). 
2.79 (br q, J = 4.5 Hz, 1H, CHCOOClh). 2.07-1.94 (m, 1H), 1.84-1.55 (m, 4H), 1.51- 
1.25 (m. 12H; includes large singlet at 1.43): l3C NMR (75 MHz, CDCI3): 5 174.2 (C),
155.3 (C). 79.0 (C), 51.5 (CH3), 49.0 (CH), 44.9 (CH3). 29.7 (CH2), 28.2 (CH3), 26.8 
(CH2), 23.7 (CH2), 22.5 (CHj); MS-ESI m/z 280.1 [M + N a)\ 537.2 [2M + Nap. 




Compound 2-6 was prepared by epimerization of the ci.r-isorner 2-5. Sodium 
(0.10 g, 4.34 mmol) was weighed out under hexane, and placed into a flame dried 
schlcnk flask outfitted with a condenser. The flask was placed under vacuum and N2 
repeatedly, three times, to remove hexane. The flask was then cooled to 0 °C, and 
anhydrous methanol (4 mL) was added. The mixture was kept under N2 and vented to 
remove evolved gases until all the sodium dissolved. In another flame-dried flask 
containing 2-5 (0.71 g, 2.76 mmol), that had been dried under vacuum overnight, was 
added anhydrous methanol (8 mL) and the flask was swirled to dissolve the ester. The




ester solution 2-5 was then transferred via cannula to the Schlenk tlask containing 
NaOMc solution. The resulting solution was then refluxed for 5 hours. The solution was 
cooled to room temperature and then 0.5 M NKiCl (16 mL) was added. The mixture was 
stored under N- overnight and colorless needle-like crystals formed during this time. The 
solvent was mostly removed on a rotary evaporator, and the precipitate collected by 
suction filtration to obtain white solid after drying under vacuum. The solid was 
recrystallized from n-heptane to afford 0.44 g (62% yield) of 2-6 as colorless crystals: 
m.p. 90-91 °C; ‘H NMR (300 MHz. CDCIj): 5 4.50 |br. 1H, NH), 3.67 (s and m, 4H. 
OCHj and CHNIIBoc), 2.23 (dt, J = 11.4, 4.2 Hz. 1H, CHCOOCH,). 2.08-2.00 (m, III), 
1.95-1.86 (m. 111), 1.81-1.53 (m, 2H), 1.51-1.29 (m, 11H; includes large singlet at 1.42), 
1.26-1.11 (m, 2H); ,JC NMR (75 MHz, CrX-lj): 6 174.3 (C), 154.7 (C). 79.0 (C). 51.5 
(CHj), 51.0 (CH), 50.0 (CH). 32.8 (CH;), 28.3 (CH2), 28.1 (CH,), 24.5 (CHS), 24.2 
(CIIj); MS-ESI m/z 280.1 [M + NaJ*. 537.2 (2M + Na]L
Synthesis of 1R. 2/()-N-rerr-butvloxvcarbonvl-rrnn,v-2-aminocvclohcxanecarbox_y)ic acid
(2-7)
^ ^ ^ N H B o c
2-7
Compound 2-7 was prepared from the corresponding ester by hydrolysis. 
Methanol (80 ntL) and water (26 mL) were added to 2-6 (1.35 g, 5.25 mmol), followed 
by LiOH.H20  (2.64 g, 62.9 mmol) and 30% aqueous H?Oj (3.72 mL.. 29 mmol). The 
mixture was stirred at room temperature for 50 hours. A solution of NajSCH (8.78 g, 69.7 
mmol) in water (52 mL) was then added at 0 °C, and the mixture stirred for 25 minutes. 
The methanol was removed on a rotary evaporator leaving a colorless solution. The
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solution was cooled to 0 °C again followed by addition of 2M HCI until white precipitate 
formed which did not dissolve on swirling. The mixture was treated with ethyl acetate 
which caused the white precipitate to dissolve. The aqueous layer was isolated and the 
pH measured (pH = 1). The aqueous layer was extracted with the original ethyl acetate 
layer once and then four times with fresh portions of ethyl acetate. The combined 
organic extracts were dried over MgSOj, concentrated on a rotary evaporator and dried 
further under vacuum to obtain 1.23 g (97% yield) of 2-7 as a shiny white solid that 
looked pure by NMR. A sample of this white solid was recrystallized in ethyl 
acetate/hcxanc but there wasn’t any marked improvement in purity: m.p. 154-155 °C; 'H  
NMR (300 MHz, CDClj): 6 11.64 (br, 111. COOH), 4.65 (br. Ill, Nil), 3.65 (br m, 1H). 
2.25 (td, J = 11.4, 3.6 Hz, HOOCCH), 2.08-1.95 (m, 2H). 1.75-1.14 (m, 6H), 1.43 (s, 9H, 
CH,); ,3C NMR (75 MHz, CDCl,): 6 179.0 (C), 154.9 (C), 79.2 (C), 50.9 (CH), 49.5 
(CH). 32.6 (CH: ), 28.4 (CH2), 28.1 (CH,). 24.4 (CH.), 24.2 (CH2); MS-ESI m/z 266.1 
[M + N a]\ 509.2 [2M + Na]f.





Compound 2-8 was prepared from the corresponding free acid by benzylation. 
The acid 2-7 (0.2 g, 0.82 mmol) was dissolved in dry benzene. Benzyl bromide (0.1 ml., 
0.82 mmol) was added followed by 1,8-diazabicyclo [5 4 0]unde-7-cne (0.12 mL, 0.82 
mmol) and the solution refluxed under N2 for 24 hours. White solid preeipitated from the 
solution in the course of the reaction. The mixture was cooled to room temperature and
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concentrated to obtain a tan solid. The crude product was purified by SiOj flash column 
chromatography eluting with 6:1 hexane: ethyl acetate (Rf = 0.24). The product eluted in 
fractions 14-30 (10 mL fractions collected) to afford 0.25 g (90% yield) of 2-8 as a white 
solid. A sample of this solid was recrystallized from n-hcplunc: m.p. 103-104 °C; 'l l  
NMR (300 MHz, CDCI3): 6 7.38-7.29 (m, 5H. ArH), 5.12 (s, 2H, ArCH,), 4.52 (br, 1H. 
NH), 3.69 (br td. J = 10.4, 9 Hz, 1H. BocHNCH), 2.31 (id, J = 11.7, 3.6 Hz. 1H, 
BnOCOCH), 2.10-2.05 (m, 1H), 1.98-1.90 (m. 111), 1.79-1.56 (m, 311), 1.39 (s, 9H, CHj), 
1.36 (m, 1H), 1.27-1.11 (m, 2H); ,3C NMR (75 MHz, CDC1,): 8 173.8 (C), 154.8 (C), 
136.0 (C), 128.6 (CH), 128.0 (CH), 79.3 (C), 66.2 (CH2), 51.3 (CH), 50.0 (CH), 33.0 
(CHj), 28.6 (CH,), 28.3 (CH3), 24.6 (CH,), 24.4 (CH2); MS-ESI m/z 356.1 [M + Na]\
689.3 (2M + Na]\
Synthesis of (IR. 2/0-2-(9//-Fluoren-9-vlmethoxvcarbonvlamino)- 
cvelohcxanecarboxvlie acid 12-9)
a.NHFmoc''COOH2-9
Compound 2-9 was prepared from the corresponding Boc-protcetcd free acid 2-7 
by two methods.
Method I
Boc-protected acid 2-7 (1.39 g, 5.72 mmol) was dissolved in 4N HCI/dioxane (10 
mL) and the mixture stirred at room temperature for 4 hours. Progress of reaction was 
checked by TLC in CH2CI2 : McOH (10:1). The solvent was removed under a stream of 
nitrogen and resulting white solid dried under vacuum for 5 hours. The free amine was 
dissolved in CH3CN/H2O (4:1, 69ml), followed by addition of DIEA (2.89 mL, 16.6
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mmol) and Fmoc-OSu (1.87 g, 5.54 mmol). The reaction mixture was then stirred at 
room temperature for 3.5 hours. Progress of reaction was monitored by TLC in 
hcxane/cthyl acetate (1:1). The reaction mixture was cooled to 0°C and 1M HCI 
(approximately lOmL) added to adjust pH to approximately 7. CH3CN was removed on 
a rotary evaporator leaving a white precipitate. Additional 1M HCI was added at 0°C 
until more white precipitate formed. The white solid was collected by suction filtration 
and washed with dilute aqueous HCI. The white solid was dissolved in large excess of 
ethyl acetate and filtered to separate undissolved impurities. The filtrate was washed 
once with 1M HCI and once with brine. Organic extracts were dried in MgSO.i and 
concentrated on a rotary evaporator at room temperature to obtain bright white solid 
which was further dried under vacuum. The TLC of the white solid in ClTCL/MeOH 
(9:1) showed a single spot of Rf= 0.40. The crude product was purified by crystallization 
from n-hexane/ethyl acetate to afford 1.68g (83%) of the Fmoc-protected ACHC as a 
white solid: mp 207-208°C; [a]“3D = -37.8 (c 0.50, acetone); Rf = 0.43, 10:1 
CH2Cl2/MeOH; ' l l  NMR (300 MHz, CDClj/CDjOD) 5 7.77 (d, J = 7.3 Hz, 2H, Arl-l). 
7.62 (d, J = 7.0 Hz, 211. Aril), 7.42-7.29 (m. 4H. ArH), 4.33-4.19 (m, 3H), 3.73-3.67 (m. 
1H), 2.35-2.28 (m, 1H), 2.02-1.98 (m. 2H), 1.78-1.73 (m, 2H), 1 63-1.51 (m, 1H), 1.41- 
1.22 (m, 3H); UC NMR (75 MHz, CDCI3/CD3OD) 6 180.61 (C), 160.16 (C), 147.69 (C), 
147.53 (C), 144.92 (C), 131.26 (CH), 130.67 (CM), 128.69 (CH), 123.47 (CH), 70.23 
(CH2), 55.12 (CH), 52.45 (CH), 50.84 (CH), 36.27 (CH2), 32.73 (CH,), 28.35 (CH2), 
28.11 (CH2); MS-ESI m/z 388.1 [M + Naf, 753.2 [2M + Na]T
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Method 2
Boc-proteeted acid (0.63 g, 2.59 mmol) was dissolved in 4N HCI/dioxane (10 
mL) and ihe mixture stirred at room temperature for 4 hours. Progress of reaction was 
checked by TLC in CHjCIj : MeOH (10:1). The solvent was removed under a stream of 
nitrogen and resulting white solid dried under vacuum for 2 hours. This solid was 
dissolved in acetone/HiO (2:1, SI mL), cooled to 0 "C and Fmoc-OSu (1.04 g, 3.08 
mmol) and NaHCOj (1.99 g, 23.7 mmol) were added. The turbid reaction mixture was 
stirred at 0 °C for 1 hour and was then allowed to stir at room temperature overnight. 
The acetone was removed under reduced pressure. The aqueous residue was diluted with 
ITO (27 mL). stirred for 1 hour at room temperature with diethyl ether (109 mL), and the 
layers were separated. Separation by extraction was not possible because the bottom 
layer contained white solid which would not drain from the separatory funnel. The solid 
was isolated by suction filtration and washed subsequently with NaHCOj, IN MCI and 
water. The solid was diluted with MCI and a large volume of ethyl acetate used for 
extraction. The combined ethyl acetate layers were dried in MgSO,i, concentrated on a 
rotary evaporator, and dried under vacuum to obtain a white solid. The crude product 
was purified by crystallization from n-hexane/ethyl acetate to afford 0.68 g (72%) of 2-9 
as a white solid: mp 206-207°C; [a]J\> = -37.6 (c 0.50, acetone); Rf = 0.45, 10:1 
CILCIi/MeOH.
Synthesis of lfthvl 2-1(170-phenvlcthvlaminol-evclolicx-l-cne carboxvlate f2-19)
Ph
2 -19
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To a solution of ketoestcr 2-18 (11.0 g, 64.7 mmol) in 100 mL of dry benzene was 
added the chiral amine (R)-(+)-a-methylbenzylamine (8.01 g, 66.1 mmol), and a catalytic 
amount of p-tolucncsulfonic acid (0.618 g, 3.25 mmol, 5 mole %). The mixture was 
refluxed under N2 with continuous removal of water using a Dean-Stark trap for 4 hours. 
After the solution was cooled to room temperature, it was washed twice with saturated 
aqueous NaHCOj. The organic extracts were dried over MgSOj, concentrated, and dried 
under vacuum to obtain a yellow oily residue. The resulting yellow oily residue was 
fractionally distilled to give 15.8 g (89%) of 2-19 as a pale yellow oil: bp 160-165°C, 2 
mm Hg; Rr = 0.32, 20: l hexane/ ethyl acetate; 'l l  NMR (300 MHz, CDC1,) 8 9.40 (d. J 
= 7.5 Hz, 1H, NH), 7.35-7.20 (m, 5H, Aril), 4.63 (quint, J = 7.2 Hz, 1H), 4.17 (dq, J = 
7.2, 1.2 Hz, 2H), 2.36-2.24 (m. 3H), 1.99-1.89 (m, IH), 1.54-1.47 (m. 7H), 1.30 (t. J = 
7.2 Hz, 311); 13C NMR (75 MHz, CDCIj) 5 170.74 (C), 158.86 (C), 145.65 (C), 128.47 
(CH), 126.58 (CI1), 125.23 (CI1), 90.34 (C), 58.50 (CH2), 51.79 (CH), 26.43 (CI12), 
25.16 (CH,). 23.60 (CH2), 22.40 (CH2), 22.22 (CH:), 14.48 (CHi); MS-ESI m/z 274 2 
[M + II]*, 296.1 [M + N af, 569.3 [2M + Na]*.
Synthesis of fltlivl ( lK.2K)-2-U 1 'A’l-Phcnvlethvll- aminoevclohcxane carboxvlatc
Sodium borohydridc (3.14 g, 83.0 mmol) was added to isobulyric acid (44 mL, 
474.0 mmol) portion wise under N2 at 0°C. This mixture was stirred at room temperature 
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in dry toluene (26.4 mL) was added drop wise under N; at 0°C. The mixture was stirred 
at 0"C for 6 hours, followed by addition of a second portion of sodium borohydride (0.20 
g, 5.29 mmol). The reaction mixture was then stirred at 0 °C overnight. The reaction 
mixture was quenched by addition of aqueous solution of IN HCI to obtain a pH of 
approximately 1. The mixture was further basified to a pH of about 10 using an aqueous 
solution of 1 N NaOH followed by extraction with four equal portions of CHjCIj (100 
mL each). The combined organic extracts were dried over MgSOj and concentrated 
under reduced pressure. The resulting oil was applied to a plug of silica gel and washed 
with 1:1 hexane/ethyl acetate. The filtrate was concentrated to obtain a pale yellow oil 
(6.01 g, 92%; Rr = 0.22, 4:1 hexane/ethyl acetate), which was dried under vacuum 
overnight. To this oil (dried under vacuum, 3.11 g, 11.29 mmol), was added freshly 
distilled ethanol (50 mL) under N;. In a separate flame-dried Schlcnk flask outfitted with 
a condenser was placed sodium (1.3 g, 56.52 mmol). The flask was cooled to 0°C, and 
dry ethanol (100 mL) was added. The mixture was kept under N2 and vented to remove 
evolved gases until all of the sodium dissolved. The clear solution of the carboxylatc was 
then transferred via cannula to the NaOLt solution. The resulting solution was refluxed 
at 80°C under Nj for 15 h. The solvent was removed on a rotary evaporator followed by 
addition of brine (100 mL). The resulting mixture was basified to a pH of approximately
10 by addition of aqueous 1 N NaOH and then extracted four times with ethyl acetate 
(100 mL each). The combined organic extracts were dried over MgS04 and concentrated 
under reduced pressure. The resulting oil was applied to a plug of silica gel and washed 
with 3:1 hexane/ethyl acetate. The filtrate was then concentrated to obtain pale yellow
011 (2.62 g, 84%). To this oil was added ethyl acetate (19 mL), followed by dropwise
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addition of 4 N HC1 in dioxane (2.8 mL. 11.2 mmol) at room temperature. The resulting 
solution was cooled to 0°C and allowed to stand at 0°C overnight. A white precipitate 
was formed during this time. The white solid was Tillered and washed three limes with 
20 mL portions of cold ethyl acetate to afford the desired crude material in 84% yield 
from 2-19. This crude product was purified by rccrystallization from acetonitrile. The 
solid was suspended in acetonitrile (36 ml) and healed to reflux for 1 h. The mixture was 
filtered through cotton wool and cooled to 0°C overnight. The resulting precipitate was 
isolated by filtration and washed three times with 10 mL portions of cold acetonitrile. 
The mother liquor and washings were combined and condensed to about half the original 
volume to gel a second crop. The combined crops were dried under vacuum to give 1.28 
g of 2-20 as a white crystalline solid (51% yield), 'll NMR of the corresponding free 
amine 2-21 indicated the diastereomcric excess to be >99%: mp 210-211°C; Rr = 0.39, 
4:1 hcxanc/cthyl acetate; 'l l  NMR (300 MHz, CDC1,) 6 9.97 (br s, III, NIL), 9.70 (brs, 
1H, NH;), 7.84-7.80 (m, 2H. Aril). 7.47-7.30 (m, 311, ArH), 4.64-4.60 (m, 1H), 4.34-4.23 
(m, 2H), 3.15-3.12 (m. 2H). 2.21-2.17 (m, IH). 1.96-1.59 (m, 8H), 1.36-1.20 (m, 5H), 
0.97-0.93 (m, 1H); l3C NMR (75 MHz, CDC1,) 5 174.14 (C), 136.62 (C), 128.93 (CH), 
128.84 (CH), 128.40 (CH), 61.14 (CH;), 59.39 (CH), 56.49 (CH), 45.85 (CH,), 29.92 
(CH;). 29.26 (CH;), 23.92 (CH;), 23.72 (CH;), 20.47 (CH), 13.94 (CH,); MS-ESI m/z
276.2 [(M -  HC1) + H]*, 298.2 [(M -  HCI) + Naf, 573.3 |2(M -  HCI) + Na]L 
Synthesis of Ellivl ( lfl.2)?)-2-f(l Tfl-Phcnvlethvll- aminocvclohcxanc carboxvlale (2-21)
2-21
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A small sample of 2-20 was mixed with an excess of saturated NaHCO, solution 
and then extracted into diethyl ether. After drying over MgSOj, the organic extract was 
concentrated under reduced pressure to give 2-21 as a colorless oil: Rf = 0.40, 4:1 
hexanc/ethyl acetate; 'l l  NMR (300 Mil/. CDCIj) 8 7.30-7.21 (m, 5H, ArH). 4.24-4.13 
(m. 2H, CH,Cli;OCO), 3.82 (q, J = 6.6 Hz, IH, ArCHNH), 2.72 (td, J = 10.7, 3.8 Hz. 
1H, HNCHCH;), 2.19-2.10 (m, HI. OCOCH), 1.91-1.82 (m, 214), 1.68-1.63 (m, 2H), 
1.32-1.11 (m, 10H); n C NMR (75 MHz, CDCI.,) 6 175.50 (C), 146.86 (C), 128.0 (CH), 
126.42 (CH), 126.20 (CH), 59.86 (CH;), 55.88 (CH), 55.44 (CH), 51.58 (CH), 32.99 
(CH;), 30.03 (CH;), 28.95 (CH:), 24.72 (CH;), 23.64 (CH,), 14.06 (CH,); MS-ES1 m/z
276.2 [M + H]L 298.2 IM + NaJ*, 573.4 [2M + Na]+.
Synthesis of (lR.2fl)-2-(9//-Fluorcn-9-vlmethoxvcarhonvlamino)-cvclohexane 
carboxylic acid KIR.2/0-2-91 from B-Ammonium Ester 2-20.
NHFmoc
Compound 2-20 (1.23 g, 3.94 mmol) was dissolved in THF/McOH/H20 (2:1:1, 
44 mL), and the solution was cooled to 0 °C. LiOH.H;0 (0.83 g, 19.8 mmol) dissolved 
in 4.5 mL H-O was added. The mixture was stirred at 0°C for 20 hours. The solvent was 
removed under reduced pressure and the residue was applied to a plug of silica gel and 
washed with CH,Cl;/McOH 6:1. The filtrate was concentrated to obtain a white solid (Rf 
0.26, 8:1 CH2CI2/MCOH). To a clear solution of this white solid in 88 mL MeOH, Pd/C 
(10%, 0.92 g) and ammonium formate (1.24 g, 19.7 mmol) were added under N2 at room 
temperature. The mixture was refluxed for 4 hours. After the reaction was complete 
(disappearance of starting material, as monitored by TLC), the cool reaction mixture was
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filtered through celite, and the filtrate concentrated to obtain a white solid. This solid 
was dissolved in acctone/H20  (2:1, 45 mL), cooled to 0"C and Fmoc-OSu (1.29 g, 3.82 
mmol) and Nal 1C02 (3.31 g, 39.4 mmol) were added. The turbid reaction mixture was 
stirred at 0°C for 1 hour and was then allowed to stir at room temperature overnight. The 
acetone was removed under reduced pressure. The aqueous residue was diluted with H20  
(45 mL), stirred for 1 hour at room temperature with diethyl ether (200 mL), and the 
layers were separated. The ether phase was washed three times with saturated NallCOj 
(100 mL each). The combined aqueous phase was acidified with 1 N aqueous HC1 and 
extracted three times with ethyl acetate (100 mL each). The organic extracts were dried 
over MgSCL and concentrated to give a white solid. The crude product was purified by 
crystallization from n-hexane/chloroform to afford 1.09 g (76%) of 2-9 as a while solid: 
mp 205-206”C; [a]23,> = 37.6 (e 0.50, acetone); Rf = 0.43, 10:1 CH2Cl2/MeOH; ‘ll NMR 
(300 MHz, CDCIj/CDjOD) 6 7.77 (d, J  = 7.3 Hz, 2H), 7.62 (d, J = 7.0 Hz, 2H), 7.42- 
7.29 (m, 4H), 4.33-4.19 (m, 3H), 3.73-3.67 (m. 1H), 2.35-2.28 (m, 1H), 2.02-1.98 (m, 
2H), 1.78 1.73 (m, 2H), 1.63-1.51 (m, 1H), 1.41-1.22 (m, 3H; liC NMR (75 MHz, 
CDCI3/CD3OD) 8 180.61 (C), 160.16 (C), 147.69 (C), 147.53 (C), 144.92 (C), 131.26 
(CH), 130.67 (CH), 128.69 (CH), 123.47 (CH), 70.23 (CH2), 55.12 (CH), 52.45 (CH), 
50.84 (CH), 36.27 (CH2), 32.73 (CH2), 28.35 (CH2), 28.11 (CH2); MS-ESI mJz 36-1.2 [M 
- H]\ 753.2 [2M - H]'.
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Synthesis of Pipcridinc-Enaminc (2-23)






The piperidine carboxylate sail 2-22 (15.3 g, 50.5 mmol) was dissolved in 
absolute ethanol (480 mL) and ammonium formate (15.7 g, 249 mmol) added. The 
mixture was then flushed with N2 continuously while adding Pd/C (10%, 2.40 g, 2.26 
mmol). The mixture was refluxed for 2 hours. The reaction mixture was cooled to room 
temperature, filtered through celite and through a syringe filter. The filtrate was 
concentrated on a rotary evaporator and dried under vacuum to afford 10.03 g (96% 
yield) of a yellowish-white solid. The amine salt was dissolved in chloroform (85 mL) 
and sonicated followed by addition of a solution of NaHCOj (4.17 g, 49.6 mmol) in water 
(80 mL) and NaCI (8.33 g, 143 mmol). A solution of Boc:0 (10.4 g, 47.5 mmol) 
dissolved in chloroform (30 mL) was slowly added during a 15 minute period, and the 
mixture was refluxed for 15 hours. The organic layer was separated and the aqueous 
layer was extracted three times with chloroform (150 mL total volume). The organic 
extracts were dried over MgSOa, concentrated and dried under vacuum to obtain reddish- 
yellow oil (13.2 g, 95%). The oil was dissolved in dry benzene (150 mL) followed by 
addition of a catalytic amount of p-toluenesulfonic acid (451 mg, 2.37 mmol, 5 mole %), 
and the chiral amine (R)-(+)-a-methylbenzylaminc (6.44 mL, 49.9 mmol). The mixture 
was refluxed under Ni with continuous removal of water using a Dean-Stark trap for 12 
hours. The reaction mixture was cooled and then washed twice with saturated aqueous
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N all CO;, (150 mL). The organic extract was dried over anhydrous MgSOj and 
concentrated on a rotary evaporator. The resulting yellow oily residue was filtered 
through a pad of silica gel and washed with CIliCK until filtrate was colorless. The 
filtrate was concentrated to obtain yellow oil. The crude product was purified by Si02 
flash column chromatography eluting with hexanc:ethyl acetate 4:1 (Rf = 0.44) to afford 
13.12 g (72%) of 2-23 as a pale yellow oil: 'l l  NMR (300 MHz, CDCIj) 8 9.27 (d, J =
7.2 Hz, 1H, NH), 7.36-7.21 (m, 5H, ArH), 4.61 (quint, J = 6.9 Hz, 111, AlCHNH), 4.18 
(q, J = 7.0 Hz, 2H, CH,CH2OCO), 4.08 (s, 2H, CCHjNBoc), 3.45-3.39 (m, 1H, 
CHjCHjNBoc), 3.35-3.28 (m, 1H, CH2CH2NBoc), 2.42-2.36 (m, 1H, NHCCH2), 2.07-
2.02 (m, 1H, NHCCH2), 1.53 (d, J = 6.9 Hz, 3H, ArCHCH,), 1.44 (s, 9H), 1.29 (t, J = 7.0 
Hz, 3H, OCOCHjCHj); 15C NMR (75 MHz, CDCIj) 6 168.78 (C), 156.89 (C), 154.35 
(C), 145.00 (C), 128.45 (CH), 126.85 (CH), 125.38 (CH), 88.33 (C), 79.38 (C), 58.75 
(Cl-12). 52.02 (CH), 41.17 (CH2), 39.40 (CH2), 28.17 (CHj), 26.02 (CH2), 24.99 (CH.,), 
14.34 (CH,); MS-ESI m/z 375.2 [M + H f, 397.2 [M + N af, 771.3 |2M + Na]+.
Synthesis of (3/C4/?)-l-((V-fm-Butvloxvcarbonvll-3-cthvloxvcarhonvl-4-l(fl)- 
phcnvlcthvlaminolpipcridine hydrochloride (2-24)
2-24
To isobutyric acid (27.1 mL, 291.7 mmol) in an oven-dried round bottom flask 
was added sodium borohydride (1,62 g, 42.8 mmol) portionwise under N2 at 0°C. The 
mixture was first stirred at room temperature for 30 minutes, followed by the addition of
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5 ml. of freshly distilled toluene and then cooling to OX'. A solution of the cnaminc 2-23 
(5.32 g, 14.2 mmol) in dry toluene (13 mL) was added drop wise under Nj at OX. The 
mixture was stirred at OX for 2 hours followed by the addition of additional sodium 
borohydride (0.12 g, 3.17 mmol). After 8 hours, the reaction was incomplete as judged 
by TLC and so another 3.17 mmol of sodium borohydride was added and mixture stirred 
overnight. Upon completion of the reaction (24 h), 50 mL of water was added and the 
mixture stirred at room temperature for 10 minutes. The mixture was then basified to a 
pH of 10 with IN NaOH and extracted three times with ethyl acetate (300 mL total 
volume). The organic extracts were dried over MgSCL and concentrated under reduced 
pressure. The resulting yellow oil was dried under vacuum and then applied to a plug of 
silica gel washing with 2:1 hexane:ethyl acetate. The filtrate was concentrated to obtain a 
pale yellow oil. The crude product was purified by SiOj flush column chromatography 
eluting with 2:1 hexanc:ethyl acetate (Rf = 0.38). The product was eluted to afford 4.126 
g (77% yield) of colorless oil. The oil (3.997 g, 10.6 mmol, vacuum dried overnight) was 
dissolved in freshly distilled dry ethanol (36 mL). In a flame-dried Schlenk flask was 
added freshly distilled dry ethanol (70 mL) and sodium (0.73 g, 31.8 mmol), and the 
mixture was stirred under N2 while venting to remove evolved gases until the sodium 
completely dissolved. The carboxylale solution was then transferred to the NaOEt 
solution and the mixture was stirred at 50X under N2 for 21 hours. The mixture was 
concentrated under reduced pressure then NaCI and IN NaOH were added until a pH of 
10 was obtained. The mixture was then extracted three times with ethyl acetate (300 mL 
total volume). The combined organic extracts were dried over MgSCL and concentrated 
on a rotary evaporator. The resulting oil was applied to a plug of silica gel and washed
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with 2:1 hexane:ethy! acetate. The filtrate was concentrated and dried under vacuum to 
obtain pale yellow oil (2.943 g, 74 % yield from the carboxylute). The oil was then 
dissolved in elhy! acetate (31.05 mL), and 4 N HC1 in dioxanc (1.92 mL) was added 
dropwise while swirling at room temperature. The resulting solution was cooled to 0"C 
and allowed to stand at this temperature overnight during which a white precipitate 
formed. The while solid was filtered and washed three times with cold ethyl acetate to 
provide the crude material. The crude product was purified by recrystallization from 
acetonitrile. The solid was suspended in acetonitrile (40 mL) and heated under reflux for 
1 hour. The mixture was then filtered through glass wool and cooled to 0"C overnight. 
The resulting white crystalline solid was isolated by filtration, and washed three times 
with fresh portions of cold acetonitrile. The mother liquor and washings were combined 
and condensed to get a second and third crop. The combined crops were dried under 
vacuum to afford 1.29 g (22% yield from 2-23) of 2-24 as a white crystalline solid: m.p. 
197-199°C; Rr = 0.37, 4:1 hcxane.ethyl acetate; ’ll NMR (300 MHz, CDC13) 8 10.24 (br 
s, 111, NH2), 9.S9 (br s, 1H, NHj), 7.81-7.78 (m, 211, ArH), 7.48-7.40 (m, 3H, Aril), 4.60 
(br s, 1H, ArCHNH), 4.28 (q, J = 6.9 Hz, 2H, CH;,CH2OCO), 3.88 (br d, J = 13.2 Hz, 1H, 
CH2CHNH2), 3.26-3.20 (m, 2H, CHCHjNBoc). 3.00-2.78 (m, 1H, OCOCH), 2.55 (br s, 
111,), 2.06-1.93 (m, 411), 1.74-1.60 (m, 1H), 1.44-1.30 (m. 12H); l3C NMR (75 MHz, 
CDCI3) 6 170.75 (C), 158.89 (C), 145.65 (C), 128.47 (CH), 126.59 (CH), 125.22 (CH), 
90.33 (C), 58.50 (CH2), 51.78 (CH), 46.44 (CH2), 25.18 (CH3), 23.61 (CH2), 22.39(CH2), 
22.00 (CH2), 14.49 (CH3); MS-ESI m/z 377.1 [M-1ICI+ H ]\ 753.3 [2(M-HC1) + H]+.
iced with permission of the copyright owner. Further reproduction prohibited without permission.
192
Synthesis of (3AV4Af)-l-(iV-/f7V-Buivloxvcarbunvl )-3-cllivlo\\'c;irbonvl-4-lfA’)- 
phcnvlethvlnminolniperidinc (2-25)
Ph '^~ NH 0




A sample of the carboxylate salt 2-24 was mixed with excess saturated NaHCOj 
solution, and the mixture was extracted with diethyl ether, The extracts were dried over 
MgSOj, concentrated under reduced pressure and dried under vacuum to afford 2-25 as a 
colorless oil (Rf = 0,31, hc,xane:cthyl acetate 3:1). The diastereomeric excess was shown 
to be > .99 % :  ' l l  NMR (300 MHz, CDCI;,) 6 7.33-7.19 (m, 5H, Aril). 4.24-4.13 (m, 3H), 
3.95 (br, 1H), 3.81 (q, J = 0.6 Hz, 1H), 2.88 (td,/ =  10.6. 4.2 Hz, 2H), 2.66 (td, 7 = 12.9, 
2.4 Hz, IH), 2.29 (td, J = 10.8, 4.2 Hz, IH), 1.76-1.72 (m, IH), 1.43 (s, 9H), 1.33-1.27 
<m, 711), 1.16-1.04 (m. IH); UC NMR (75 MHz, CDCI.,) 5 172.89 (C), 154.22 (C), 
146.45 (C), 128.19 (CM), 126.71 (CH), 126.24 (CH), 79.63 (C), 60.46 (CH:), 55.77 
(CH), 55.19 (CH). 49.66 (CH). 44.91 (CH2). 42.48 (CH,), 32.00 (CHj), 28.16(CH3), 
23.91 (CH3), 14.08 (Cll3); MS-ESI m/z 377.2 [M + H]+, 399.2 [M + Na]\ 753.4 [2M+ 
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The carboxylatc salt 2-24 (0.084 g, 0.204 mmol) was dissolved in 
THF/MeOH/H:0  (6:3:1, 9 mL) and the solution cooled to 0°C. LiOH*H:0  (0.045 g,
1.07 mmol) dissolved in 0.4 mL ILO was added. The mixture was stirred at 0 °C for 20 
hours. The solvent was removed under reduced pressure to give a while solid (Rf = 0.31, 
CHjCli.MeOH 10:1). The white solid was dissolved in McOH followed by addition of 
ammonium formate (0,106 g, 1.68 mmol) and Pd/C (10%, 0.049 g) under N2. The 
mixture was refluxed for 3 hours. The solution was cooled, filtered through celite and 
syringe filter and the filtrate concentrated on a rotary evaporator to afford a white solid. 
The solid was dissolved in acetonc/l-LO (2:1, 9 mL) and cooled to 0°C, followed by the 
addition of Fmoc-OSu (0.067 g, 0.199 mmol) and NaHCO^ (0.16 g. 1.90 mmol). The 
turbid reaction mixture was stirred at 0°C for 1 hour and was then allowed to stir at room 
temperature overnight. Acetone was mostly removed under reduced pressure. The 
aqueous residue was diluted with H..:0  (2 mL), diethyl ether (9 mL) added and the 
mixture stirred at room temperature for 1 hour. The layers were separated and the ether 
layer was washed three times with saturated NaHCO.i. The aqueous phases were 
combined, acidified with IN HCI and extracted three times with ethyl acetate (75 mL 
total volume). The combined organic extracts were dried over MgS04, concentrated on a 
rotary evaporator, and dried under vacuum to afford a white solid. The caidc product 
was purified by three crystallizations from n-hexane/chloroform to afford 0.05g (53% 
yield) of 2-26 as white fluffy crystals: rn.p. 206-208°C; Rr = 0.44, 10:1 CH2C12:McOH; 
[a]“ D = -36.0 (e 0.50, acetone); *H NMR (300 MHz, CDClVCD,OD) 8 7.77 (d. J = 7.5 
Hz, 211, Aril), 7.62 (d, J = 6.9 Hz, 2H, Aril), 7.43-7.29 (m, 4H. Aril), 4.36-4.22 (m, 3H), 
4.07-4.02 (m, 1H), 3.93-3.86 (m. 1H), 3.09-2.82 (m, 2H), 2.44-2.38 (m, 1H), 2.02-1.97
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(m, 1H), 1.50-1.43 (m, 1H), 1.47 (s, 911); 13C NMR (75 MHz, CDCI3/CD3OD) 6 173.38 
(C), 155.83 (C), 154.21 (C), 143.23 (C), 140.69 (C), 127.07 (CH), 126.46 (CH), 124.42 
(CH), 119.27 (ClI), 80.00 (C), 66.35 (CII2), 49.73 (CH), 47.77 (CH), 46.57 (CH), 44.33 
(CH:), 41.68 (CH:), 30.63 (CH:), 27.51 (CH.,); MS-ES1 m/z 243.1 [M - Fmoc], 465.1 
1M- HI . 931.2 [2M- H]\
Synthesis of Boc-D-Ala-ACHC-OBn (2-27)
Boc-D-Ala-ACHC-OBn (2-27)
In an oven-dried round bottom flask, Boc-ACHC-OBrt (0.25 g, 0.75 mmol) was 
dissolved in 5 mL of HCl/dioxane (4 M) at 0 °C. The mixture was allowed to warm to 
room temperature and stirred for 2 hours. The solvent was then removed under a stream 
of N2 and under reduced pressure to obtain a white solid. The residue was dried under 
vacuum for 1 hour. The HCI salts were used without further purification. In an oven- 
dried round bottom flask, the resulting HCI salt was dissolved in 6 mL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, HOBt (0.22 g, 1.63 mmol), 
EDCHHCI (0.31 g. 1.63 mmol), DIEA (0.15 mL, 0.86 mmol), and a solution of Boc-O- 
Ala-OH (0.14 g, 0.75 mmol) in 4 mL of anhydrous DMT were added. The mixture was 
allowed to warm to room temperature and stirred for 48 hours under Nj. The mixture 
was diluted with 20 mL CH:CI: and solvent evaporated under reduced pressure. The 
solid residue was dissolved in 25 mL CH2C1: and washed with 50 mL of 1 N HCI 
solution three limes followed by 50 mL of saturated NaHCO, and 50 mL of saturated 
NaCI solution. The combined organic phase was dried over anhydrous MgSO, and the
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solvent was evaporated under reduced pressure to obtain yellow oil which was dried 
further under vacuum. The crude product was purified by Si02 flash column 
chromatography eluting beginning with CHiC12 and increased polarity to 10:1 
CHiCliiMeOII (Rr = 0.38). The product was eluted to afford 0.278 g (92% yield) of 2-27 
as a yellowish-white solid. Crystals were grown by slow vapor diffusion of ;i-heptane 
into a solution of 2-27 in 1,2-dichloroethanc: m.p. 92-93°C; 'H NMR (300 MHz, CDCIj) 
8 7.30-7.36 (m, 5H, ArH), 5.97 (br d, J = 9 Hz, 1H, NH), 5.09 (s, 2H, ArCH2), 4.92 (br d, 
7=11 Hz. 1H, NH). 4.03-3.93 (m. 2H. BocHNCH and CONHCH). 2.37 (id, J = 13, 4.5 
Hz, III, BnOCOCH), 2.08-1.90 (m, 211). 1.80-1.62 (m, 311), 1.50-1.10 (m. 3H). 1.44 (s, 
9H), 1.21 (d, J = 8 Hz, 3H, CHj); MS-ES1 m/z 427.2 (M + N af, 831.4 |2M + Na]\
In an oven-dried round bottom flask, Boc-ACHC-OBn (0.20 g, 0.60 mmol) was 
dissolved in 4 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to warm to 
room temperature and stirred for 2.5 hours. The solvent was then removed under a 
stream of N2 and under reduced pressure to obtain a white solid. The residue was dried 
under vacuum for 1 hour. The MCI salts were used without further purification. In an 
oven-dried round bottom flask, the resulting HCI salt was dissolved in 5 mL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, HOBt (0.18 g, 1.30 mmol), 
EDCHICI (0.25 g, 1.30 mmol), DIEA (0.12 mL, 0.69 mmol), and a solution of Boc-D-
Svnthesis of Boc-D-Phe-ACHC-OBn (2-28)
Boc-D-Phe-ACHC-OBn (2-28)
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Phe-OH (0.16 g, 0.60 mmol) in 3 mL of anhydrous DMF were added. The mixture was 
allowed to warm to room temperature and stirred for 60 hours under N2. Solvent was 
removed under reduced pressure and the solid residue dissolved in 20 mL CH’Cli. The 
resulting solution was washed with 40 mL of I N HC1 solution three times followed by 
40 mL of saturated NaHCOj and 40 mL of saturated NaCI solution. The combined 
organic phase was dried over anhydrous MgSO* and the solvent was evaporated under 
reduced pressure to obtain a white solid which was dried further under vacuum. The 
crude product was purified by Si02 Hash column chromatography eluting with 70:1 
CILCIcMeOH (Rr = 0.29). The product eluted in fractions 9-13 (10 mL fractions 
collected) to afford 0.270 g (94% yield) of 2-28 as a while solid. Crystals were grown by 
slow vapor diffusion of n-heptane into a solution of 2-28 in 1 ,2-dichloroethane: m.p. 181- 
182 °C; *H NMR (300 MHz. CDC13) 8 7.37-7.18 (m. 10H, ArH), 5.87 (br d, J = 8.7 Hz. 
1H, NH), 5.04 (app q, = 8 Hz, 2H, ArCH2OCO), 4.90 (br s, 1H, NH). 4.24-4.17 (m. 
1H, BocllNCH), 4.00 (tdd, J  = 11.1, 8.7, 4.2 Hz, 1H, CONHCH), 2.98 (d, J = 6.6 Hz, 
2H, ArCH-CH), 2.34 (td, J = 11.1, 3.9 Hz. 1H, BnOCOCH), 2.01-1.87 (m, 2H), 1.72- 
1.33 (m, 4H), 1.41 (s. 9H), 1.27-1.11 (m, 2H); MS-ESI ni/z 503.2 [M + Na]*, 983.4 [2M 
+ Naf.
Synthesis of Boc-D-Val-ACHC-OBn (2-29)
H3C ch3
Boc-D-Val-ACHC-OBn (2-29)
In an oven-dried round bottom flask, Boc-ACHC-OBn (0.53 g, 1.58 mmol) was 
dissolved in 3 mL of HCI/dioxanc (4 M) at 0°C. The mixture was allowed to warm to
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room temperature and stirred for 3.5 hours. The solvent was then removed under a 
stream of N2 and under reduced pressure to obtain a white solid. The residue was dried 
under vacuum for 1 hour. The HC1 salts were used without further purification. In an 
oven-dried round bottom flask, the resulting HC1 salt was dissolved in 10 mL of 
anhydrous DMF and cooled to 0°C. After stilting for 5 minutes, HOBt (0.47 g, 3.47 
mmol), EDCl’HCI (0.67 g, 3.47 mmol), DIEA (0.41 mL, 2.37 mmol), and a solution of 
Boc-D-Val-OII (0.34 g, 1.58 mmol) in 6 mL of anhydrous DMF were added. The 
mixture was allowed to warm to room temperature and stirred for 48 hours under N2. 
Diluted mixture with 25 mL CbLCL and transferred to a larger flask. Solvent was 
removed under reduced pressure and the solid residue dissolved in 30 mL CH2C12. The 
resulting solution was washed with 50 mL of 1 N HC1 solution three times followed by 
50 mL of saturated NaHCO.i and 50 mL of saturated NaCI solution. The combined 
organic phase was dried over anhydrous MgS04 and the solvent was evaporated under 
reduced pressure to obtain a white solid which was dried further under vacuum. The 
crude product was punfied by Si02 flash column chromatography eluting with 30:1 
ClLClcMeOII (Ri = 0.28). The product was eluted to afford 0.55 g (80% yield) of 2-29 
as a white solid. Crystals were grown by slow vapor diffusion of /(-heptane into a 
solution of 2-29 in 1,2-dichloroelhanc: m.p. 138-140°C; 'l l  NMR (300 MHz, CDCI3) 5 
7.40-7.28 (m, 5H, Aril), 5.80 (br d, J = 8.4 Hz, 1H, NH), 5.14-5.09 (m, 3H, ArCHj & 
NH), 4.07 (ddd, J = 14.7, 8.4, 3.9 Hz, 1H, BocHNCH), 3.75 (app q, Jm  = 6.3, 111, 
CONHCH), 2.39 (td, J = 11.4, 3.9 Hz, 1H, BnOCOCH), 2.09-1.94 (m, 3H), 1.76-1.52 
(nr, 4H), 1.45 (s, 9H), 1.40-1.15 (m, 2H) 0.89 (t, ./=  6.9, 6H, 2CHj); MS-ESI m/z 455.2 
[M + N a]\ 887.4 [2M + Naf.
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Synthesis of Boc-D-Val-D-Phe-ACHC-OBn (2-30)
\  h 9  




0  A  H o
Boc-D-Val-DiPhe-ACHC-OBn (2-30)
In an oven-dried round bottom flask, Boc-D-Phe-ACHC-OBn (0.227 g, 0.47 
mmol) was dissolved in 2 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to 
warm to room temperature and stirred for 2 hours. The solvent was then removed under 
a stream of Nj and under reduced pressure to obtain a white solid. The residue was dried 
under vacuum for I hour. The HC1 salts were used without further purification. In an 
oven-dried round bottom flask, the resulting 1ICI salt was dissolved in 3 mL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, 1.42 mmol of D1EA was added via 
syringe and the mixture was stirred for 10 minutes. In another oven-dried round bottom 
llask. Boc-D-Val-OII (0.102 g, 0.47 mmol) was dissolved in 3 mL of DM1- followed by 
addition of HOBt (0.141 g, 1.04 mmol), and HDCI'HCI (0.199 g, 1.04 mmol), and the 
mixture was cooled to 0°C. The solution of amine and DIEA was then transferred to the 
flask containing Boc-Val-OH, HOBt and EDCI'HCI. The mixture was allowed to warm 
to room temperature and stirred for 72 hours under N2. The mixture was diluted with 20 
mL CH2CI2 and transferred to a larger flask. The solvent was removed under reduced 
pressure and the solid residue dissolved in 25 mL CII2CI2. The resulting solution was 
washed with 30 mL of 1 N HCi solution three times followed by 30 mL of saturated 
NaHCOj and 30 mL of saturated NaCI solution. The combined organic phase was dried 
over anhydrous MgSOj, and the solvent was evaporated under reduced pressure to obtain
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a while solid which was dried further under vacuum. The crude product was purified by 
SiO; Hash column chromatography eluting with 30:1 CHiCI2:MeOH (Rf = 0.21). The 
product eluted in fractions 9-13 (10 mL fractions collected) to afford 0.233 g (85% yield) 
of 2-30 as a tan solid. Crystals were grown by slow vapor diffusion of 1:1 1,2- 
dichloroethane:hexane into a solution of 2-30 in 1,2-dichloroethane and methanol: m.p. 
187-189 °C; *11 N\1R (300 MHz, CDCI3) 8 7.37-7.14 (m, 10H, ArH), 6.34 (br d, J = 7.2 
Hz, 1H, NH), 6.20 (br d, J = 7.2 Hz, 1H. NH), 5.07 (app q, J,„  = 6.3 Hz, 2H, 
ArCHiOCO), 4.76 (br d. J = 4.2 Hz. 1H, NH), 4.59-4.52 (m, IH, ArCH:CH), 4.03 (ddd, 
J = 12.6, 10.8, 3.9, HI, BocHNCH), 3.81 (app q, Jm  = 5.1, 1H, CONHCH), 3.13-3.04 
(in, IH, ArCHj), 2.98-2.88 (m, HI, ArCH>), 2.36 (td, J = 11.4, 3.9 Hz, 1H, BnOCOCH), 
2.20-2.09 (m, IH), 1.94-1.87 (m, 2H), 1.69-1.43 (m. 4H), 1.44-1.00 (m, 211), 1.39 (s. 
9H), 0.89 (d, J = 6.9 Hz, 3H, CHj) 0.77 (d. J = 6.9 Hz, 3H, CH3); MS-ESI m/z 602.3 [M 
+ N a]\ 1181.6 [2M + Na]*.
In an oven-dried round bottom flask, Boc-D-Phe-ACHC-OBn (0.047 g, 0.097 
mmol) was dissolved in 1 mL of HCl/dioxane (4 M) at 0°C. The mixture was allowed to 
warm to room temperature and stirred for 2 hours. The solvent was then removed under 
a stream of N2 and under reduced pressure to obtain a white solid. The residue was dried 
under vacuum for 1 hour. The HCI salts were used without further purification. In an
Synthesis of Boc-ACHC-O-Phe-ACHC-OBn (2-31)
Boc-ACHC-D-Phe-ACHC-OBn (2-31)
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oven-dried round bottom flask, the resulting HC1 salt was dissolved in 3 niL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, 0.388 mmol of D1EA was added 
via syringe and the mixture was stirred for 10 minutes. In another oven-dried round 
bottom flask, Boc-ACHC-OH (0.0236 g, 0.097 mmol) was dissolved in 3 mL of DMF 
followed by addition of HOBt (0.016 g, 0.117 mmol), and EDC1*HCI (0.022 g, 0.117 
mmol) and the mixture cooled to 0°C. The solution of amine and DIEA was then 
transferred to the flask containing Boc-ACHC-OH, HOBt and EDCI'HCl. The mixture 
was allowed to warm to room temperature and stirred for 38 hours under Nj. The solvent 
was removed under a stream of Na and reduced pressure and the residue was dried under 
vacuum. This residue was washed with 1 N HC1 solution and saturated NaHCOj 
solution. The solid that did not dissolve was collected by suction filtration and dried 
under vacuum to obtain a brownish-white solid. The crude product was purified by SiOa 
flash column chromatography eluting with 30:1 CHClj.MeOH (Rf = 0.30). The product 
was eluted to afford 0.031 g (52% yield) of 2-31 as a white solid. Crystals were grown 
by slow vapor diffusion of 1:1 l,2-dichloroethane:hexane into a solution of 2-31 in 1,2- 
dichloroethanc and methanol: m.p. 232-235°C; 'l l  NMR (300 MHz, CDCI3/CD3OD) 6 
7.46-7.13 (m, 10H, ArH), 5.05 (br s, 2H, ArCHrOCO), 4.53-4.48 (m, 1H, ArClBCH), 
4.00-3.98 (m, 1H, BocHNCH), 3.49-3.40 (m, 1H, CONHCH), 3.00-2.94 (m, 1H, ArCH2), 
2.80-2.72 (m. 111, ArCH2), 2.39 (td, J = 11.4, 3.6 Hz, 111, BnOCOCH), 2.09-1.90 (m, 
4H), 1.77-1.53 (m, 7H), 1.45-1.14 (in, 5H), 1.40 (s, 9H); MS-ESI m/z 628.3 (M + Na]+, 
1234.6 [2M + Na]*.
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Synthesis of ACHC-D-Val-ACHC-OBn (2-32)
Boc-ACHC-D-Val-ACHC-OBn (2-32)
In an oven-dried round bottom flask, Boc-D-Val-ACHC-OBn (0.118 g, 0.272 
mmol) was dissolved in 2 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to 
warm to room temperature and stirred for 1.5 hours. The solvent was then removed 
under a stream of Nj and under reduced pressure to obtain a white solid. The residue 
was dried under vacuum for 1 hour. The HCI salts were used without further 
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in 
3 mL of anhydrous DMF and cooled to 0°C. After stirring for 5 minutes, 1.085 mmol of 
DIEA was added via syringe and the mixture was stirred for 10 minutes. In another 
oven-dried round bottom flask, Boc-ACHC-OH (0.0661 g, 0.272 mmol) was dissolved in 
3 mL of DMF followed by addition of HOBt (0.0441 g, 0.326 mmol), and EDCFHCI 
(0.0625 g, 0.326 mmol) and the mixture was cooled to 0°C. The solution of amine and 
DIEA was then transferred to the flask containing Boc-ACHC-OH, HOBt and 
EDCM1CI. The mixture was allowed to warm to room temperature and stirred for 40 
hours under N2. The solvent was removed under a stream of N2 and reduced pressure and 
the residue was dried under vacuum. This residue was washed with 1 N HCI solution and 
saturated NaHCOa solution. The solid that did not dissolve was collected by suction 
filtration and dried under vacuum to obtain a white solid. The crude product was purified 
by Si02 flash column chromatography eluting with 30:1 CHCIj:MeOH (Rr = 0.36). The 
product was eluted to afford 0.094 g (62% yield) of 2-32 as a white solid. Crystals were
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grown by slow vapor diffusion of 1:1 l,2-dichloroethanc:hexane into a solution of 2-32 in 
1,2-dichloroethane and methanol: m.p. 245-247°C; ‘ll NMR (300 MHz, CDCI3/CD3OD) 
5 7.48-7.30 (m, 5H, ArH), 5.09 (s. 2H, ArCH;OCO), 4.09-4.00 (m, 2H, BocHNCH & 
(CHj),CHCH), 3.58-3.49 (m, 1H, CONHCH), 2.43 (td, J = 11.7, 4.0 Hz, 1H, 
BnOCOCH), 2.18 (td, J = 11.7, 4.0 Hz. IH, NHCOCH), 2.10-1.86 (m. 5H), 1.82-1.73 
(m, 411), 1.61-1.54 (m. 3H), 1.44-1.13 (m, 511), 1.41 (s, 9H), 0.88 (d, J = 3.9 Hz. 3H, 
CHj), 0.86 (d, J = 3.9 Hz, 3H, CH3); MS-ESI m/z 580.3 [M + Na]*, 1138.7 [2M + Na]f.
In an oven-dried round bottom flask, Boc-D-Val-ACHC-OBn (0.186 g, 0.430 
mmol) was dissolved in 2 mL of HCI/dioxanc (4 M) at 0°C. The mixture was allowed to 
warm to room temperature and stirred for 2 hours. The solvent was then removed under 
a stream of N2 and under reduced pressure to obtain a while solid. The residue was dried 
under vacuum for 1 hour. The HC1 salts were used without further purification. In an 
oven-dried round bottom flask, the resulting HCI salt was dissolved in 3 mL of anhydrous 
DMF and cooled to 0"C. After stirring for 5 minutes, 0,642 mmol of DIEA was added 
via syringe and the mixture was stirred for 10 minutes. In another oven-dried round
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bottom flask, Boe-D-Lys(2-CI-Z)-OH (0.178 g, 0.430 mmol) was dissolved in 3 mL of 
DMF followed by addition of HOBt (0.128 g, 0.950 mmol), and EDC1-HCI (0.181 g, 
0.950 mmol), and the mixture was cooled to 0°C. The solution of amine and DIEA was 
then transferred to the flask containing Boc-£)-Lys(2-Cl-Z)-OH, HOBt and EDCI'HCl. 
The mixture was allowed to warm to room temperature and stirred for 48 hours under Nj. 
The solvent was removed under a stream of NS and reduced pressure and the residue w<as 
dried under vacuum. This residue was washed with 1 N 11CI solution and saturated 
NaHCOj solution. The solid that did not dissolve was collected by suction filtration and 
dried under vacuum to obtain a white solid. The crude product was purified by Si02 
Hash column chromatography eluting with 30:1 CHCfpMeOH (Rr = 0.20). The product 
eluted after increasing solvent polarity to CHCfpMeOH 1:1. Product was dried under 
vacuum to afford 0.263 g (84% yield) of 2-33 as a white solid. Crystals were grown by 
slow vapor diffusion of 1:1 l,2-dichlorocthane:licxane into a solution of 2-33 in 1,2- 
dichloroethane and methanol: m.p. 210-2I2°C; ’ll NMR (300 MHz, CDCI5/CD3OD) 6 
7.70 (hr d, J  = 4.2, IH, NH) 7.44-7.24 (nt, 9H, ArH), 5.20 (s, 2H, ArCICHj), 5.06 (s, 2H, 
ArCLLOCO), 4.06-3.96 (m, 311), 3.39-3.37 (m, III), 3.16 (t, J = 6.3 Hz, 2H), 2.39 (td, J = 
12.0, 3.6 Hz, 1H, BnOCOCfj), 2.10-1.90 (m, 3H), 1.76-1.68 (m, 3H), 1.60-1.09 (m, 911), 
1.43 (s, 9H), 0.87 (d. J = 3.6 Hz, 3H, CHj), 0.84 (d, J = 3.6 Hz, 3H, CH3); MS-ESI mfz
751.3 [M + N af, 1481.6 [2M + Naf.
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Synthesis of Boc-P-Ala-ACHC-fl-Ala-ACHC-OBn (2-34)
_ o ch3 o
7
'  O C H , "
Boc-D-Ala-ACHC-D-Ala-ACHC-OBn (2-34)
In an oven-dried round bottom flask, Boc-£>-Ala-ACHC-OBn (0.056 g, 0.139 
mmol) was dissolved in 1 mL of HCl/dioxane (4 M) at 0°C. The mixture was allowed to 
warm to room temperature and stirred for 2 hours. The solvent was then removed under 
a stream of Nj and under reduced pressure to obtain a tan solid. The residue was dried 
under vacuum for 1 hour. The MCI salts were used without further purification. In an 
oven-dried round bottom flask, the resulting HC1 salt was dissolved in 2 mL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, 0.208 mmol of DIEA was added 
via syringe and the mixture was stirred for 10 minutes. In another oven-dried round 
bottom flask, Boc-D-Ala-ACHC-OH (0.0435 g, 0.139 mmol) was dissolved in 2 mL of 
DMF followed by addition of HOBl (0.041 g, 0.305 mmol), and EDCI*HCI (0.058 g, 
0.305 mmol), and the mixture was cooled to 0'C. The solution of amine and DIEA was 
then transferred to the flask containing Boc-D-Ala-ACHC-OH, HOBt and EDCI’HCl. 
The mixture was allowed to warm to room temperature and stirred for 76 hours under N;. 
The solvent was removed under a stream of Ni and reduced pressure and the residue was 
dried under vacuum. This residue was diluted with CH2CI2 and washed three times with 
20 mL 1 N HC1 solution, three times with 20 mL saturated NaHCOj solution and once 
with 20 mL aqueous NaCl solution. The organic phase was dried in anhydrous MgSOj 
and concentrated on a rotary evaporator. The residue was dried under vacuum to obtain a
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pale yellow solid. The crude product was purified by SiC>2 flash column chromatography 
eluting with 20:1 CHiCI;:MeOH (Rf = 0.30). The product was then dried under vacuum 
to afford 0.062 g (75% yield) of 2-34 as a white solid. Crystals were grown by slow 
vapor diffusion of i:l l,2-dichlorocthane:hcxane into a solution of 2-34 in 1,2- 
dichlorocthane and methanol: m.p. 202-203°C; ' l l  NMR (300 MHz, CDCIVCDiOH) 6 
7.70 (hr d, 7 = 8.7, 1H, NH), 7.57 (br d, 7 = 8.1. 1H, NH), 7.36-7.28 (nn, 5H, ArH), 6.00 
(br d, 7 = 6.9, 1H, NH), 5.08 (s, 2H, AiCHjOCO), 4.18-4.14 (m, 2H, NHCHCO), 4.08- 
3.96 (m, 2H, CONHCH ), 2.36 (td, 7 = 11.7, 3.6 Hz, 1H, HNCOCH), 2.30-2.22 (m, 1H, 
BnOCOCH), 2.01-1.74 (m, 7H), 1.64-1.25 (m. 9H), 1.44 (s, 9H), 1.20 (d, 7=  6.9 Hz, 3H, 
CHi), 1.16 (d, 7 = 6.9 Hz, 3H, CH,); MS-ESI ni/z 623.3 [M + Na)+, 1223.6 [2M + Naf.
Boc-O-Phe-ACHC-D-Phe-ACHC-OBn (2-35)
In an oven-dried round bottom flask, Boc-D-Phe-ACHC-OBn (0.0167 g, 0.035 
mmol) was dissolved in 1 mL of HCI/dioxane (4 M) at 0°C. The mixture was allowed to 
warm to room temperature and stirred for 2 hours. The solvent was then removed under 
a stream of N2 and under reduced pressure to obtain a white solid. The residue was dried 
under vacuum for 1 hour. The HCI salts were used without further purification. In an 
oven-dried round bottom flask, the resulting HCI salt was dissolved in 1 mL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, 0.052 mmol of D1EA was added
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via syringe and the mixture was stirred for 10 minutes. Boc-D-Phe-ACHC-OH (0.0134 
g, 0.035 mmol), HOBt (0.0103 g, 0.076 mmol), and EDCI'HCI (0.0147 g, 0.076 mmol) 
were added at 0”C. The mixture was allowed to warm to room temperature and stirred 
for 53 hours under Nj. The solvent was removed under a stream of Nj and reduced 
pressure and the residue was dried under vacuum. This residue was diluted with CH2CI2 
and washed three times with 20 mL 1 N HCI solution, three times with 20 mL saturated 
NaHCOj solution and once with 20 mL aqueous NaCl solution. The organic phase was 
dried in anhydrous MgSOj and concentrated on a rotary evaporator. The residue was 
dried under vacuum to obtain a brown solid. The crude product was purified by Si02 
flash column chromatography eluting with 30:1 CHCb:MeOH (Rr = 0.29). The product 
was dried under vacuum to afford 0.0187 g (72% yield) of 2-35 as a while solid. Crystals 
were grown by slow vapor diffusion of 1:1 l,2-dichlorocthane:hcxanc into a solution of 
2-35 in 1,2-dichlorocthane and methanol: m.p. 244-245°C; 'l l  NMR (300 MHz, 
CDCI3/CD3OD) 7.36-7.15 (m, 15H, ArH), 5.06 (s, 2H, ArCH2OCO), 4.59-4.55 (m, 1H, 
N’HCHCO), 4.25-4.22 (m, IH, NHCHCO), 3.87-3.77 (m, 2H), 2.94-2.88 (m, 2H, 
A1CH2), 2.70-2.59 (m. 2H, A1CH2), 2.30-2.17(m, 2H), 1.99-1.85 (m, 2H), 1.74-1.05 (m, 
12H), 1.32 (s, 9H), 0.92-0.85(m, 211); MS-ESI m/z 775.4 [M + Na]f




In an oven-dried round bottom flask, Boc-D-Val-ACHC-OBn (0.111 g, 0.257 
mmol) was dissolved in 3 mL of HCI/dioxanc (4 M) at 0°C. The mixture was allowed to
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warm to room temperature and stirred for 2 hours. The solvent was then removed under 
a stream of N? and under reduced pressure to obtain a white solid. The residue was dried 
under vacuum for 1 hour. The HCI salts were used without further purification. In an 
oven-dried round bottom flask, the resulting HCI salt was dissolved in 3 mL of anhydrous 
DMF and cooled to 0°C. After stirring for 5 minutes, 1.03 mmol of D1EA was added via 
syringe and the mixture was stirred for 10 minutes. In another oven-dried round bottom 
flask, Boc-D-Val-ACHC-OH (0.088 g, 0.257 mmol) was dissolved in 3 mL of DMF 
followed by addition of HOBt (0.042 g, 0.311 mmol), and EDCl'HCI (0.059 g, 0.311 
mmol), and the mixture cooled to 0°C. The solution of amine and DIEA was then 
transferred to the flask containing Boc-D-Val-ACHC-OH, HOBt and EDCEHCI. The 
mixture was allowed to warm to room temperature and stirred for 48 hours under N2 
during which time a white solid precipitated. The solvent was removed under a stream of 
Ni and reduced pressure and the residue was dried under vacuum. This residue was 
diluted with CH2CI2 (sparingly soluble) and washed three times with 25 mL 1 N HCI 
solution, three times with 25 mL saturated NaHCOi solution and once with 25 mL 
aqueous NaCl solution. The organic phase was dried in anhydrous MgSO* and 
concentrated on a rotary evaporator. The residue was dried under vacuum to obtain a 
white solid. The crude product could not be purified by SiCL flash column 
chromatography because of poor solubility in organic solvents. The crude product was 
purified by washing with acetone and filtering to obtain 0.135 g (80%) of 2-36 as a white 
solid. A mini workup for NMR purposes involved taking a sample of the product and 
reacting with CF3COOH to obtain the trifluoroacctatc and then dissolving in acetone and 
filtered to obtain a white solid (free amine). This white solid could then be dissolved in
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CDCI3/CD3OD for NMR analysis. Crystals were grown by slow vapor diffusion of 1:1
l, 2-dichloroethane:hcxanc into a solution of 2-36 in 1,2-dichloroethane and methanol:
m. p. 254-256°C (free amine); 'l l  NMR (300 MHz, CDCI3/CD3OD) (Free amine) 5 7.39- 
7.32 (m, 5H, ArH), 5.08 (app q, J = 12.6 Hz, ArCHj), 4.06-3.95 (m. 2H), 3.61 (td, J = 
10.8, 3.3 Hz, 1H, CONHCJ4), 3.40-3.35 (m, 1H, CONHCH), 2.69 (td, J = 11.1, 3.0 Hz, 
1H, HNCOCH), 2.44 (td ,./ = 11.7, 3.9 Hz, 1H, BnOCOCH). 2.13-1.81 (m, I0H), 1.62- 
1.18 (m, 8H), 0.99 (app q, J = 3.3 Hz, 614, 2C.Hj), 0.87 (br d, J = 6 Hz, 6H, 2CH3); MS- 
ES1 m/z (Free amine) 557.3 [M + H ]\ 579.3 1M + Na|*. 1135.6 [2M + Na]*; (Boc- 
product) 679.4 |M + Na]\ 1335.7 [2M + Na]*.
Synthesis of Boc-Q-Lvs(2-Cl Z)-/J-Val-P-Phc-ACHC-OBii (2-37)
In an oven-dried round bottom flask, Boc-/J-Val-D-Phe-ACllC-OBn (0.274 g, 
0.473 mmol) was dissolved in 2 mL of HCl/dioxane (4 M) at 0“C. The mixture w'as 
allowed to warm to room temperature and stirred for 2 hours. The solvent was then 
removed under a stream of 1N2 and under reduced pressure to obtain a white solid. The 
residue was dried under vacuum for 1 hour. The HC1 salts were used without further 
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in 
2 mL of anhydrous DMF and cooled to 0°C. After stirring for 5 minutes, 0.712 mmol of
Cl
Boc-D-Lys (2-CI-Z)-D-Val-D-Phe-ACHC-OBn (2 -37)
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D1EA was added via syringe and the mixture was stirred for 10 minutes. In another 
oven-dried round bottom flask. Boc-Z?-Lys(2-CI-Z)-OH (0.196 g, 0.473 mmol) was 
dissolved in 3 mL of DMF followed by addition of HOBt (0.141 g, 1.04 mmol), and 
EDCHICl (0.199 g, 1.04 mmol), and the mixture was cooled to 0°C. The solution of 
amine and DIEA was then transferred to the flask containing Boc-D-Lys(2-CI-Z)-OH, 
HOBt and EDCHICl. The mixture was allowed to warm to room temperature and 
stirred for 48 hours under N2. The solvent was removed under a stream of N2 and 
reduced pressure and the residue was dried under vacuum. This residue was washed with 
1 N HCI solution and saturated NallCOj solution. The solid that did not dissolve was 
collected by suction filtration and dried under vacuum to obtain a tan solid. The crude 
product was purified by SiO.> flash column chromatography eluting with 2:1 
CIIiCkMeOH (R| -  0.40). The Product was dried under vacuum to afford 0.249 g (60% 
yield) of 2-37 as a white solid. Crystals were grown by slow vapor diffusion of 1:1 1,2- 
dichloroethane:hexane into a solution of 2-37 in 1,2-diehloroelhane and methanol: m.p. 
192-194 °C: 'H NMR (300 MHz, CDC1/CD30D) 6 7.54 (br d. J = 6.3, 111, NH), 7.45- 
7.14 (m, 14H, Aril), 6.50(1,/= 5.4 Hz, 111, NH),5.21 (s, 2H, AtCICHH, 5.03 (appq, Japp 
= 12.3 Hz, 2H, ArQHOCO), 4.09 (br d, /  = 6.0, 1H), 4.02-3.99 (m, 2H), 3.78-3.72 (m, 
1H), 3.19-3.13 (m, 2H), 2.82 (app q, 7W = 8.7 Hz, HI), 2.49-2.42 (m, 1H, BnOCOCH), 
2.05-1.88 (m, 311), 1.75-1.16 (m, 14H), 1.44 (s, 911), 0.84 (d, J = 6.9 Hz, 3H, CH3), 0.80 
(d, J = 6.9 Hz, 3H, CH3); MS-ESI m/z 898.4 [M + Naf.
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Synthesis of Boc-»-Lvs(2-Cl-Zl-ACHC-D-V:il-ACHC-OBn (2-38) 
0
o A  » ?
H N -C -C —
CHj
c h 2 
c h 2 
c h 2I
Boc-D-Lys (2-CI-Z)-ACHC-D-Val-ACHC-OBn (2-38)
In an oven-dried round bottom flask. Boc-O-ACHC-D-Val-ACHC-OBn (0.06S g, 
0.122 mmol) was dissolved in 1 raL of HCI/dioxane (4 M) at 0°C. The mixture was 
allowed to warm to room temperature and stirred for 2 hours. The solvent was then 
removed under a stream of N2 and under reduced pressure to obtain a white solid. The 
residue was dried under vacuum for 1 hour. The HCI salts were used without further 
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in 
2 mL of anhydrous DMF and cooled to 0"C. After slitting for 5 minutes, 0.183 mmol of 
D1EA was added via syringe and the mixture was stirred for 10 minutes. In another 
oven-dried round bottom flask, Boc-/3-Lys(2-CI-Z)-OH (0.0506 g, 0.122 mmol) was 
dissolved in 1 mL of DMF followed by addition of liOBt (0.036 g, 0.266 mmol), and 
EDCFHCl (0.051 g, 0.266 mmol), and the mixture was cooled to 0°C. The solution of 
amine and DIEA was then transferred to the flask containing Boc-D-Lys(2-CI-Z)-OH, 
HOBt and EDCFHCI. The mixture was allowed to warm to room temperature and 
stirred for 48 hours under N2. The solvent was removed under a stream of N2 and 
reduced pressure and the residue was dried under vacuum. This residue was washed with 
1 N HCI solution and saturated NaHCOj solution. The solid that did not dissolve was
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collected by suction filtration and dried under vacuum to obtain a white solid. The crude 
product was purified by precipitation. Purification involved dissolving the white solid in 
minimum amount of MeOH/TFE/CHClj and sonicationg. Excess diethyl ether was 
added and mixture kept at 0°C for 5 minutes and after centrifuging, the ether layer was 
decanted. The process was repeated three times with fresh portions of diethyl ether. The 
product was dried under vacuum to afford 0.094 g (90% yield) of 2-38 as a white solid: 
m.p. 217-219°C; 'l l  NMR (300 MIIz, CDCIj/CD^OD) 8 7.53 (br d. J = 4.2, 1H, NH), 
7.41 (br d. J = 5.1, 1H, NH), 7.36-7.24 (m, 9H, ArH). 5.20 (app q, Jm  = 11.7 Hz, 2H. 
ArCH:OCO), 5.07 (s, 2H, ArCICH:), 4.12-3.99 (m. 310, 3.86-3.80 (m, 1H, CONHCH), 
3.18-3.12 (m, 211), 2.99-2.88 (m, 1H), 2.44-2.26 (m. 211). 2.05-1.15 (m. 23H), 1.43 (s, 
9H), 0.85 (br d. J = 6.3 Hz, 611. 2CH,); MS-ESI mfz 876.4 |M + Nap.
Synthesis of l)oc-ACHC-/J-l.vs(2-CI-/.l-/J-Val ACHC-OBn (2-39)
Boc-ACHC-D-Lys (2-CI-Z)-0-Val-ACHC-OBn (2-39)
In an oven-dried round bottom flask, Boc-D-Lys(2-Cl-Z)-D-Val-ACHC-OBn 
(0.239 g, 0.328 mmol) was dissolved in 2 mL of HCI/dioxanc (4 M) at 0°C. The mixture 
was allowed to warm to room temperature and stirred for 2 hours. The solvent was then 
removed under a stream of N2 and under reduced pressure to obtain a white solid. The
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residue was dried under vacuum for 1 hour. The HCI salts were used without further 
purification. In an oven-dried round bottom flask, the resulting HCI salt was dissolved in 
1 mL of anhydrous DMF and cooled to 0°C. After stirring for 5 minutes, 0.492 mmol of 
DIEA was added via syringe and the mixture was stirred for 10 minutes. In another 
oven-dried round bottom flask, Boc-ACHC-OH (0.08 g, 0.328 mmol) was dissolved in 2 
mL of DMF followed by addition of HOBt (0.097 g, 0.721 mmol), and EDCPHCI (0.138 
g, 0.721 mmol) and the mixture was cooled to 0°C. The solution of amine and DIEA was 
then transferred to the flask containing Boc-ACHC-OH, HOBt and EDCI'HCI. The 
mixture was allowed to warm to room temperature and stirred for 48 hours under Nj. 
The solvent was removed under a stream of N2 and reduced pressure and the residue was 
dried under vacuum. This residue was washed with 1 N HCI solution and saturated 
NallCOj solution. The solid that did not dissolve was collected by suction filtration and 
dried under vacuum to obtain a white solid. The crude product was purified by 
precipitation. Purification involved dissolving the white solid in minimum amount of 
MeOH/TFE/CHCI3 and sonicating. Excess diethyl ether was added and mixture kept at 0 
°C for 5 minutes and after centrifuging, the ether layer was decanted. The process was 
repeated three times with fresh portions of diethyl ether. The product was dried under 
vacuum to afford 0.210 g (75% yield) of 2-39 as a white solid: m.p. 288-290°C; 'H NMR 
(300 MHz, CDClj/CDjOD/TFE) 8 7.47-7.23 (m, 9H, ArH), 5.19 (s, 2H, ArCICHi), 5.06 
(s, 2H, AiCHjOCO), 3.66-3.57 (m, 2H), 3.52-3.41 (m, HI), 3.17-3.10 (m, 3H), 2.46-2.37 
(m, IH, N'HCOCH), 2.27-2.15 (m, 1H, BnOCOCH), 1.97-1.17 <m, 23H), 1.40 (s, 9H), 
0.87 (d, J «  5.0 Hz, 3H, CH3), 0.85 (d, J = 5.0 Hz, 3H, CH3); MS-ESI m/z 876.4 [M + 
Naf.
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The synthesis was performed as described under the General Procedures for Solid 
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 /tmol scale for each 
residue was used for coupling. Cleavage of the peptide and simultaneous side chain 
deprotection was performed as described under the General Procedures. Extended 
deprotection and extended coupling (2 hours) were employed. The crude peptide was 
dissolved in the HPLC A solvent and purified by reverse phase IIPLC employing a linear 
gradient from 15% to 75% solvent B over 40 minutes. MALD1-TOF-MS m/z ealed for 




The synthesis was performed as described under the General Procedures for Solid 
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 /tmol scale for each 
residue was used for coupling. Cleavage of the peptide and simultaneous side chain
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deprolection was performed as described under the General Procedures. Extended 
deprotection and extended coupling (2 hour) were employed. The crude peptide was 
dissolved in the HPLC A solvent and purified by reverse phase HPLC employing a linear 
gradient from 17% to 47% solvent B over 60 minutes. MALDI-TOF-MS mJz ealed for 
(C44H71 NqOr) [M] 854.09. found 854.0 |M], 855.0 [M + HP, 877.0 [M + Na]+, 893.0 [M 
+ K]*.
Synthesis of Ac-ACHC-D-Lvs-ACHC-P-Tvr-ACHC-D-Lvs-ACHC-D-Tvr-NH? (2-42)
NH,
O - . n _









The synthesis was performed as described under the General Procedures for Solid 
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 jmiol scale for each 
residue was used for coupling. Cleavage of the peptide and simultaneous side chain 
deprotection was performed as described under the General Procedures. Extended 
deprotection and extended coupling (2 hour) were employed. The crude peptide was 
dissolved in the HPLC A solvent and purified by reverse phase HPLC employing a linear 
gradient from 35% to 95% solvent B over 40 minutes and 20% to 45% solvent B over 30 
minutes. MALDI-TOF-MS m/z ealed for (CWH,,;NnO,,) [M] 1142.43, found 1142.1 
[M], 1180.1 [(M-H) + K f.
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Synthesis of Ac-ACHC-Z.-Lvs-ACHC-/J-Tvr-ACHC-/,-Lvs-ACHC-£-Tvr-NH? (2-43)
OH
Ac-ACHC-GLys-ACHC-l.-Tyr-ACHC-/.-lys-ACHC-f.-Tyr-NH2 (2-43)
The synthesis was performed as described under the General Procedures for Solid 
Phase Peptide Synthesis on the automated peptide synthesizer. A 75 pmol scale for each 
residue was used for coupling. Cleavage of the peptide and simultaneous side chain 
deprotection was performed as described under the General Procedures. Extended 
deprotection and extended coupling (2 hour) w'ere employed. The crude peptide was 
dissolved in the HPLC A solvent and purified by reverse phase IIPLC employing a linear 
gradient from 25% to 40% solvent B over 30 minutes. MALDI-TOF-MS m /z  ealed for 
(CsoHEiNnOii) [M] 1142.43, found 1142.3 [M], 1I43.1[M + H]*, 1165.4 [M + Na]\ 
1181.4 [M + K]*.
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CHAPTER 4
MODELING HETEROGENEOUS OLIGOMERS 
4.1 Introduction
Homogeneous and heterogeneous backbone oligomers are modeled with the 
intention of predicting, qualitatively, the helical secondary structures adopted by 
oligomers based on the hydrogen-bonding pattern. The experimental data available for 
homogeneous backbone oligomers ate used as standards to validate the modeling method. 
Among p-amino acid homo-oligomers, different helical conformations have been 
reported, specified by the number of atoms involved in hydrogen bonding. p-Peptides 
constructed from cycloalkane based residues have been shown to adopt stable helical 
conformations, characterized by 12- and 14-mcmbercd ring hydrogen bonds.710'14'4 '41* 
Helical conformations have also been reported for P-peptides built from acyclic 
residues.12-1632
Homogeneous backbone oligomers are oligomers containing residues of the same 
kind (for example cither only a- or P-amino acids) as monomer units. Heterogeneous 
backbone oligomers are oligomers containing both a- and P-amino acids as the monomer 
units. Three cx-amino acids Ala, Pile and Val and two P-amino acids, amino cyclohexane 
carboxylic acid (ACHC) and amino cyclopcntanc carboxylic acid (ACPC) were used to 
build various oligomers (hexamers) and molecular modeling studies performed on these 
oligomers.
216
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It was logically thought to begin modeling studies with homogeneous backbone 
oligomers of Ala, Phe and Val. In building the homo-oligomers of a-peptides, both the 
L- and D-forms of Ala, Phe and Val were used. In building the homo-oligomers of (J- 
pcptidcs. the (R, Reconfiguration of ACHC and ACPC were used. The (R. R)- 
configuration of ACHC and ACPC and the D-form of the a-amino acids were used to 
build the heterogeneous backbone oligomers.
To determine what kind of conformation the oligomers had and to view any 
particular hydrogen bonding arrangement, a combination of Monte Carlo (MC) 
conformational search, energy minimization and dynamics were performed. 
Representative sequence of each of the homogeneous and heterogeneous backbone 
oligomers are shown in Figures 4.1 and 4.2.
Boc-[3-D-Ala-P-D-Ala-p-D-Ala-|V-D-Ala-t)-D-Ala-p-D-Ala-OBn 
Boc-ACHC-ACHC-ACHC-ACHC-ACHC-ACHC-OBn 
j Boc-ACPC-ACPC-ACPC-ACPC -ACPC-ACPC-OBn 
Homogeneous Oligomers





Figure 4.2 Heterogeneous oligomers.
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In each sequence, the N-terminus is protected by a fert-butyloxycarbonyl group (Boc) 
and the C-terminus by a benzyloxy group (OBn). Residues are numbered from the N- 
temnnus towards the C-terminus.
4.2 Methods
The starting models, for the oligomers of a-amino acids, were built using 
standard parameters for amino acid residues supplied with the INSIGHT II (MSI, San 
Diego) software package. For the oligomers of (5-amino acids, of which standard 
parameters are not supplied with the INSIGHT II software package, a short input/output 
program was written enabling the addition of such parameters into the Aminos library of 
INSIGHT II. With the (5-amino acid residues added, it was then possible to build 
homogeneous peptides containing (5-amino acids and heterogeneous peptides containing 
both a- and (5-amino acids. Preliminary energy minimization, first with 500 steps of 
steepest descent and then 1000 steps of conjugate gradient (CG), were performed to 
refine the starting models. Except in the case of the homogeneous backbone oligomers 
where both the /^-configuration and /.-configuration of a-amino acids were used for the 
modeling, all other oligomers contained a-amino acids in the ^-configuration. Because 
all the a-amino acid residues in the residue library are natural amino acids with L- 
configuration, the stereochemistry had to be inverted to ascertain that oligomers had the 
desired stereochemistry (all D). Similarly, the stereochemistry for the p-amino acid 
(ACHC) was maintained as (R,R). Due to the flexibility inherent in the oligomers, with 
many degrees of freedom it was desirable to carry out an extensive conformational search 
in order to locate the lowest energy conformation (global minimum).
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Because an extensive conformational search such as Monte Carlo (MC) can not 
be carried out in INSIGHT II, the models were exported to PC Spartan Pro 
(Wavefunction, Inc.) where the search was performed. MC Spartan conformer program 
was used to carry out the conformational search using the SYBYL72 force field and 
generating low energy conformations. Starting with an initial temperature of 5000K, the 
molecule is gradually cooled down until the conformational search is complete when the 
temperature stabilizes at 300K. MC conformational search was carried out in vacuo, as 
this is the only condition available in PC Spartan Pro. At the end of the conformational 
search, the low energy conformations were saved, and were opened on a spreadsheet 
permitting the conformations to be compared. All structures within 5.0 kcal/mol of the 
lowest energy conformation were further saved in a protein data bank (pdb) format. 
These structures were then exported back to Insight II where energy minimization and 
dynamics were performed.
Minimization and molecular dynamics (MD) simulations were performed on a 
Silicon Graphics workstation using the DISCOVER program (version 97.0, Molecular 
Simulations Inc.) using the Amber73 force field and the Consistent Valence force field 
(Cvff).74'76 In minimization, the Conjugate Gradient (CG) algorithm was used and the 
number of iterations were set to 10,000 with a derivative of 0.001. Cross term and 
Morse term were added with the Cvff force field, but not with the Amber force field. In 
performing MD, the structures were equilibrated at 100 steps for a total of 10,000 
iterations and the History file was written every 100 steps. All simulations were carried 
out at 300K with a time step of 1.0 fs. At the end of the MD simulations, a total of 102 
conformations were generated for each starting structure, and each of these
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conformations was examined for the H-bonding arrangement. Hydrogen bonding was 
assigned on the basis of the N-H- • -0 angle and the H- • -0 distance. In all cases 
examined, the N-H- • -O angle was close to linearity and the H- • -O distance was 
approximately 2 A. Calculations in INSIGHT II were carried out at dielectric constants 
of 1.00 and 32.63, the gaseous and methanol dielectrics respectively.
4.3 Results
Results are presented in the sections that follow, based on the type of oligomer 
and starting with simple homo-oligomers of a-amino acids. Results are classified based 
on the type of force field and dielectric constant.
4.3.1 Homo-Oligomers of Ala. Phe. Val
The a-amino acids, in both the D-configuration and L-configuration, were used to 
build oligomers in -INSIGHT II, and after minimization and dynamics the resulting 
structures were analyzed by comparing the hydrogen bonding patterns. It should be 
noted that except for the case of Phe, where a difference was observed in the H-bond 
pattern upon varying the configuration (D or L), no difference was observed in the 
hydrogen bonding pattern when either the D- or L-configuration of Ala and Val was used 
to build oligomers. Because the goal of this study was to model 3-amino acid oligomers, 
not much time was spent on analyzing the a-amino acid oligomers. Only one force field 
was used (Amber force field) and a dielectric of 1.00 was used in all calculations. For 
purposes of explaining the position of the H-bonds, the protective groups Boc and OBn 
were counted as residues making a total of 8 residues.
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For the oligomers of Ala (D- and /.-configurations), three 13-membered ring H- 
bonds were found between the following residues as shown below.
(Res 1) C=0----------H-N (Res 5)
(Res 2) C=0----------H-N (Res 6)
(Res 3) C=0----------H-N (Res 7)
Two different H-bonding patterns were observed in the oligomers of Phe 
depending on the configuration of Phe. In the hexamer containing the L-configuration of 
Phe, three H-bonds (all 13-membered rings) were observed as follows.
(Res 1) C=0----------H-N (Res 5)
(Res 2) C=0.............H-N (Res 6)
(Res 3) C=0----------H-N (Res 7)
In the hexamer containing the /^-configuration of Phe, two prominent H-bonds were 
observed as shown below. It should be noted that unlike in the other cases, where the H- 
bonds were regular in which case a fixed number of residues per H-bond were seen, here 
the number of residues per H-bond varied.
(Res 2) C=0--------- H-N (Res 4) 7-membered ring
(Res 3) C=0--------- H-N (Res 6) 10-membered ring
For the oligomers of Val (D- and /.-configurations), three 13-membered ring H- 
bonds were found between the following residues as shown below.
(Res 1) C=0-— ......H-N (Res 5)
(Res 2) C=0-— -— H-N (Res 6)
(Res 3) C-O...... - —H-N (Res 7)
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4.3.2 Homo-Oligomers of (3-Amino Acids
Homo-oligomers of (3-Ala, ACPC, and ACHC were modeled at dielectric 
constants of 1.00 and 32.63 using the Amber and Cvff force fields.
4.3.2.1 Boc-fB-AlaW-OBn at dielectric of 1.00
(i) Amber Force Field
In all the structures examined after MD, single intra-residue hydrogen bonded 
structures were common. Predominant intra-residue hydrogen bonds, 6-membered rings, 
were observed for residues 3, 4, 5, and 7. This is a rare occurrence in conventional 
peptides. Some inter-residue single hydrogen bonded structures were also observed 
either toward the C- or N-terminus. Among these, a prominence of 10-membered 
hydrogen bonded ring structure toward the N-terminus was observed. The other single 
hydrogen bonded structures contained 8-membered and 20-membered hydrogen bonded 
rings all towards the C-terminus.
(ii) Cvff Force Field
Here, more inter-residue hydrogen bonded structures were observed with only a 
few intra-residue hydrogen bonded structures. Hydrogen bonded structures observed 
include single, double and triple hydrogen bonded structures. Among the single 
hydrogen bonded structures, 8-membered ring structures towards the C-terminus, 10- and 
14-membered ring structures towards the N-terminus were observed. 8-membered and 
14-membered rings oriented towards the C- and N-terminus respectively dominated the 
2-hydrogen bonded structures observed. The 3-hydrogen bonded structures included 6- 
and 10-membered rings towards the N-terminus and an 8-membered ring towards the C- 
terminus.
roduced with permission of the copyright owner. Further reproduction prohibited without permission.
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4.3.2.2 Boc-(B-AlaWOBn at dielectric of 32,63
(i) Amber Force Field
Only a few H-bonded structures were observed and all were 1-hydrogen bonded 
structures with some intra-residue hydrogen bonded structures. The 1-hydrogen bonded 
structures observed included 8-membered and 16-membered rings towards the C- 
terminus and 26-membered ring towards the N-terminus.
(ii) Cvff Force Field
Only a few hydrogen-bonded structures were observed, and all were single 
hydrogen bonded structures. No intra-residue hydrogen bonded structures were 
observed. Among the single hydrogen bonded structures, the most prominent was an 18- 
membered ring structure between residues 3 and 6, and this hydrogen bond was oriented 
towards the N-terminus. Others included 10-, 14- and 22-membered rings all towards the 
N-terminus.
4.3.2.3 Boc-(ACPCyOBn at dielectric of 1.00 
(i) Amber Force Field
Hydrogen bonded structures observed ranged from single to multiple hydrogen 
bonded structures with no intra-residue hydrogen bonded structures. All the single 
hydrogen bonded structures were 8-membered ring structures oriented towards the C- 
terminus. Among the 2-hydrogen bonded structures, the most common was 8-membered 
ring between residues 1 and 3 and then 3 and 5 all towards the C-terminus. Among the 3- 
hydrogen bonded structures, two prominent hydrogen-bonding arrangements were 
observed. In one case, it involved all 8-membered ring structures oriented towards the C- 
terminus between residues (1,3), (2,4), and (3,5). The other included two 8-membered
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rings and a 12-membered ring all oriented towards the C-terminus between the following 
residues, (2,4), (3,5), and (3,6). In the case of the 4-hydrogen bonded structures, the most 
prominent structure was observed between the following residues, (1,3), (2,4), (3,5), and 
(5,7) and involved all 8-membered rings towards the C-terminus. A 5-hydrogen bonded 
structure was also observed and contained all 8-membered rings towards the C-terminus, 
between the following residues, (1,3), (2,4), (3,5), (4,6), and (5,7).
(ii) Cvff Force Field
Hydrogen bonded structures observed ranged from only one to four hydrogen 
bonded structures with no intra-residue hydrogen bonded structures noticed. Single 
hydrogen bonded structures included 8-, 12-, and 16-membered ring structures all 
towards the C-terminus and 14-membered ring towards the N-terminus. The 2-hydrogen 
bonded structures observed involved 8-, 12- or 16-membered ring all towards the C- 
terminus. The most common involved all 12-membered rings between residues (1,4) and
(2.5) . The 3-hydrogen bonded structures also involved 8-, 12-, 16-membered rings 
oriented towards the C-terminus. The most common and prominent around a particular 
region being an all 12-membered ring structure between the following residues, (1,4),
(2.5) , and (3,6). The 4-hydrogen bonded structures included 8- and 12-membered ring 
hydrogen bonds oriented towards the C-terminus. The most prominent structure involved 
12-membered ring hydrogen bonds between residues (1,4), and (2,5) and 8-membered 
ring hydrogen bonds between residues (4,6), and (5,7).
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4.3.2.4 Boc-(ACPCyOBn at dielectric of 32.63
(i) Amber Force Field
Hydrogen bonded structures were rarely observed. Only a total of twelve 
hydrogen bonded structures, from the hundred and two structures examined after 
molecular dynamics, were observed. For the 1-hydrogen bonded structures, 8-, 18-, and 
22-membered ring hydrogen bonds were observed with the 8-membered ring oriented 
towards the C-terminus and the 18- and 22-membered rings towards the N-terminus. The 
18-membered ring structure was the most common. Also observed were 2-hydrogen 
bonded structures, one of which involved all 8-membered rings oriented towards the C- 
terminus and the other a 14-membered ring and a 22-membered ring oriented towards the 
N-terminus.
(ii) Cvff Force Field
A total of only eleven hydrogen-bonded structures were observed and all were 1- 
hydrogen bonded structures. All these 1-hydrogen bonded structures were 8-membered 
ring hydrogen bonded structures oriented towards the C-terminus.
4.3.2.5 Boc-fACHCV'-OBn at dielectric of 1.00 
(i) Amber Force Field
Hydrogen bonded structures observed ranged from 1-, 2- and 3-hydrogen bonded 
structures oriented either towards the C- or N-terminus. The 1-hydrogen bonded 
structures observed were either 8-membered, 10-membered or 16-membered ring 
hydrogen bonded structures. Both the 8- and 16-membered ring hydrogen bonded 
structures were oriented towards the C-terminus, while the 10-membered ring structure 
was oriented towards the N-terminus. The 10-membered ring 1-hydrogen bonded
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structures were more common. The 2-hydrogen bonded structures contained a 
combination involving any two of the following, 6-, 8-, 10-, 12-, or 16-membered ring 
hydrogen bonded structures. The most common structure contained an 8-membered ring 
oriented towards the C-terminus and a 10-membered ring oriented towards the N- 
terminus. In the case of the 3-hydrogen bonded structures examined, a combination 
involving any three of the following, 6-, 8-, 10-, 16-, and 18-membered ring hydrogen 
bonded structures was observed. The most common structure contained an 8-membered 
ring and a 16-membered ring both oriented towards the C-terminus, and a 10-membered 
ring oriented towards the N-terminus.
(ii) Cvff Force Field
Structures observed ranged from 1- to 4-hydrogen bonded structures with no 
intra-residue hydrogen bonds evident. The 1-hydrogen bonded structures observed 
contained 10-, 16- or 18-membered ring oriented towards the C- or N-terminus. The 
most common structure was an 18-membered ring hydrogen bonded structure. Among 
the 2-hydrogen bonded structures, the most common contained a 10-membered ring 
oriented towards the N-terminus and a 16-membered ring oriented towards the C- 
terminus. The 3-hydrogen bonded structures observed contained a combination of any 
three of the following, 8-, 10-, 16- or 18-membered ring oriented either towards the C- 
terminus or N-terminus. The most common 3-hydrogen bonded structure contained a 10- 
and 18-membered ring both oriented towards the N-terminus and a 16-membered ring 
oriented towards the C-terminus. A 4-hydrogen bonded structure was observed 
containing two 10-membered rings, an 18-membered ring all oriented towards the N- 
terminus and a 16-membered ring oriented towards the C-terminus.
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4.3.2.6 Boc-(ACHCV,-OBn at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, 1-, 2-, and 3-hydrogen bonded structures were 
observed with the 1-hydrogen bonded structures being more common. The hydrogen 
bonds were oriented either towards the C- or N-terminus. The 1-hydrogen bonded 
structures contained 10-, 16- or 18-membered ring hydrogen bonds with the 10- 
membered ring, oriented towards the N-terminus, being the most common. The 2- 
hydrogen bonded structures observed contained a combination of two of the following, 
10-, 16-, 18-, 20-membered ring. The most common structure contained a 10-membered 
ring oriented towards the N-terminus and a 16-membered ring oriented towards the C- 
terminus. A 3-hydrogen bonded structure was also observed containing two 10- 
membered rings oriented towards the N-terminus and a 16-membered ring oriented 
towards the C-terminus. A few intra-residue hydrogen bonds were also observed but 
nothing really significant.
(ii) Cvff Force Field
Only a few hydrogen-bonded structures, a total of seven were observed with no 
intra-residue hydrogen bonds. Most of the structures were 1-hydrogen bonded structures 
containing either 10- or 16-membered ring hydrogen bonds. Of these, the 10-membered 
ring hydrogen bonded structures were the most prominent and were oriented towards the 
N-terminus while the 16-membered H-bonded structures were oriented towards the C- 
terminus. A 2-hydrogen bonded structure was observed containing a 10-membered ring 
hydrogen bond oriented towards the N-terminus and a 16-membered ring hydrogen bond 
oriented towards the C-terminus.
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4.3.3 Heterogeneous Backbone Oligomers
Heterogeneous backbone oligomers were also modeled at the dielectric constants 
of vacuum and methanol at two different force fields. Results are presented for both the 
Amber and Cvff force fields.
4.3.3.1 Hexamer of Phe and ACHC at dielectric of 1.00
(i) Amber Force Field
Upon examination of all the structures obtained after molecular dynamics, 1-, 2-, 
3- and 4-hydrogen bonded structures were observed. The 1-hydrogen bonded structures 
were all oriented towards the C-terminus and all contained 7-membered hydrogen bonded 
rings. Some intra-residue hydrogen bonds were observed. The 2-hydrogen bonded 
structures observed were all oriented towards the C-terminus and contained 7-membered 
ring hydrogen bonds. All 3-hydrogen bonded structures observed were oriented towards 
the C-terminus and contained 7-membered ring hydrogen bonds. The most common 
structure contained hydrogen bonds formed between the following residues, (1,3), (3,5), 
and (5,7). A 4-hydrogen bonded structure was also observed between the following 
residues, (1,3), (2,4), (3,5), (5,7) and all hydrogen bonds were oriented towards the C- 
terminus. Three of these hydrogen bonds contained 7-membered rings while one 
contained an 8-membered ring.
(ii) Cvff Force Field
Structures containing 1-, 2- and 3-hydrogen bonds were observed. The 1- 
hydrogen bonded structures either contained 7-membered ring hydrogen bonds or 8- 
membered ring hydrogen bonds all oriented towards the C-terminus. The 7-membered 
ring hydrogen bond structure is more common. The 2-hydrogen bonded structures
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contained a combination of two of the following; 7- and 8-membered ring hydrogen 
bonds. The most common structure contained two 7-membered ring hydrogen bonds. 
The most common 3-hydrogen bonded structure observed contained hydrogen bonds 
formed between the following residues, (1,3), (3,5), and (5,7).
4.3.3.2 Hexamer of Phe and ACHC at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, 1-, 2-, 3- and 4-hydrogen bonded structures were 
observed. Hydrogen bonds were either oriented towards the C- or N-terminus. Among 
the 1-hydrogen bonded structures, a 7-membered ring oriented towards the C-terminus 
was the most common. The 2-hydrogen bonded structures were dominated by a structure 
having a 7-membered ring hydrogen bond oriented towards the C-terminus and a 16- 
membered ring hydrogen bond towards the N-terminus. The 3-hydrogen bonded 
structures were dominated by a structure having 9- and 16-membered ring hydrogen 
bonds oriented towards the N-terminus and 7-membered ring oriented towards the C- 
terminus. A 4-hydrogen bonded structure was observed containing two 7-membered 
hydrogen bonded rings oriented towards the C-terminus, a 9-membered ring and 16- 
membered ring hydrogen bonds oriented towards the N-terminus.
(ii) Cvff Force Field
Most of the structures observed in this case were 1-hydrogen bonded structures 
with a few 2-hydrogen bonded structures. All structures were oriented towards the C- 
terminus. The 1-hydrogen bonded structures include 7-, 8- and 11-membered ring 
hydrogen bonds with the 7-membered ring being the most common. All 2-hydrogen 
bonded structures observed contained 7-membered ring hydrogen bonds.
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4.3.3.3 Hexamer of Ala and ACHC at dielectric of 1.00
(i) Amber Force Field
Upon examination of all the structures obtained after molecular dynamics, 1-, 2-, 
3-, 4- and 5-hydrogen bonded structures were observed. The 1-hydrogen bonded 
structures were all oriented towards the N-terminus and all contained 13-membered 
hydrogen bonded rings. Some intra-residue hydrogen bonds were observed. The 2- 
hydrogen bonded structures observed were oriented either towards the C-terminus or the 
N-terminus with the most common containing 7-membered ring hydrogen bonds and 11- 
membered ring hydrogen bonds both towards the C-terminus. Among the 3-hydrogen 
bonded structures observed the most common contained two 7-membered hydrogen 
bonds and an 11-membered hydrogen bond all oriented towards the C-terminus. The 
most common 4-hydrogen bonded structure was observed between the following 
residues, (1,3), (1,4), (3,5), (5,7) and all hydrogen bonds were oriented towards the C- 
terminus. Three of these hydrogen bonds contained 7-membered rings while one 
contained an 11-membered ring. A 5-hydrogen bonded structure was observed between 
the following residues, (1,3), (1,4), (3,5), (3,6), and (5,7) all of which were oriented 
towards the C-terminus. Three of these structures contained 7-membered ring hydrogen 
bonds and two contained 11-membered ring hydrogen bond.
(ii) Cvff Force Field
Only 1-hydrogen bonded structures were observed and all were oriented towards 
the N-terminus. The most common of these structures contained a 9-membered ring 
hydrogen bond between residues 6 and 7.
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4.3.3.4 Hexamer of Phe and ACHC at dielectric of 32.63
(i) Amber Force Field
Among the structures examined, mostly 1-hydrogen bonded structures were 
observed with some 2- and 3-hydrogen bonded structures. Hydrogen bonds were either 
oriented towards the C- or N-terminus. Among the 1-hydrogen bonded structures, a 16- 
membered ring oriented towards the N-terminus was the most common. The 2-hydrogen 
bonded structures were dominated by a structure having a 7-membered ring hydrogen 
bond oriented towards the C-terminus and a 16-membered ring hydrogen bond towards 
the N-terminus. Two 3-hydrogen bonded structures were observed. One of these 
structures had 7- and 11-membered ring hydrogen bonds oriented towards the C-terminus 
and a 6-membered ring hydrogen bond towards the N-terminus. The other 3-hydrogen 
bonded structure had 6- and 16-membered ring hydrogen bonds oriented towards the N- 
terminus and an 8-membered ring towards the C-terminus.
(ii) Cvff Force Field
Only 1-hydrogen bonded structures were observed and all were oriented towards 
the N-terminus. These structures were either a 9-membered ring hydrogen bonded 
structure or a 12-membered ring hydrogen bonded structure.
4.3.3.5 Hexamer of Val and ACHC at dielectric of 1.00 
(ii) Amber Force Field
Analysis of all the structures obtained after molecular dynamics showed the 
presence of 1-, 2-, and 3-hydrogen bonded structures. The 1-hydrogen bonded structures 
were all oriented towards the C-terminus and all contained either 7-, or 8-membered ring 
hydrogen bonds. Some intra-residue hydrogen bonds were observed. The 2-hydrogen
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bonded structures observed were oriented either towards the C-terminus or the N- 
terminus with the most common containing 7-membered ring hydrogen bonds and 8- 
membered ring hydrogen bonds both towards the C-terminus. Among the 3-hydrogen 
bonded structures observed, the most common contained two 7-membered hydrogen 
bonds and an 8-membered hydrogen bond all oriented towards the C-terminus.
(ii) Cvff Force Field
Structures containing 1-, 2- and 3-hydrogen bonds were observed. The hydrogen 
bonded structures were either oriented towards the C-terminus or N-terminus. Among 
the 1-hydrogen bonded structures, a structure containing a 21-membered ring hydrogen 
bond was most common. This was observed between the carbonyl oxygen of residue one 
and the hydrogen of residue seven. Other 1-hydrogen bonded structures observed 
contained 8-, 9-, 11- or 18-membered ring. The most common 2-hydrogen bonded 
structure observed contained a 9-membered ring towards the N-terminus and a 21- 
membered ring towards the C-terminus. Only one 3-hydrogen bonded structure was 
observed and this contained a 9- and an 11-membered ring hydrogen bond towards the N- 
terminus and a 21-membered ring hydrogen bond towards the C-terminus.
4.3.3.6 Hexamer of Val and ACHC at dielectric of 32.63 
(i) Amber Force Field
Among the structures examined, mostly 1-hydrogen bonded structures were 
noticed with a few 2-hydrogen bonded structures. Hydrogen bonds were either oriented 
towards the C- or N-terminus. Among the 1-hydrogen bonded structures, a 7-membered 
ring oriented towards the C-terminus was the most common. The 2-hydrogen bonded
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structures were dominated by 7-and 8-membered ring hydrogen bond structures oriented 
towards the C-terminus 
(ii) Cvff Force Field
Only 1-hydrogen bonded structures were observed and all were oriented towards 
the C-terminus. These structures contained either 7-, 8- or 21-membered ring hydrogen 
bonds.
4.4 Discussion
The attempt at using molecular modeling in predicting the structure of 
homogeneous and heterogeneous peptides has not been successful. The method is based 
on predicting structure using the hydrogen-bonding pattern. The hydrogen-bonding 
pattern, from experiment, for the homogeneous peptides of ACHC and ACPC was used 
as a reference to validate the molecular modeling method. Several factors may be 
responsible for the failure of this method such as the nature of the force field, the 
dielectric constant and the lack of structural NMR parameters. Structural NMR 
parameters such as interproton distances from NOE or hydrogen bonds from temperature 
coefficients can only be obtained from experiments. However, because the 
heterogeneous peptides, for which our interest in this study is geared towards, do not 
have any experimental data available we could not rely on constraints. Also the force 
fields available in Insight II, Amber and Cvff, have been parameterized for natural amino 
acids (a-amino acid) and when these force fields are used to model |3-amino acid 
containing peptides, provision is not made to account for the introduction of additional 
atoms. The use of a force field specifically design for P-amino acids may be necessary. 
To determine the presence or absence of ordered secondary structure in solution, it may
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be necessary to perform molecular dynamics using solvent conditions that may best 
represent experimental conditions. A closer look at all the structures obtained after 
molecular dynamics shows that for the most part there is no regular pattern of hydrogen 
bond arrangement.
4.5 Summary
The goal of this study was to carry out basic modeling that might allow a 
qualitative prediction of ordered oligomer conformations based on the hydrogen bonding 
tendencies. The modeling method, however, was not successful as it was not able to 
reproduce experimental results. Some potential explanations can be given for the failure. 
Firstly, the method was carried out with no inclusion of solvent conditions which is not a 
good representation of experimental conditions. Secondly, the force fields used, Amber 
and Cvff incorporated in Insight II, have not been parameterized for p-amino acids. In 
addition, no constraints were applied to make sure the residues in each oligomer were at 
the right conformations (lowest energy conformations). A more systematic approach will 
be to start from a dipeptide model and then by a combination of molecular mechanics and 
quantum mechanics method, the geometry can be optimized and energy evaluated. A 
more thorough conformational search can be performed using MacroModel. 7 7  The effect 
of solvent on relative stabilities of various conformers can also be approximated using the 
GB/SA solvation model7 8  available in MacroModel. There is still prospect therefore, in 
the use of molecular modeling in predicting structures of heterogeneous oligomers if the 
right force field and right computer package is used.
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CHAPTER 5
COMPUTER SIMULATION OF LINKERS BETWEEN a- AND (3-PEPTIDE HELICES
5.1 Background and Significance
Fos and Jun are products of the nuclear oncogenes that are known to bind to DNA
79 80and modulate transcription through the formation of heterodimers. ' The structural 
feature common in these proteins that is important for heterodimer formation is the 
presence of the leucine zipper region. The leucine zipper region is defined as the region 
containing five leucine residues in which any two adjacent leucine residues are separated 
by six residues. 81 Jun proteins can both homodimerize and heterodimerize with Fos 
proteins, while Fos proteins do not homodimerize but require heterodimer formation to 
bind DNA. 8 0
Both Fos and Jun family proteins serve as dimeric transcription factors that bind 
to AP-1 transcription response elements of a variety of mammalian genes. 8 0  The cellular 
transcription factor Jun usually exists as a homodimer which moderately activates the 
AP-1 transcription response element (left, Figure 5.1). The Fos oncoprotein, when over 
expressed, leads to cancer by heterodimerizing with Jun and over activating AP-1 (center, 
Figure 5.1) . 8 0  Blocking this leucine zipper interaction with a synthetic oligomer (right. 
Figure 5.1) could have wide-ranging biomedical applications. Synthetic (3-peptides, 
possessing numerous biological activities, 1 8 ' 2 2  have been reported in the literature. They 
also adopt stable secondary structures at lengths much shorter than do a-peptides.
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Normal Cancer Putative
(Low Fos) (High Fos) Intervention
Figure 5.1 Model for the interaction of Fos and Jun dimers with DNA.
In particular, oligomers of /ram-2-aminocyclopentanecarboxylic acid (ACPC) or trans-2- 
aminocyclohexanecarboxylic acid (ACHC) adopt distinct helical structures in the solid
8 9and solution states. ’
To systematically explore the structure-activity relationship of (3-peptide 
sequences binding to Fos or Jun, it would be desirable to link helical (3-peptide segments 
to an a-peptide biasing element. Chimerae of a- and (3-peptides, however, are largely 
unexplored; the basic question of how such a linkage should be constructed has, to my 
knowledge, not been addressed in theory or practice.
Figure 5.2 Structures of amino acid residues and representative structures of a- and (3- 
peptides.
roduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Herein, theoretical studies of such chimerae with the a- and P-peptide helices 
linked by the flexible amino acids glycine (Gly) or P-alanine (P-Ala) (Figure 5.2) are 
described. P-Peptides, constituting of the cyclic amino acid ACPC (Figure 5.2) residues, 
were used in the studies. The two end moieties of the linkers, N- and C-terminus, should 
provide hydrogen bonding groups that serve to continue the helical conformation of the 
individual modules.
5.1.1 Study Goal and Objectives
In performing computational simulations on the flexible linkers, it is important to 
understand how, in a chimera of a- and p-peptide helices, various linkers constrain the 
spatial relationship between the segments. In this light, the objectives were defined: (a) 
determine low-energy conformations for chimeric peptides linked by Gly or P-Ala; (b) 
determine, for each system, whether conformations where the helices are roughly 
collinear (“unkinked” conformations) are particularly favored or disfavored; (c) estimate 
how much enthalpic strain is required to “unkink” each chimeric peptide; (d) estimate, as 
an entropic measure, the flexibility or rigidity of the low energy and “unkinked” 
conformations.
5.2 Methods
All computations were performed on a Silicon Graphics Octane workstation using 
the molecular modeling package Insight®II (Accelrys, San Diego, CA). Conformational 
searches and energy minimizations were done using the DISCOVER module with the 
AMBER force field. 7 3  A dielectric constant of 1.0 was assumed in all calculations.
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5.2.1 Atomic Models
The a- and p-peptide helical segment models were derived from crystal structures 
of the Fos/Jun complex (RCSB Protein Data Bank, structure 1A02, residues 167-192 of 
Fos and 285-310 of Jun) and the previously published ACPC oligomer crystal structure. 8 
In the original crystal structure of Fos, residue number 175 was modified from glutamate 
to Lysine (E to K), while residue number 310 in the original crystal structure of Jun was 
modified from methionine to alanine (M to A). The sequence of the helical modules of 
Fos and Jun are shown in Figure 5.3. The p-Ala linker was constructed by addition of 
one methylene to a Gly residue (Figure 5.2).
Fos = E T D Q L E D K K S A L Q T E I A N L L K E K E K
167 192
Jun = R I A R L E E K V K T L K A Q N S E L A S T A N A  
285 310
Figure 5.3 Sequence of Fos and Jun helical modules.
5.2.2 Conformational Search
The conformational space was mapped by calculating the conformational energy 
at 36° intervals for the torsion angles <j), \|/ of Gly and P-Ala. The co angles were fixed at 
180°. For the Gly linker, conformational search at 36° increments for the two dihedral 
angles (p and\)/ translates to calculation of 100 structures. For the P-Ala, a systematic 
conformational search with 36° increments for the three dihedral angles <J), 0, and \)/ 
would mean the calculation of 1,000 structures. This is impractical since each structure 
has to be visualized for the presence or absence of kinks. Therefore, instead of exploring 
the whole potential energy surface, energy maps were computed for the P-Ala linker at
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five 0 angles: 180°, -60°, 60°, -120°, 120° . 8 2  This selection of angles is supported by the 
average 0 angles found in the literature for (3-Ala residues. 8 3 ' 8 5
5.2.3 Energy minimization
Minimum-energy conformations were obtained in the low-energy regions of the 
conformational search (torsional drive). Each energy minimization consisted of 1,000 
steps of steepest descent followed by 1 , 0 0 0  steps of conjugate gradient minimization. 
Conformational energies are expressed as AE  = E  -  E0 with E0 being the energy of the 
most stable conformation.
5.2.4 Data Processing
Filled contour plots were generated using SigmaPlot 2000 (SPSS, Chicago, IL). 
Data were truncated at 0 kcal/mol to avoid graphing errors arising from extremely high 
values when the peptide segments overlapped. Color scaling on the figures was adjusted 
so that the red-blue range would be 1 2  kcal/mol, with blue being the global energy 
minimum for the molecule. This method sacrifices information on barrier heights in 
order to present more detailed depictions of energy wells. Unkinked conformations are 
shown as white dots.
5.3 Glycine Linker
The energies of the low-energy conformations from the rigid rotor maps for Gly 
linker between Fos and ACPC are shown in Table 5.1, while the energies of the low- 
energy conformations for Gly between Jun and ACPC are given in Table 5.2. Rigid rotor 
(cj), y) maps for Gly linker between Fos and ACPC and between Jun and ACPC are 
shown in Figures 5.4 and 5.5 respectively, with the dots indicating unkinked 
conformations.
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Table 5.1 Low Energy Conformations for Gly Linker between Fos and ACPC.
V(°) AE  (kcal/mol)
36 -36 0 . 0 0
36 -72 0.43




Table 5.2 Low Energy Conformations for Gly Linker between Jun and ACPC.
<t>(°) V(°) AE  (kcal/mol)






5.3,1 Glv Linker between Fos and ACPC
The lowest minimum energy conformation corresponds to a structure with <j) and 
V values of 36° and -36° respectively (Table 5.1). Other low energy conformations were
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within a reasonable and close energy range from the lowest energy conformation and 
might be accessible. The Ramachandran plot shows a single, broad energy minimum 
around <() = 36°, i|/ = -36°. No unkinked conformations were observed for this linker
(Figure 5.4).
Fos Glycine Linker
- 1 8 0  
1 4 4  
1 0 8
7 2  
3 6
5- 0
- 3 6  
- 7 2  
- 1 0 8  
- 1 4 4  
- 1 8 0
- 1 8 0  - 1 4 4  - 1 0 8  - 7 2  - 3 6  0  3 6  7 2  1 0 8  1 4 4  - 1 8 0
<i>
Figure 5.4 Rigid rotor map for Gly between Fos and ACPC.
5.3.2 Glv Linker between Jun and ACPC
Again there is a single broad energy minimum around <(> = 36°, = -36° (Table
5 .2 ) ,  although here the potential well is even shallower (Figure 5 .5 ) .  Other low energy 
conformations are much closer in energy to the lowest energy conformation than was 
observed for Fos and ACPC (Tables 5.1 and 5.2). Several unkinked conformations 
([<t>> My] = [36°, 0°]; [-180°, 0°]; [-180°, 36°]), have strain energy of less than 2 kcal
R e l a t i v e
E n e r g y
( k c a l / m o l )
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compared to the lowest energy conformation (Figure 5.5). Unkinked conformations at 
(<)>, i)/) values of (0°, -108°) and (108°, -36°) have strain energy of more than at least 4 
kcal compared to the lowest energy conformation (Figure 5.5).
Jun Glycine Linker
- 1 8 0  
1 4 4  
1 0 8  
7 2  
3 6
3- 0
- 3 6  
- 7 2  
- 1 0 8  
- 1 4 4  
- 1 8 0
- 1 8 0  - 1 4 4  - 1 0 8  - 7 2  - 3 6  0  3 6  7 2  1 0 8  1 4 4  - 1 8 0
<t>
Figure 5.5 Rigid rotor map for Gly between Jun and ACPC.
5.4 p*Alanine Linker
The energies of the low energy conformations from the rigid rotor maps for P-Ala 
linker between Fos and ACPC and between Jun and ACPC are shown in Tables 5.3 and
5.4 respectively. Rigid rotor (<J), i|/) maps for 0 angles of 180°, 120°, -120°, 60°, and -60° 
for p-Ala linker between Fos and ACPC are shown in Figure 5.6 with the dots 
representing unkinked conformations. Rigid rotor (<|), vj/) maps for 0 angles of 180°, 120°,
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-120°, 60°, and -60° for (3-Ala linker between Jun and ACPC are shown in Figure 5.7, 
again with the dots representing unkinked conformations.
Table 5.3 Low Energy Conformations for [3-Ala Linker between Fos and ACPC.
<t>(°) 0  (°) V(°) AE  (kcal/mol)
36 60 -72 0 . 0 0
0 60 -72 1.49
72 -60 0 1.72
72 180 72 6.49
-36 1 2 0 -72 6.52
72 - 1 2 0 72 7.42
5.4.1 B-Ala Linker between FOS and ACPC 
The lowest energy conformation occurs at 0 = 60° for <)) = 36° and \j/ = -72° 
(Table 5.3). The difference in energy between 0 = 60°, <j) = 72°, \j/ = 0° and 0 = 60°, <|) = 
0°, y  = -72° is not great but moving to 0 = 180°, 120°, and -120°, there is a big jump in 
energy making these conformations less favorable compared to the lowest energy 
conformation (Table 5.3). Examination of the truncated rigid rotor maps shows that 
among the conformations studied, the Fos chimera has three narrow energy wells, at (<j>, 
0, V|r) = (-72°, 60°, -72°); (-72°, 60°, 36°); (36°, 60°, -72°); and (72°, -60°, 72°) (Figure 
5 .6 ) .  M o s t  o f  th e  u n k in k e d  c o n f o r m a t io n s  h a v e  e n t h a lp y  a t l e a s t  8  k c a l /m o l  a b o v e  t h e s e  
minima. The lowest energy unkinked conformations occur at 0 = 60°, <() = -180° and \\i = 
0°, 36°, 72° or 144° (Figure 5.6). AE  for this set of unkinked conformations is 6  kcal,
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and these conformations seem to be at the edge of a broad shelf of low energy connecting




























-180-144-108-72 -36 0 36 72 108 144 180
4>
F O S _ A C P C  0 = 6 0
-180-144-108-72 -36 0 36 72 108 144 180
4>


















Figure 5.6 Rigid rotor maps for p-Ala linker between Fos and ACPC with 0 = 180°, 120°,
- 1 2 0 °, 60°, and -60°.
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Thus, these conformations represent the best possibility for an accessible unkinked 
conformation for (ACPC)s-p-Ala-Fos.
5.4.2 p-Ala Linker between Jun and ACPC 
The lowest minimum energy conformation corresponds to a structure with 0 = 
60°, <J) = 144° and \j/= -108° (Table 5.4). A relatively smaller energy difference exist 
between the conformation at 0  = 60°, <j) = -180°, \|f = -108° and the lowest energy 
conformation (Table 5.4). However at 0 values of -60°, 180°, 120°, and -120° there is 
greater energy difference between the conformations and the lowest energy conformation 
(Table 5.4).
Table 5.4 Low Energy Conformations for P-Ala Linker between Jun and ACPC.
<M°) e n V(°) AE (kcal/mol)
144 60 -108 0 . 0 0
-180 60 -108 1.03
-144 -60 -36 2.37
144 180 72 4.09
-72 1 2 0 -72 5.04
108 - 1 2 0 72 5.09
The truncated energy maps for (ACPQs-P-Ala-Jun show two relatively narrow 
p o t e n t ia l  w e l l s ,  a t (<)>, 0 ,  y )  = (144°, 60°, -108°) and (-144°, -60°, -12 °) ( F ig u r e  5 .7 ) .  
Several other unkinked conformations exist at 0  values of 180°, 120°, -120°, and -60°, 
but AE > 8  kcal/mol for all of these (and, in most cases, AE »  12 kcal/mol).
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G = 180 0 =  120
-180-144-108-72 -36 0  36 72 108 144-180
♦
0 =  -120

































Figure 5.7 Rigid rotor maps for (3-Ala linker between Jun and ACPC with 0 = 180°, 120°, 
- 1 2 0 °, 60°, and -60°.
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The energy well at 0 = 60° seems to have greater conformational freedom for the <J> angle 
than the \|/angle, but the high-energy area at 0  = 180° appears to be defined by the 
<|) angle (Figure 5.7). A single unkinked conformation at <}> = -108°, 0 = 60°, = -108°
(Figure 5.7) has relatively low AE  of 5 kcal/mol; this is the most promising unkinked 
conformation for this sequence.
5.5 Comparing Linkers
The energy wells for the Gly linker are, surprisingly, much broader than those for 
the p-Ala linker. Perhaps the P-Ala linker’s greater torsional freedom allows it to adopt a 
wider variety of conformations, permitting it to find isolated low-energy pockets that are 
inaccessible with only two free-rotating bonds.
This flexibility of the P-Ala linker, on the other hand, seems to work against the 
goal of favoring unkinked conformations. Because specific low-energy conformations 
are available to the p-Ala-linked chimerae and not to the Gly-linked chimerae, the 
enthalpic strain required to force the p-Ala-linked structures into an unkinked 
conformation is significantly greater. At least 5-6 kcal/mol worth of binding interactions 
appear necessary to counterbalance the less favorable linker conformation for these 
chimerae. On the other hand, the Gly-linked Jun chimera has several unkinked 
conformations which would require less than 2  kcal/mol of binding energy to overcome 
linker-derived strain.
roduced with permission of the copyright owner. Further reproduction prohibited without permission.
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5.6 Summary
Although attempt at locating low energy conformations of two linked peptides, el­
and (3-helices, in which the helical axis is continuous without kinks, has not been 
completely successful, some interesting conclusions can be made. Whereas linkage with 
glycine produces the broad energy wells seen in a typical Ramachandran plot for Gly, 
linkage with (3-Ala gives narrow and deep energy minima. The (3-Ala energy wells seem 
to leave more conformational freedom for the \j/ angle than the <J) angle. Although some 
promising unkinked conformations were seen, for the most part these flexible linkers 
favor conformations in which the helices are not aligned to allow tandem binding to a 
common a-helical target. Under these conditions, at least for Jun, the glycine linker 
appears superior to the (3-Ala linker. A possible solution could be to further control the 
linker conformation by strategic substitution at the a- and/or p-carbons.
Possible future direction of this project may involve generating control 
Ramachandran plots of linkers by themselves, and then determine the effect of the helical 
segments on linker conformation. The simulations can be carried out at higher dielectric 
constant, incorporating solvent conditions. The simulations can also be repeated at finer 
resolution, such as 5° intervals, although this will mean dealing with thousands of 
structures, which may be cumbersome. Another possibility will be to repeat the 
simulations by interchanging the a- and P-peptide segments. The simulations can be 
repeated with P-peptide segments made from ACHC or with P-substituted P-amino acids 
(P-homoamino acids). Lastly, the simulations may be carried out with substituted linkers.
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APPENDIX A (Part One)
SELECTED 'H NMR, COSY AND UV SPECTRA
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Figure 15A 500 MHz COSY spectrum of Bis-adduct 4-7 in CDC13.
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APPENDIX B (Part Two) 
SELECTED *H AND 13C NMR SPECTRA
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